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Murine atypical chemokine receptor 4, ACKR4, which binds to chemokines CCL19, 
CCL21 and CCL25, is expressed specifically in germinal centre (GC) B cells and in a 
layer of stromal cells surrounding the splenic marginal zone. Although ACKR4 is 
unable to signal as classical GPCRs, it creates gradients of its ligands.  
It is shown here that ACKR4 deficiency in the stroma causes infiltration of naïve B cells 
into the GC area. ACKR4 deficiency in the B cells causes dysregulation of the 
intragerminal centre distribution, with enlarged light zones and reduced dark zones 
when compared to ACKR4-competent mice. This skewed GC distribution is caused by 
the inability of ACKR4-deficient B cells to downregulate c-Myc, as they receive 
increased signalling though the CCR7- p-Akt - c-Myc signalling pathway.  
Moreover, ACKR4-deficient mice contain elevated numbers of memory B cells (MBC) 
in the distant lymphoid organs. MBCs are retained in the draining lymph node (drLN) 
by the presence of a CCL19/21 gradient towards the subcapsular sinus (SCS). When 
this gradient is absent, as occurs in ACKR4-deficient mice, MBCs escape the drLN 
easier through the SCS and appear in other sites in elevated numbers.  
Together, this shows a new role for ACKR4 in the GC response and in the migration of 
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Chapter 1. Introduction 
1.1. Overview: The B lymphocyte 
The immune system has developed to protect the host against pathogenic microbes and 
also to eliminate harmful or allergenic substances. There are two players: the innate 
immune response and the adaptive immune response. The innate immune response 
constitutes the first and more rapid response from the host. The adaptive immune 
response follows the innate response and has specificity for the antigens. Antigen-
specific receptors are expressed in the surface of B and T lymphocytes. 
B cell antigen-specific receptors are encoded by genes that are assembled by somatic 
rearrangements of germ-line gene elements to form immunoglobulin receptors. B cells 
are characterised by expression of surface bound immunoglobulins (antibody). In mice, 
B cells constitute 15% of peripheral leukocytes in blood and home to the peripheral 
lymphoid organs. In response to antigens, with or without the help of T lymphocytes, 
antigen-specific B cells undergo clonal expansion and differentiate into other types of B 
cells such as plasmablasts, plasma cells, germinal centre B cells or memory B cells, 
depending on the signals they receive. 
Germinal centres (GCs) are the hallmark of T-dependent responses and constitute a 
place where B cell proliferation, hypermutation, class-switch recombination and 
selection take place. GC B cells can further differentiate into plasma cells, which 




The signals that cause the post-GC differentiation are far from being fully understood. 
In this thesis, I aim to elucidate the role of atypical chemokine receptor 4, which is 
specifically expressed in GC B cells, in this process.  
 
1.2 Secondary lymphoid organs 
Secondary lymphoid organs (SLO) include lymph nodes (LN), spleen and Peyer’s 
patches and they are highly organised and compartmentalised structures that facilitate 
the encounter of cells of the immune system with antigens. 
Lymph nodes are subdivided into cortical, paracortical and medullary areas (Malhotra, 
Fletcher et al. 2013). Each of them is composed of specific areas of the LN lobules 
surrounded by sinuses, containing motile lymphocytes in search of antigens. This 
arrangement creates a very effective and efficient venue for antigen surveillance, 
lymphocyte production, antibody secretion and lymph filtration (Willard-Mack 2006). 
The spleen is the largest filter of the blood and is organised as a tree of branching 
arterial vessels. It is surrounded by a capsule of connective tissue (dense fibrous tissue, 
elastic fibres and smooth muscle) (Mebius and Kraal 2005). Its interior is divided into 
red pulp and white pulp. Blood enters the spleen at the hilus via the splenic artery which 
divides into trabecular arteries, central arterioles entering the red pulp and even smaller 
arterioles in the white pulp (Cesta 2006). 
The red pulp filters the blood to remove old erythrocytes and recycle the iron and 
platelets. In rodents, it is a place for haematopoiesis, especially during the foetal and 
neonatal stages (Cesta 2006). Antibodies are produced in the red pulp, because 
plasmablasts (PB) and plasma cells (PC) are situated there. The white pulp is 
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subdivided into the periarteriolar lymphoid sheath (PALS), the follicles and the 
marginal zone (MZ). It is composed of lymphocytes, macrophages, dendritic cells (DC), 
PCs, arterioles and capillaries (Cesta 2006). While the inner PALS around the arterial 
vessels contains mainly T lymphocytes, stroma and DCs; follicles are populated by the 
B lymphocyte compartment (Mebius and Kraal 2005).  
The recirculation of B and T lymphocytes between blood, SLOs and lymph is crucial 
for immune vigilance. B and T lymphocytes enter into LNs from the blood through high 
endothelial venules (HEV) and the spleen via the marginal sinus. B and T lymphocytes 
migrate to particular regions within SLOs as to the chemokine receptors they express 
and the availability of chemokines within a particular area. B cells migrate to the 
follicles expressing CXCR5, which binds to CXCL13, produced by CD35
+
 follicular 
dendritic cells (FDCs) and follicular stroma (Ansel, Ngo et al. 2000). CCL19 and 
CCL21, produced by stromal cells, attract T cells and DCs through receptor CCR7 to 
the T zone (Forster, Schubel et al. 1999).  Deficiency in CXCR5 and CCR7 leads to 
absence of peripheral lymph nodes. These mice also present an altered architecture to 
mesenteric LN and spleen; in particular, B cells fail to migrate into the white pulp and 
develop as small unorganised lymphocyte clusters rather than in B cell follicles (Ohl, 
Henning et al. 2003). B cell follicles in the spleen are surrounded by the MZ. The MZ is 
a transit area and contains particular cells (Mebius and Kraal 2005) like the MZ 
macrophages and MZ B cells that, although they can move into the follicle, they 
constitute a unique population. The main function of the MZ is to screen the systemic 
circulation for antigens and pathogens and it plays an essential part in antigen 
processing (Cesta 2006). PBs and PCs upregulate the chemokine receptor CXCR4, that 
binds CXCL12, which is expressed in the red pulp of the spleen and the medullary 
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cords of the LNs, and downregulate CXCR5 and CCR7, enabling movement into the 
red pulp and association with the vessels (Hargreaves, Hyman et al. 2001). 
If the lymphocytes do not encounter antigenic stimuli, they will leave the SLOs after a 
characteristic residence time, different for each population. CD4
+
 T cells have the 
shortest residence times (4-6h), followed by CD8
+
 T cells (6-10h), while B cells present 
a longer residency, of 12-24 h. DC replacement is slower than T and B lymphocytes, at 
a rate of 30% per day (Tomura, Yoshida et al. 2008). 




Figure 1.1: The structure of the murine spleen. White pulps are discrete areas within the red pulp in 
the spleen. In the middle of the white pulp, also known as periarteriolar lymphoid sheath (PALS), there 
is the central arteriole. Surrounding the arteriole there is a central T cell area with several B cell 
follicles adjacent to it, Follicles are surrounded by the marginal zone. 
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1.3 Early B cell development 
In the adult, early B cell development takes place in the bone marrow (BM). A number 
of factors determine commitment to the B cell lineage. Expression of the transcription 
factor Pax5 is important to B cell development (Nutt, Heavey et al. 1999) and develop 
through various checkpoints of immunoglobulin (Ig) rearrangements (Rolink, Schaniel 
et al. 2001) (See Fig. 1.2). Immature B cells express IgM and then migrate to the spleen 
to undergo further antigen-driven maturation (Cancro and Kearney 2004). Immature B 
cells travel through different states, named early transitional (T1) and late transitional 
(T2) and then become either mature follicular or mature marginal zone B cells (Loder, 
Mutschler et al. 1999). Some of the immature B cells will express an immunoglobulin 
receptor that recognises self-antigen and there is a need to eliminate these cells. The 
elimination of autoreactive B cell clones takes place both in the BM and in the 
periphery by negative selection. Moreover, positive selection, dictated by the strength of 
signalling via the B cell receptor (BCR) mediates B cell survival, maturation, lineage 
commitment (Cancro and Kearney 2004). 
There are 2 types of mature B cells, namely B1 B cells and B2 B cells. B1 B cells are a 
self-replicating population (Hardy and Hayakawa 2001). They are the dominant 
population of B cells in the peritoneal cavity, infrequent in the spleen and almost absent 
in the lymph nodes. B1 B cells express a high level of surface-IgM, low levels of B220 
and IgD and do not express CD23 (Fagarasan, Watanabe et al. 2000). B1 B cells can 
recognise self-antigens and common bacterial antigens and without the help of T cells 
produce low-affinity antibodies that have a wide ranging specificity (Fagarasan, 
Watanabe et al. 2000). B1 B cells have been further subdivided in the basis of their 
expression of CD5. B1a are CD5
+





B2 B cells are recirculating and they express high levels of CD23, B220 and IgD and a 
low level of IgM. Most of the B2 B cells constitute the follicular B cell population. 
Follicular B cells home to B cell follicles in SLOs, while marginal zone B cells are 
sessile, express high levels of CD21 and CD1d and home to the MZ sinus. The decision 
to become a follicular or a MZ B cell lies on signalling through the BCR, Notch2, 
BAFF-R, the canonical NF-κB pathway and signals that are involved in migration and 
anatomical retention (Pillai and Cariappa 2009). In particular, it has also been shown 
that mice deficient for BAFF and APRIL do not generate marginal zone or follicular B 
cells, whilst B1 B cells are unaffected (Schneider, Takatsuka et al. 2001). In the spleen, 
both follicular and marginal zone B cells can respond to T-dependent antigens, while 
only marginal zone B cells can respond to T-independent antigens (Pillai and Cariappa 
2009). However, B2 B cells can respond to T-independent antigens in the bone marrow 





1.4 The types of B cell responses 
Very early studies of B cell responses revealed that antigens can be classified as either 
T-dependent (TD) or T-independent (TI) depending on the nature of the antigen and of 
the B cell population recruited to the response (Feldmann and Easten 1971, Lewis, 
Ranken et al. 1976).  
 
1.4.1 Thymus-dependent (TD) responses 
TD responses need T cells for full activation and expansion of B cells (Gershon and 
Kondo 1970). These responses are elicited by protein antigens that are specifically 
Figure 1.2: Early B cell development. B cell development takes place in the bone marrow in adult 
mice and consist of a series of sequential recombinations at IgH (heavy chain) and IgL (light chain) 




recognised by the BCR in the presence of cognate T cell help. Once B cells have 
recognised the antigen, it is processed and presented as peptides on the major 
histocompatibility complex (MHC) class II molecule to T cells in the B cell follicle-T 
zone border. Activated B and T cells form stable contacts through the interaction of 
CD40-CD40L and both these cells secrete cytokines (Noelle and Snow 1990). 
Immunoglobulin class-switching starts occurring at this point and B cells differentiate 
into extrafollicular PCs, early MBCs or GC B cells (Smith, Hewitson et al. 1996, 
Toellner, Gulbranson-Judge et al. 1996, Garside, Ingulli et al. 1998).  
 
1.4.2 Thymus-independent (TI) responses 
TI antigens induce antibody production by B cells without the involvement of T cell 
help.  TI antigens are further classified in TI type I (TI-I) or TI type 2 (TI-II) as to 
whether these responses can occur in mice deficient in the Bruton's tyrosine kinase 
(Btk) and  they differ in the mechanisms of B cell activation (Mosier, Mond et al. 1977). 
TI-I antigens do stimulate an antibody response in the absence of Btk. They activate B 
cells directly through Toll-like receptors (TLR), causing extensive proliferation and 
differentiation of B cells. Lipopeptides, lipopolysaccharide, some viral-coating particles 
and bacterial nucleic acids are examples of this type of antigens (Bekeredjian-Ding and 
Jego 2009). TI-I responses occur faster than TD responses and cause the generation of 
extrafollicular PCs and MBCs (Martin, Oliver et al. 2001). 
TI-II antigens are highly repetitive structures that are present in the surface of bacteria 
or viruses. The epitopes cause multiple BCR-crosslinking and provide the B cell with a 
persistent signal transmitted through Btk. B cells proliferate and form robust PC 
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responses in the extrafollicular foci. TI-II antigens do not cause memory B cell (MBC) 
generation (Garcia de Vinuesa, O'Leary et al. 1999). During TI-II responses, germinal 
centres (GC) have been reported to be generated very quickly at a high concentration of 
antigen but these are non-productive. These GCs abort at the point at which centrocytes 
would be selected, showing that T cells are not required until this point in GC biology. 
TI-II GCs are located in the follicles and contain mature FDCs. However, there is no 
somatic hypermutation happening within these GCs (de Vinuesa, Cook et al. 2000, 
Lentz and Manser 2001). 
Recently, it has been shown that B cells can receive help from natural killer cells (NKT) 
in a TD manner and from other cells such as neutrophils in a TI manner. These new 
findings have led to a re-classification of the B cell responses to take into account help 
from the above cells (Vinuesa and Chang 2013).  
 
1.5 The activation and differentiation of B cells 
Naïve B cells and naïve T cells recognising the same antigen have to interact, but the 
chance of these cells encountering one another in the 3D space is remote. So, primed B 
cells upregulate chemokine receptors that are responsible for their migration to the 
zones where T cells are situated (MacLennan, Toellner et al. 2003). Upon encounter 
with antigen in the blood or in the splenic marginal zone, naïve B cells upregulate 
CCR7 expression 2-3 folds, which attracts them to the border of the T-zone and B 
follicles (Reif, Ekland et al. 2002). Increased expression of CCR7 is sufficient to direct 
B cells to the T zone and overexpression of CXCR5 is enough to prevent this movement 
to the T zone (Reif, Ekland et al. 2002). CXCR5 expression remains unchanged and this 
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new balance between CCR7 and CXCR5 expression makes B cells less prone to be 
directed by CXCL13 into the B cell follicle (Okada and Cyster 2006).  
T-B interaction is a multistage process and requires integrin-mediated adhesion for the 
initial contact, and SLAM-associated protein (SAP) and CD84 are implicated in 
sustaining the contact (Cannons, Qi et al. 2010). CD40-CD40L interactions are essential 
for TD responses and their disruption aborts GC formation, MBC differentiation and the 
generation of long-lived PC (Erickson, Durell et al. 2002). 
Activated B cells at the B-T zone border transform into large B-blasts that will follow 
one of three different pathways (Sagaert, Sprangers et al. 2007). Most of them will 
rapidly proliferate into short-living PCs that will be in charge of producing low-affinity 
antibodies to provide a first-line of defence. Some activated B cells will become early 
recirculating MBCs. The rest of the B-blasts will re-enter the follicle accompanied by 
some T cells and differentiate into GC B cells. This decision-making is controlled by 
the strength of binding of the BCR to the antigen. Strong binding will select B cells to 
contribute to the extrafollicular response, while weaker unions will lead them to the GC 
pathway (Paus, Phan et al. 2006), Moreover, antigen affinity has been shown to regulate 
proliferation and survival of extrafollicular switched plasmablasts (Chan, Gatto et al. 
2009). 
 
1.5.1 The non- GC or extrafollicular pathway 
The non-GC pathway occurs in the medullary cords in the lymph nodes and in foci in 
the red pulp of the spleen (MacLennan, Toellner et al. 2003). Some antigens, such as 
polysaccharides, provoke antibody responses without T cell help in the extrafollicular 
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sites and these responses last for months, contrary to extrafollicular PCs generated after 
TD antigens (Hsu, Toellner et al. 2006).  
B-blasts primed to become plasma cells leave the T zone to the extrafollicular site and 
there, without any help from T cells and in association with CD11c
high
 dendritic cells, 
differentiate into plasma cells. This differentiation is associated with the upregulation of 
Blimp-1 expression (Shaffer, Lin et al. 2002). Ig class switch recombination (CSR) 
occurs in B-blasts rather than in plasmablasts (Marshall, Zhang et al. 2011). Some of 
these recently formed plasma cells will make contact with stromal cells to prolong their 
life span (MacLennan, Toellner et al. 2003). CD154-deficiency (CD40L), a key ligand 
of CD40, has been shown to be required for extrafollicular TD antibody responses as 
well as for GC responses (Cunningham, Serre et al. 2004). miR-182 is upregulated in 
activated B cells and its expression is important for normal antibody responses 
immediately after T-dependent immunisation and essential for antibody responses in T-
independent type II antigens (Li, Ou et al. 2016). 
Discriminating in vivo antibody responses as either T-dependent or T-independent is not 
entirely natural for the reason that bacteria and virus will elicit both types of responses. 
The extrafollicular response, as to expansion, differentiation and isotype switching of B 
cells can take place in the absence of T cells and such, has important consequences as to 
the generation of autoreactive B cells. In particular, TLR-ligands have a greater ability 
to cause autoreactive B cell activation in the absence of T cells (Sweet, Ols et al. 2011). 
 
1.5.2 The GC or follicular pathway 
The B and T cells that migrate back into the follicle upregulate CXCR5 and they are 
attracted by CXCL13 expressing cells, such as FDCs. CXCR5-deficient mice have an 
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aberrant distribution of B cell follicles, which form a ring around the T zone. Even so, 
the role of CXCR5 in T-B collaborations is contradictory (Junt, Fink et al. 2005). Upon 
immunisation with T-dependent antigen, CXCR5-deficient mice produced normal levels 
of switched Ig isotypes (Forster, Mattis et al. 1996) and GCs are formed in the 
proximity of the arterioles. These GCs contain FDC but do not segregate into LZ/DZ 
and B cells are highly proliferative. Affinity maturation and hypermutation occurrs 
normally in these ectopic GCs (Voigt, Camacho et al. 2000). However, the role of 
CXCR5 is antigen dose-dependent. When the availability of the Ag was limited, 
CXCR5-deficiency reduced the responsiveness of B cells to viruses (Junt, Fink et al. 
2005). 
At the T-B interface, B cells proliferate for 1 or 2 days. After that, activated B cells 
migrate to the perimeter of follicle which is next to the marginal zone. In this location, 
activated B cells proliferate but they do not hypermutate and they undergo little 
switching (Coffey, Alabyev et al. 2009). EBI2 (Epstein-Barr virus induced molecule-2 
or GPR183) controls movement of B cells to the outer follicle; EBI2-deficient B cells 
are unable to move to the outer follicle at day 2 after activation, while its overexpression 
is sufficient to localise B cells in the outer follicle (Pereira, Kelly et al. 2009).  
Seeding of the GCs is as yet unclear, but Bcl-6, a transcriptional repressor, has to be 
expressed. One of the targets of Bcl-6 is EBI2 (Basso and Dalla-Favera 2010). EBI2 is 
strongly downregulated in all GC B cells as compared to naïve B cells and it has been 
shown that LZ B cells express ∼4-fold higher levels of EBI2 than DZ B cells (Gatto, 
Wood et al. 2011). When antigen-specific EBI2-deficient B cells were transferred into 
WT hosts, they gave rise to slightly elevated levels of LZ B cells and affinity maturation 
was not affected (Gatto, Wood et al. 2011). 
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GC B cells upregulate S1PR2 (sphingosine-1-phosphate receptor 2), a G-protein 
coupled receptor (GPCR) that plays an important role in GC positioning and GC 
homeostasis (Green, Suzuki et al. 2011). S1PR2 inhibits the migration of cells out of the 
GCs, helping to confine them to the GC niche, due to its coupling to Gα12 and Gα13 
(Green, Suzuki et al. 2011). Its ligand, S1P, is present in a decaying gradient in the 
follicle (Green and Cyster 2012). Schwickert and colleagues (Schwickert, Victora et al. 
2011) have shown that low-affinity B cells can seed the GC, but they fail to expand and 
become activated when high-affinity B cells are present, which prevents low-affinity B 
cells from reaching an intermediary pre-GC stage (upregulation of Fas, Gl-7 and 
CCR6). 
Fully formed GCs, the hallmarks of T-dependent antibody responses, are highly 
specialised structures, characterised by high mitotic and apoptotic activity 
(Nieuwenhuis and Opstelten 1984) and are the place where high affinity antibodies are 
produced (MacLennan 1994). Class-switch recombination and hypermutation require 
Activation-induce cytidine deaminase (AID) (Muramatsu, Kinoshita et al. 2000). AID is 
a member of the RNA-editing deaminase family and it is expressed only in GC B cells 
and B cells that are induced to switch in vitro. AID has also been shown to be involved 
in a rare human immunodeficiency, the hyper-IgM syndrome (Revy, Muto et al. 2000), 
which is characterised by absence of IgG, IgA and IgE antibodies while IgM levels are 
normal. These patients are highly susceptible to infections. 
Somatic hypermutation creates a huge number of point mutations in the VDJ exons, 
producing sequence variants that through selection and continued evolution may give 
rise to higher affinity antibodies. This process is named affinity maturation. These point 
mutations appear due to the repair of double-strand breaks by homologous 
recombination (Papavasiliou and Schatz 2000). Class-switch recombination (CSR) 
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replaces the Ig heavy chain constant region (CH) from Cµ to other CH genes, causing 
switching from IgM isotype to IgG, IgE or IgA (Muramatsu, Kinoshita et al. 2000). 
GCs are divided into two anatomically distinct regions: the light zone (LZ), situated 
towards the marginal zone, where smaller, non-dividing B cells (centrocytes), antigen-
specific T cells called Tfh cells (follicular helper cells), tingible body macrophages and 
follicular dendritic cells (FDCs) with antigen deposited on their surface stay; and the 
dark zone (DZ), where large, mitotically active B cells (centroblasts) stay (MacLennan 
1994). Although initial studies suggested that centroblasts are larger than centrocytes, it 
has been shown that LZ and DZ B cells are the same size and cellular complexity 
(Victora and Nussenzweig 2012). The gene expression profiles of these two populations 













 (Victora, Schwickert et al. 2010). See Figure 1.3.  
GC dark and light zone organisation is mediated by CXCR4 and CXCR5 (Allen, Ansel 
et al. 2004), whereby centroblasts express high levels of CXCR4 and CXCL12 is found 
mainly in the DZ and CXCL13 in the LZ. GC B cells cycle between the dark zone and 
the light zone. CXCR4-deficient GC B cells are restricted to the LZ, carry less 
mutations and are outcompeted by WT cells overtime (Bannard, Horton et al. 2013), 
suggesting that in order to facilitate more effective rounds of mutation and selection 




Figure 1.3: The morphology of the germinal centre. GCs form in the centre of follicles and are 
divided in the light zone and the dark zone, which sits adjacent to the T zone. FDCs, tingible body 
macrophages and Tfh cells are localised in the LZ. Selection occurs in the LZ and cells proliferate in 
the DZ. 
Black arrows indicate previously described movements of cells within the GCs. Curved continuous 
arrows denote recirculation of cells in the DZ or in the LZ. Straight discontinuous arrows indicate 
migration from LZ to DZ or vice-versa. Straight dotted arrows indicate migration of naïve B cells to 
and from the GC area. 
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Thanks to the use of two-photon microscopy it has been possible to observe B cell 
motility in vivo, specifically bi-directional B cell migration between compartments 
within the GC (Allen, Okada et al. 2007, Schwickert, Lindquist et al. 2007). The 
findings from these studies have led to the cyclic re-entry model. Other two-photon 
microscopy studies combined with mathematical modelling have shown that GC B cells 
recirculate mostly intra-zonally within the LZ or the DZ, implying that inter-zonal 
migration is not necessary for consecutive rounds of mutation and selection (Hauser, 
Junt et al. 2007). However, re-analysis of the multi-photon microscopy data 
demonstrated that the intra-zonal pattern of migration is improbable and a new model 
was predicted (Figge, Garin et al. 2008). This new model stated that GC B cells in the 
LZ and DZ perform random walk migration but centroblasts and centrocytes acquire 
sensitivity to CXCL12 and CXCL13 respectively (Figge, Garin et al. 2008, Meyer-
Hermann, Figge et al. 2009). The application of mathematical models has also revealed 
that chemokine-induced receptor downregulation, receptor-mediated chemotaxis and the 
presence of a simple fixed spatial distribution of the relevant chemokines is sufficient to 
induce complex migratory patterns (Chan, Billard et al. 2013).  
GC are continually visited by follicular naïve B cells (Schwickert, Lindquist et al. 2007) 
but while the movement of naïve B cells is considered random, the migration of GC B 
cells is directed (O'Connor, Hauser et al. 2011). Interestingly, GC B cells present a 
varied morphology, some of the cells are polarised cells and only the ones that are 
dividing have a rounded shape (Hauser, Shlomchik et al. 2007). Cell division has 
classically been considered to be restricted to the DZ (Nieuwenhuis and Opstelten 
1984), but several studies, especially in murine models, have observed that the onset of 
proliferation is triggered  in the LZ (Allen, Okada et al. 2007) (Hauser, Junt et al. 2007). 
A new technique that combined transgenic photoactivatable fluorescent protein traced 
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with multi-photon microscopy has helped to show that the final stages of cell division 
are only occurring in the DZ. GC B cells enter the S phase in the LZ and transit to 
G2/M phases in the DZ. Genes for the G2/M phases such as Ccnb2 are enriched in the 
DZ (Victora, Schwickert et al. 2010). 
Photoactivatable fluorescent protein traced with multi-photon microscopy has also 
revealed that there is increased movement from DZ to LZ and the decision to return to 
the DZ is controlled by T helper cells. This help from T cells is the limiting factor as to 
GC selection of high-affinity B cells (Victora, Schwickert et al. 2010). T cells select 
high-affinity B cells based on the amount of peptide-MHC presented in the LZ and 
induce them to cycle to the DZ (Victora, Schwickert et al. 2010). T cell selection 
triggers c-Myc expression in the LZ and subsequent cell-cycle entry. c-Myc is essential 
for the formation and maintenance of the GCs (Calado, Sasaki et al. 2012, Dominguez-
Sola, Victora et al. 2012). 
A second model for high-affinity B cell selection has been described. In this model, GC 
B cells compete for the limiting amount of antigen presented on the FDC network 
through their BCRs. The high-affinity clones then divide more than those with lower 
affinity BCR (Victora and Nussenzweig 2012). However, this model was dismissed by 
the antibody feedback model, as the amount of antigen in the GC is not limited (Zhang, 
Meyer-Hermann et al. 2013). By injecting monoclonal antibodies of defined affinity, 
the authors demonstrated that the antibodies produced outside the GC, whose affinity 
increase over time, are able to restrict the access of GC B cells to antigen presented on 
FDC and, therefore, influence B cell selection (Zhang, Meyer-Hermann et al. 2013). 
Evolution towards higher affinity antibody is achieved by a slow but consistent increase 
in the selection stringency and this constant increase explains the termination of the GC 
reaction, when the restriction of access to antigen is too high to allow for GC B cell 
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survival (Zhang, Meyer-Hermann et al. 2013, Zhang, Garcia-Ibanez et al. 2016). 
Although the BCR is essential for GC B cell survival and selection, its specific role in 
the GC reaction still has to be determined. Within the GC microenvironment, 
proliferating B cells undergo SHM that introduces mutations into the Ig gene region that 
encodes for the antigen-binding site (Sagaert, Sprangers et al. 2007). Most of these 
mutations do not improve the affinity of the receptor and so they don’t interact correctly 
with the antigen presented by the FDCs, and therefore such cells do not receive 
appropriate survival signals. Further, self-reactive B cells may appear as consequence of 
SHM. 
GC B cells express a variety of pro-apoptotic factors such as Fas, which is required for 
the elimination of low-affinity clones (Peperzak, Vikstrom et al. 2012). Autoreactive 
and low-affinity clones die via apoptosis and are quickly eliminated by tingible body 
macrophages. The impairment of the clearance of the apoptotic bodies results in 
autoantibody production, loss of B cell tolerance and autoimmunity (Rahman 2011). 
After successfully completing a round of affinity maturation GC B cells may undergo 
further rounds or differentiate into post-GC cells. Bcl-6, as previously mentioned, is 
expressed in GC B cells and downregulates the signals implicated in B-cell activation, 
survival and differentiation at the end of the GC reaction (Basso, Saito et al. 2010). 
When high-affinity B cells interact with T cells through CD40-mediated signalling, Bcl-
6 is downregulated to release the inactivation of the signals that regulate post-GC 




1.6 The chemokine superfamily 
Chemokines regulate in vivo leukocyte migration. They also have a role during 
morphogenesis and the repair of tissue damage (Bajoghli 2013). In humans, there are 48 
genes that encode chemokines, but taking into account polymorphisms, differential 
splicing and N- and C-terminal enzymatic processing, there are more than one hundred 
different chemokines (Ulvmar, Hub et al. 2011). Chemokines transmit their signals 
through one or more of 18 distinct heptahelical G-protein coupled receptors (GPCRs). 
Some receptors bind a single ligand and some of them are very promiscuous, binding up 
to ten ligands, but with different affinities and outcomes downstream (Rot and von 
Andrian 2004). There is functional redundancy in the chemokine system.  
 
1.6.1 The chemokines 
Chemokines are secreted proteins of small size, between 8 and 14 kDa and are defined 
on the basis of their amino acid composition rather than their function. Specifically, the 
presence of a highly-conserved tetra-cysteine motif is used to define chemokine families 
(Baggiolini, Dewald et al. 1997). Their monomeric structures are very similar and 
comprise of a NH2-terminal loop, three antiparallel β-strands connected by loops, and a 
COOH-terminal α-helix (Baggiolini, Dewald et al. 1997). Chemokines are divided into 
four different groups depending on the position of the N-terminal cysteine residues. 
‘CXC’ and ‘CC’ are the two main groups. The chemokines belonging to the ‘CXC’ 
group have an amino acid between the two first cysteines, also called α-chemokines; 
and the ones belonging to the ‘CC’ group, also called β-chemokines, do not (Zlotnik 
and Yoshie 2000). A third and fourth groups have been described, the ‘C’ group, or γ-
chemokines, that lacks two out of four of the canonical cysteines; and the ‘CX3C’ 
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group, or δ-chemokines, that has 3 residues in between the two first cysteines (Zlotnik 
and Yoshie 2000). 
Most chemokines have arisen from gene duplication from a single ancestral gene and 
they are clustered in specific chromosomal locations (Zlotnik and Yoshie 2000). 
Chemokines can also be divided in homeostatic and inflammatory. The former are 
constitutively present in the tissue while the later are dramatically upregulated by 
inflammatory and immune stimuli. 
 
1.6.2 The chemokine receptors 
Chemokine receptors are G- protein coupled receptors (GPCRs) with seven 
transmembrane domains. Neurotransmitters, peptides, chemokines, lipid-derived 
messengers, divalent cations, hormones, and ligands for light and odour perception 
transduce signals into intracellular pathways through GPCRs (Khoja, Wang et al. 2000). 
There are 19 different GPCRs for chemokines in humans. Five structural motifs are 
conserved within the transmembrane (TM) domain. They are: TD(X)YLLNLA 
(X2)DLLF(X2)TLP(X)W in TM2, the NH2- and COOH-terminal extensions of the 
DRYLAIVHA-motif in TM3 and the second intracellular loop, PLL(X)M(X2)CY in 
TM5, W(X)PYN in TM6, and HCC(X)NP(X)IYAF(X)G(X2)FR in TM7. Moreover, all 
of the receptors have two conserved cysteines, one in the NH2-terminal domain and the 
other in the third extracellular loop that are assumed to form a disulphide bond critical 
for the conformation of the ligand-binding pocket (Baggiolini, Dewald et al. 1997). 
Chemokine receptors are coupled to Gα proteins and their activation leads to inhibition 
of production of cyclic adenosine monophosphate (cAMP). Other signalling pathways 
22 
 
are also implicated in the signalling from these receptors such as those involving MAPK 
and PI3K (Rollins 1997). 
 
1.6.3 The atypical chemokine receptors 
Atypical chemokine receptors (ACKRs) are also heptaspanning membrane receptors, 
homologous to chemokine GPCRs, but unable to provoke any classical GPCR 
downstream signalling (Ulvmar, Hub et al. 2011). This is due to the absence of one of 
the conserved domains, the DRYLAIV motif in the second intracellular loop, which 
impedes the ability to couple to G-proteins (Mantovani, Bonecchi et al. 2006).  
As atypical receptors are unable to signal through the classical GPCRs pathways they 
have been excluded the standard nomenclature system, and a different standardised 
nomenclature has not been assigned (Bachelerie, Graham et al. 2014). In 2014, a 
committee representing scientists working in the field voted to adopt a unique 
designation, ‘ACKR’, an acronym for atypical chemokine receptor and this named 
system was approved by several committees (Bachelerie, Graham et al. 2014). There are 
four members in the ACKR family: ACKR1, (previously known as DARC, Duffy 
antigen, Fy antigen or CD234); ACKR2, (also known as D6, CCR9, CCR10, CCBP2 or 
CMKBR9); ACKR3, (previously CXCR7, RDC1 or CMKOR1); and ACKR4, (known 
as CCRL1, CCX-CKR or CCR11).  
In general, ACKRs mediate internalisation and subcellular localisation of chemokines. 
Internalised chemokines can be directed to two different fates. On the one hand, they 
can be targeted to the lysosome, leading to chemokine degradation, and for this reason 
ACKRs are also called “scavenging decoys” (Ulvmar, Hub et al. 2011). The free 
receptor cycles back to the cell membrane to continue eliminating more extracellular 
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chemokines (revised in (Nibbs and Graham 2013)). On the other hand, ACKRs can 
transcytose chemokines, carrying them through biological barriers and concentrating 
them in micro-anatomical domains (Ulvmar, Hub et al. 2011). Both fates are able to 
form gradients of chemokines, either soluble or immobilised. These gradients may be 
directing cell responses to chemokines in vivo. ACKRs, as conventional chemokine 
receptors, dimerise. They can homodimerise (ACKR3) as well as heterodimerise 
(ACKR3-CXCR4). Some of them can even hetero-oligomerise (ACKR1-CCR5). 
Dimerization provides an additional way of control of chemokine activity (revised in 
(Nibbs and Graham 2013)). 
 
1.7 The atypical chemokine receptor 4 (ACKR4) 
The project described in this thesis is focused on the role of ACKR4 during the GC 
response.  
ACKR4 was identified by homology searches using BLAST, looking for nucleotide 
sequences corresponding to the conserved motif in chemokine receptors in the human 
EST database (Khoja, Wang et al. 2000). Deposit H67224, with a length of 328 
nucleotides and coming from olfactory epithelium, had a 95% homology to the 
consensus sequence. The full-length amino acid sequence consists of 350 aa 
(approximately 45 kDa). ACKR4 is a glycosylated seven transmembrane polypeptide 
with numerous intracellular serine and threonine residues (Khoja, Wang et al. 2000). 
ACKR4 lacks a signal sequence at the amino terminus. The BLAST program revealed 
an 86% amino acid sequence homology to bovine gustatory receptor-PPR1 (GenBank 
Accession No. S63848). ACKR4 and PPR1 are orthologous. ACKR4 also presents a 
37%, 33% and 32% identity to the chemokines receptors CCR7, CCR9 and CCR6 
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respectively, meaning that ACKR4 resembles CCRs receptors more than CXCRs 
(Khoja, Wang et al. 2000, Schweickart, Epp et al. 2001). ACKR4 is mapped to 
chromosome 6 (Khoja, Wang et al. 2000). The canonical DRYLAIVHA transmembrane 
motif is replaced by DRYWAITKA in mouse and DRYVAVTKV in human (Townson 
and Nibbs 2002). Bioinformatic modelling of the ACKR4 structure has been provided 
by Behjati and colleagues (Behjati, Torktaz et al. 2012). 
In mice, two distinct transcripts originate from two independently regulated promoters. 
The first one is abundantly expressed in heart (muscle cells) and lung; the rarer one is 
only expressed in brain and testes. Apart from heart and lung, ACKR4 mRNA 
transcripts have been detected in human DC, T cells, spleen and lymph nodes (Gosling, 
Dairaghi et al. 2000). In the adult thymus it is expressed in perivascular thymic 
epithelial cells (TECs) of the corticomedullary junction and the medulla and in the 
subcapsular epithelial layers (Heinzel, Benz et al. 2007).  
Ligand profiles were determined by use of stalkokines (immobilized chemokines 
constructed on stalks) as bait for adhesion of cells expressing ACKR4 and further 
determined using radiolabelled ligand binding (Gosling, Dairaghi et al. 2000). High 
affinity ligands for ACKR4 (IC50< 15 nM) are those in the β-chemokine group and 
include CCL19 (ELC or MIP-3β), CCL21 (6Ckine) and CCL25 (TECK). CCR7 is the 
canonical receptor for the first two ligands and CCR9 for the third high affinity ligand. 
Lower affinity ligands (IC50< 150 nM) are CXCL13 (BLC) and vMIP-II (Gosling, 
Dairaghi et al. 2000). CCL19, CCL21 and CCL25 bind both in human and in mice, 
while CXCL13 has only been described to bind in humans (Gosling, Dairaghi et al. 
2000). The binding of these chemokines to the receptor does not induce the classical 
calcium response (Heinzel, Benz et al. 2007) and, in transfected HEK293 cells, the 
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binding of ligand does not result in ligand-induced MAP kinase phosphorylation 
(Townson and Nibbs 2002). 
ACKR4 is able to efficiently internalise, retain and degrade CCL19 with a higher 
capacity than CCR7 because ACKR4 is not desensitized by ligand stimulation, 
increasing its internalization and degrading capacity with the ligand concentration 
(Comerford, Milasta et al. 2006). This internalisation is independent of β-arrestins and 
clathrin-coated pits, as it is not impaired in Eps15 and Rab5 mutants (Comerford, 
Milasta et al. 2006). ACKR4 is internalised via caveolae (caveolin and cholesterol 
dependent) (Comerford, Milasta et al. 2006). The degrading capacity of ACKR4 for 
CCL19 and CCL21 has been shown in vivo, as in ACKR4
-/-
 mice, CCL19 and CCL21 
levels are increased in the serum as compared to WT mice (Comerford, Nibbs et al. 
2010). In a more recent study (Watts, Verkaar et al. 2013), it has been shown that 
although ACKR4 does not cause constitutive β-arrestin relocalisation like other ACKRs 
(Nibbs and Graham 2013), the stimulation of ACKR4 with any of its ligands induces β-
arrestin2 translocation, which does not take place in the absence of chemokines. From 
this result is not possible to exclude the role of β-arrestins in ACKR4-mediated 
endocytosis. After this internalisation, the receptor cycles back to the surface of the cell 
(Nibbs and Graham 2013). See Figure 1.4. 





 dendritic cells to skin-draining lymph nodes via afferent lymphatics 
but not in the homing of dendritic cells that enter via the blood (Heinzel, Benz et al. 
2007). In inflamed skin, ACKR4-expression by keratinocytes and by dermal lymphatic 
endothelial cells scavenges CCL19 in situ facilitating skin-derived CCR7
+
 APC 
emigration to draining lymph nodes (Bryce, Wilson et al. 2016). 
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ACKR4 is also implicated in the immigration of embryonic thymic precursors to the 
thymic anlage in vivo, as its overexpression impairs colonisation of the thymus by 
haematopoietic precursors (Heinzel, Benz et al. 2007). Despite this, thymocyte numbers 
reached normal levels in the new born mice when ACKR4 was overexpressed, ruling 
out a function for ACKR4 in the later stages of thymus development (Heinzel, Benz et 
al. 2007). However, an independent study provided contradictory results. Bunting et al. 
have shown that ACKR4 controls cortical and medullary size, leading to altered 
thymocyte development with the production of elevated numbers of CD4
+
 T cells and a 
reduced transition from immature to mature phenotype in the single-positive T cells 
(Bunting, Comerford et al. 2013). ACKR4 expression in the thymus has been 
characterised by using ACKR4-GFP reporter mice both at the neonatal and adult stages. 
ACKR4 is expressed in both subpopulations of cTECs and mTECs and can be used to 
subdivide these populations (Ribeiro, Meireles et al. 2014). A third study was in 
agreement with the first study. Although ACKR4 is expressed in key thymic 
microenvironments in the thymic cortex and in stromal cells surrounding pericytes of 
vessels, the study found that ACKR4 does not affect thymus size, cellularity, T cell 
development or thymic output (Lucas, White et al. 2015). 
ACKR4
-/-
 mice develop spontaneous autoimmune lesions in the submandibular gland 
and in the liver that resemble Sjögren syndrome (Bunting, Comerford et al. 2013). 
Moreover, ACKR4-deficiency accelerates the onset of EAE (experimental autoimmune 
encephalomyelitis) induced by immunisation and EAE is more severe than in WT 
counterparts after immunisation (Comerford, Nibbs et al. 2010). This is associated with 
the increase of CCL21 in the central nervous system. Also, in this model, the balance 




mice, due to increased CCL19/CCL21-driven IL-23 production (Comerford, Nibbs et al. 
2010). 
ACKR4 has been described recently to be expressed by a layer of lymphatic endothelial 
cells of the ceiling of the lymph node subcapsular sinus in steady state conditions 
(Ulvmar, Werth et al. 2014). This expression scavenges chemokines and creates 
functional CCL21 gradients that guide CCR7
+
 dendritic cell entrance via afferent 
lymphatics towards the T cell areas (Ulvmar, Werth et al. 2014). 
Interestingly, in Salmonella Typhimurium-infected pigs, ACKR4 expression, together 
with CCR9 and CCL25 expression, are downregulated in the gut wall and Peyer’s 
patch, opening the possibility for a bacterial strategy to reduce lymphocyte homing to 
the intestines and therefore, for a role for ACKR4 in gut-lymphocyte homing (Meurens, 





Figure 1.4: ACKR4 structure. ACKR4 is a seven-transmembrane receptor. It binds with high-
affinity to CCL19, CCL21 and CCL25. Due to a mutation in the third intracellular loop, ACKR4 is 
unable to signal through GPCRs. Instead, when it is bound to its ligands causes β-arrestin 
translocation and the whole complex is internalised for ligand degradation and receptor recirculation 
back to the cell membrane. 
ACKR4 model taken from (Behjati, Torktaz et al. 2012) 
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1.8 The C-C chemokine receptor type 7 (CCR7) 
CCR7, a seven-transmembrane-spanning receptor which signals through heterotrimeric 
G proteins, is the canonical receptor for the two homeostatic chemokines CCL19 and 
CCL21 (Rot and von Andrian 2004). CCR7 is expressed by B and T lymphocytes and 
was first described as a gene that is induced in B lymphocytes by Epstein-Barr virus 
(EBV) infection, so it was previously known as EBI1 (EBV-induced gene 1) 
(Birkenbach, Josefsen et al. 1993). CCR7 has a high homology to IL-8 receptors, both 
at the RNA and protein level (Birkenbach, Josefsen et al. 1993). Murine CCR7 has an 
86% protein homology to the human receptor (Schweickart, Raport et al. 1994). CCR7 
is encoded by the region 17q12-q21.2 of the human chromosome and CCL19 (ELC) 
and CCL21 (SLC) form a mini-cluster at human chromosome 9p13. Both ligands cause 
calcium mobilization and induction of chemotaxis when bound to CCR7 (Yoshida, Imai 
et al. 1997, Yoshida, Nagira et al. 1998). 
CCR7 is constitutively ubiquitylated and this ubiquitylation is essential for ligand-
independent basal receptor trafficking and for the ligand-induced recycling via the 
trans-Golgi network and plays a pivotal role in immune migration (Schaeuble, Hauser et 
al. 2012). CCR7 is sialylated and reduction of this sialylation decreases CCL19-
dependent downstream signalling (Su, Chang et al. 2014). This sialylation occurs in 
human CCR7 at the N-terminus and at the extracellular loop 3 and different cells carry 
different levels of sialylation which can be regulated by glycosidases that are secreted 
by mature DCs (Hauser, Kindinger et al. 2016). 
CCR7 has been shown to control a variety of process within the immune system. CCR7 
is involved in regulation of lymphocyte homing to SLO, in establishment of the 
peripheral tolerance and in autoimmunity (Forster, Davalos-Misslitz et al. 2008).  CCR7 
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controls T cell entrance to lymph nodes via HEVs, as lymph nodes and Peyer patches 
from CCR7
-/-
 mice lack T cells, although they can home to the spleen where they 
accumulate in the red pulp (Forster, Schubel et al. 1999). When DCs mature as a 
consequence of antigen encounter they upregulate CCR7 and other molecules and 
migrate from peripheral tissues to lymph nodes where they can stimulate T cells and 
initiate T-dependent responses (Yanagihara, Komura et al. 1998). CCR7
-/-
 DCs fail to 
migrate to the draining lymph nodes from skin, intestine and lungs (Hintzen, Ohl et al. 
2006, Worbs, Bode et al. 2006). 
CCR7 together with CXCR5, as previously mentioned, are in charge of white pulp 
organisation. CCR7 guides cells to the T cell zones and CXCR5 guides cells to the B 
cell follicles (Ohl, Henning et al. 2003). Activated B cells downregulate CXCR5 and 
upregulate CCR7, allowing their migration to the T-B border (Reif, Ekland et al. 2002). 
Similarly, Tfh cells upregulate CXCR5 and downregulate CCR7 which permits their 
migration inside the follicle and subsequently, help during GC responses (Hardtke, Ohl 
et al. 2005). CCR7-upregulation in activated B cells and consecutive interaction with T 
cells has been shown to be essential for the production of antiviral neutralising 
antibodies to vesicular stomatitis virus when there is limited antigen availability 
(Scandella, Fink et al. 2007). 
CCR7-deficient mice develop generalised autoimmune phenotypes and organs such as 
pancreas, stomach, kidneys and salivary and lachrymal glands are affected. Moreover, 
CCR7-deficient mice are also more susceptible to induced diabetes (Davalos-Misslitz, 
Rieckenberg et al. 2007). Additionally, CCR7-deficient mice develop persistent GCs in 
response to TI-II antigens and these GCs are located in the periarteriolar area and 
contain a ring of FDCs around them and T cells. However, affinity maturation, class-
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switching, MBC generation and Treg distribution was seen to be normal (Achtman, 
Hopken et al. 2009). 
CCR7-expression by tumours has been correlated with a bad prognosis and increased 
metastases to lymph nodes. The tumours include breast tumours, melanoma, colorectal 
cancer, gastric carcinoma, non-small cell lung cancer, cervical cancer, T-cell leukaemia 
and chronic lymphocytic leukaemia (Mburu, Wang et al. 2006, Ben-Baruch 2008). This 
increased metastases is thought to be caused by CCL21-CCR7-dependent induction of 
actin polymerisation, migration adhesion and invasion of CCR7-expressing tumour cells 
(Ben-Baruch 2008). 
 
1.9 The chemokines CCL19 and CCL21 
CCL19 and CCL21 bind to the chemokine receptors CCR7 and ACKR4. CCL19 and 
CCL21 are produced constitutively by a variety of stromal cell in the SLOs. CCL19-
expressing cells include FRCs, mature DCs and mTECs; while CCL21-expressing cells 
include HEVs, LECs, FRCs and mTECs (Comerford, Harata-Lee et al. 2013).  
Although CCL19 and CCL21 bind CCR7 with similar affinity, they are very different in 
structure, function and regulation (Comerford, Harata-Lee et al. 2013). CCL19 and 
CCL21 only share a 25% similarity in amino acid sequence. However, their tertiary 
structure contains conserved characteristics: a disordered N terminus, followed by a 
core domain containing an N-loop, a 3-stranded β-sheet and a C-terminal helix. The N-
terminal domain has been shown to be important for stabilisation of the active receptor 
conformation and even if these regions from CCL19 and CCL21 only share one aa, 
swapping them does not cause a difference in signalling (Ott, Lio et al. 2006).  
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CCL21 contains a unique 30 aa length carboxyl-terminal extension with 2 extra cysteine 
residues and 12 of these residues are basic (Nagira, Imai et al. 1997). In humans, there is 
only one gene encoding CCL21. In mice, there have been identified two different 
isoforms of CCL21 with one aa variance at position 65. CCL21a (CCL21-Ser) is mainly 
expressed by mTECs and HEVs in SLOs and FRCs in T cell areas, while CCL21b 
(CCL21-Leu) is expressed mainly by LECs in peripheral tissues (Comerford, Harata-
Lee et al. 2013). The carboxi-terminal extension allows CCL21 to bind to the matrix 
glycosaminoglycans and this is required for efficient presentation at the surface of 
endothelial cells (Yoshida, Nagira et al. 1998). 
CCL19-deficient mice have only minor defects, which means that CCL21 is sufficient 
for most of the CCR7-dependent processes (Hauser and Legler 2016). Mice of the 
mutant strain plt (paucity of lymph node T cells), which are a result of a recessive 
spontaneous mutation, lack the gene for CCL21-Ser and for CCL19, while they express 
CCL21-Leu (Vassileva, Soto et al. 1999, Luther, Tang et al. 2000, Nakano and Gunn 
2001). These mice have reduced numbers of naïve T cells in SLOs due to a defect in 
homing. DC numbers and migration towards T zones after stimuli are also impaired in 
these mice. However, DCs exhibit normal emigration from skin epidermis (Gunn, 
Kyuwa et al. 1999). 
Both CCL19 and CCL21 induce G protein activation and calcium mobilisation to the 
same extent (Kohout, Nicholas et al. 2004). Moreover, both are able to cause 
polarisation of the actomyosin cytoskeleton, triggering chemotactic movement (Hauser 
and Legler 2016). Both ligands activate GRK6 (G-protein coupled kinases), but only 
CCL19 can activate GRK3. Cell polarisation is caused by small GTPases such as Rac, 
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RhoA and Cdc42 and it includes lamellipodia formation and stabilisation and uropod 
definition (Hauser and Legler 2016). 
CCL19 efficiently stimulates CCR7 phosphorylation in several Ser and Thr in the 
region 373-378 of the carboxyl terminus and internalisation, which causes receptor 
desensitisation by β-arrestin recruitment. Although CCL21 is also able to cause ERK1/2 
activation, CCL19 causes increased activation (Kohout, Nicholas et al. 2004). Receptor 
desensitisation by CCL19 may indicate that CCL19-mediated responses have a shorter 
time-span that those provoked by CCL21 binding (Forster, Davalos-Misslitz et al. 
2008). As CCL21 is immobilised, it can cause integrin activation leading to cell 
adhesion. When DCs contact with CCL21, they are able to trim CCL21-anchoring 
residues, releasing a soluble form of CCL21, whose behaviour resembles that of CCL19 
(Schumann, Lammermann et al. 2010). DCs subjected to immobilised CCL21 and 
soluble CCL19 use CCL21 for adhesive random migration while following CCL19-
gradients. So, immobilised and soluble chemokines are able to shape the migration 
together (Schumann, Lammermann et al. 2010). 
The observation that some ligands can induce more β-arrestin mobilisation than others 
gave rise to the notion that has been denominated ‘phosphorylation barcode theory’. 
According to this theory, each ligand stabilises ligand-specific receptor conformations, 
which leads to specific recruitment of GRKs that provoke a definite phosphorylation 
pattern in the C-terminus end of the receptor. This phosphorylation pattern defines the 
strength and stability of β-arrestin union that will subsequently determine if the GPCR 
is desensitised or desensitised and internalised (Hauser and Legler 2016). CCL19 and 
CCL21 binding to CCR7 also cause the stabilisation of different conformational states. 
CCL21 modifies CCR7 conformation towards an active state of TM6, while CCL19 
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stabilises more varied conformations and may have an effect specifically in TM7 
(Hauser and Legler 2016). 
 
1.10 General aims of this thesis 
The principal aim of this thesis is to broaden the knowledge about the signals that 
determine the pathway that a GC B cell will follow. The signals that help in the 
decisions that have to be made in the GC are just starting to be understood. Interactions 
with FDCs and Tfh cells have been shown to have a role in the post-GC differentiation 
as PCs or MBCs. 
Chapter 3 characterises the role of atypical chemokine receptor 4 (ACKR4), which is 
differentially expressed in the GC B cells, in the B cell responses, taking advantage of 
the ACKR4
-/-
 mouse model.  
Chapter 4 studies the role of chemokines CCL19 and CCL21, through their receptors 





Chapter 2. Materials and methods 
2.1 Mice 
Mice were bred and maintained under specific pathogen-free conditions at the 
Biomedical Services Unit, University of Birmingham, UK. All animal experiments 
preformed were approved by the institutional ethics committee and the Home Office, 
UK. Mice were used between 6 and 12 weeks old. 
 
2.1.1 WT mice 
C57BL/6 mice (wild type, WT) were purchased from Harlan laboratories. These mice 







) mice were a kind gift from R. Nibbs (University of 
Glasgow) and they were generated as described by Comerford and colleagues 
(Comerford, Nibbs et al. 2010). Briefly, the open reading frame of ACKR4 was 
replaced with a knock-out cassette that contained a floxed phosphoglycerine kinase 
promoter driven neomycin resistance gene and injected in mouse ES cells. Positive 
clones were identified and injected into blastocysts to generate chimeric mice. This 
offspring was crossed with ZP3-Cre transgenic mice and female offspring carrying both 
transgenes identified. Recombination occurred during oogenesis of the offspring from 
those females. Mice lacking ZP3-Cre and carrying the targeted version of ACKR4 were 
identified. They were then backcrossed for at least ten generations to C57BL/6. 
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2.1.3 ACKR4-GFP mice 
ACKR4-GFP mice have been previously described by Heinzel and co-workers 
(Heinzel, Benz et al. 2007). Shortly, 578 bp of ACKR4 coding sequence (nucleotides 
45-622 of the mRNA) were replaced in frame by an eGFP together with a neomycin 
resistance cassette, which was electroporated into ES cells. Specific integration was 
confirmed by Southern blotting and targeted ES cell were injected into C57BL/6 
blastocysts and later backcrossed onto the C57BL76 background. 
 
2.1.4 Quasi-monoclonal mice 
Quasi-monoclonal (QM) mice were first described by Cascalho and colleagues 
(Cascalho, Ma et al. 1996). These mice have a rearranged V(D)J segment at the 
immunoglobulin (Ig) heavy chain locus, being the other allele and the kappa light chain 
allele non-functional. This heavy chain paired with any lambda chain is specific for the 
hapten (4-hydroxy-3-nitrophenyl) acetyl) NP. Somatic hypermutation and secondary 
rearrangements change the specificity of approximately 20% of the B cells antigen 
receptors. For the purposes of this project, QM mice have been considered as those with 
a rearranged V(D)J segment at the immunoglobulin (Ig) heavy chain locus in both 
alleles and both alleles from the kappa light chain are non-functional. QM mice were 










). QM mice were crossed onto a Tdtomato strain (QM-TdTomato
+











2.1.5 Cγ1-Cre mice 
Cγ1-Cre mice have been previously described by Casola and co-workers (Casola, 
Cattoretti et al. 2006). In these mice, the expression of Cre recombinase is induced by 
the transcription of the Ig γ1 constant region gene segment (Cγ1), providing conditional 
gene targeting in the majority of the GC B cells that are generated after immunisation 
with TD antigens (Casola, Cattoretti et al. 2006). An internal ribosome entry site (IRES) 
followed by the Cre-coding sequence has been incorporated into the 3’ region of the 
Cγ1 locus between the last membrane-coding exon and the polyadenylation site. This 
approach creates two independent transcripts, the Cγ1 and the Cre. The carrying of two 








 mice were a kind gift from A. Rot (University of York, UK) and were 
generated as described in (Forster, Schubel et al. 1999). Briefly, a vector was 
constructed carrying a neomycin resistant gene to target the Ccr7 gene by deleting large 
parts of exon 3. Blastocysts were injected and heterozygous animals were crossed. 
About a quarter of the offspring carry the disrupted locus of both alleles. CCR7
-/-
 mice 









2.2.1 T-dependent antigens 
To study the primary response to thymus dependent antigens (TD), mice were 
immunised intraperitoneally (i.p.) with 50 μg NP-CGG ((4-hydroxy-3-nitrophenyl) 
acetyl Chicken γ- globulin) alum-precipitated. NP was conjugated to CGG at a ratio of 
NP18-CGG, a kind gift from Ms Chandra Raykundalia. NP-CGG is presented as a 5 
mg/ml solution and an equivalent volume of 9% AlK(SO4)2 is added. The pH is 
adjusted to 6.5 with NaOH 10 M and material is left spinning in dark for 30 min to 
allow maximum precipitation. The precipitate is washed twice in PBS (Sigma-Aldrich, 
UK) and the pellet resuspended in PBS to a final concentration of 250 µg/ml. 
When the primary response was studied in the popliteal lymph node (pLN), mice were 
immunised subcutaneously in one or both footpads with 20 μg NP-CGG alum 
precipitated prepared as the paragraph before. The pellet is resuspended to a final 
concentration of 1000 μg/ml. In order to study the secondary response to TD antigens, 
mice were primed i.p. with 50 μg alum–precipitated CGG (Rockland antibodies & 
assays, USA). CGG is precipitated in alum. CGG is presented as a 5 mg/ml solution and 
it is precipitated as NP-CGG. The pellet is resuspended to a final concentration of 250 
µg/ml. 1x10
5
 chemically inactivated Bordetella pertussis (b.p.) bacteria (LEE 
laboratories, BC, USA) were added as an adjuvant in all primary immunisations. 
Mice were challenged 5 weeks after priming with 50 µg of NP-CGG in 200 µl of PBS 
i.p. If the boosting was in the footpad, 20 µg of NP-CGG diluted in 20 µl of PBS were 
injected per leg in anesthetised mice. 
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Sheep red blood cells (SRBC) were also used as a TD antigen. 2x10
8
 SRBCs (TCS 
Biosciences, UK) in PBS were injected i.v. (intravenously) in the lateral tail vein. 
SRBCs were prepared by washing with PBS 3 times, followed by centrifugation and 
resuspension in PBS to a volume of 200 μl per mouse. 
 
2.2.2 T-independent antigens 
To study the response to thymus independent type II (TI-II) antigens, mice were 




Spleens were snap-frozen and stored at -80˚C. Lymph nodes were snap-frozen in OCT 
tissue-freezing solution (Leica Microsystems, UK) and stored at -80˚C. Spleen and 
lymph node cryosections (Bright Instruments, Huntingdon, UK) of 6 µm were placed 
onto either multispot slides (Hendley-Essex, UK) or Surgipath X-tra Adhesive Clipped 
Corned slides (Leica Biosystems). Slides were fixed in acetone (Acros Organics, USA) 
at 4˚C for 20 min, air dried and stored at -20˚C in polyethylene bags until further use.  
If the tissues were eYFP
+
, they had to be fixated prior to freezing. First, for 8 h in 1% 
paraformaldehyde (PFA, TAAB Laboratories, UK) and then 24 h in 30% sucrose 
(Sigma-Aldrich) at 4ºC. Before staining, frozen slides were allowed to reach room 




2.3.1 Immunofluorescence  
Slides were rehydrated in PBS. Once they were hydrated they should not be let to dry. 
Slides were blocked using 10% horse serum in PBS-10% BSA (Sigma-Aldrich) for 15 
min and permeabilised with 0.2% Triton X-100 (Sigma-Aldrich) in PBS for 10 min. 
Antibodies were diluted at the optimal dilution in PBS-10% BSA and incubated in a 
humid dark chamber for 1 h (Table i). Secondary and tertiary antibodies were incubated 
for 45 min with 5 min wash in PBS between incubations (Table ii). Slides were 
mounted in ProLong Gold antifade reagent (Invitrogen, USA) and let dry in a dark 
chamber for 24 h. Slides were stored at -20ºC in dark until observation.  
 
2.3.1a CCL21 staining 
In order to achieve optimal staining of CCL21 gradients, CCL21 staining has to be 
performed in fresh tissue. Briefly, spleen and lymph nodes were dissected and snap-
frozen in OCT immediately. Tissues had to be cut on the same day and stained without 
fixation. Image analysis gave better results when realised on the same day. 
 
2.3.2 Immunohistochemistry 
Slides were rehydrated in 5 mM Tris Buffered Saline pH 7.6 (TBS) prior to incubation. 
Antibodies were diluted at the optimal concentration in TBS (Table i) and incubated for 
1 h. Secondary antibodies conjugated to biotin or horseradish peroxidase were applied 
with 10% normal mouse serum for 45 min. The biotinylated secondary antibodies were 
detected using biotin-conjugated StreptABComplex-alkaline phosphatase complex 
(Dako, Glostrup, Denmark). Slides were developed sequentially. First, 3,3 
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diaminobenzidine tetrahydrochloride (DAB) (Sigma-Aldrich) was used as a substrate 
for HRP enzyme. Slides were washed between the additions of substrates. Then, fast 
blue substrate (Sigma-Aldrich) was used as substrate for alkaline phosphate enzyme. 
Both substrates were made up freshly before use. Slides were washed in TBS and in 
distilled water and mounted in glycerol gelatin (Sigma-Aldrich).  
 
Table i: Primary antibodies 
Target Isotype Clone Dilution Manufacturer 
CXCR4 Rat anti-mouse 2B11 1/100 BD Pharmingen 
LYVE-1 Rabbit anti-mouse 14917 1/200 Abcam 
Ki67 Rabbit anti-mouse 15580 1/300 Abcam 
CD138 Biotin anti-mouse 281-2 1/100 BD Pharmingen 
PNA Biotin anti-mouse B-1075 1/200 Vector Laboratories 
CCXCKR 
(ACKR4) 
Goat anti-mouse C-16 1/50 Santa Cruz Biotech 
IgD Rat anti-mouse 11-26c 1/500 BD Pharmingen 
CD3 Hamster anti-mouse 145-2C11 1/500 BD Pharmingen 
NP Sheep anti-mouse  1/3000 In house 
c-myc Rabbit anti-mouse Y69 1/200 Abcam 
CCL21 Goat anti-mouse AF457 1/20 R&D Systems 
CCR7 Rat anti-mouse 4B12 1/50 eBioscience 
 
Table ii: Secondary and tertiary antibodies 
Target Conjugation Dilution Manufacturer 
Rat anti-mouse CD4 APC 1/100 eBioscience 
Rat anti-mouse IgD APC 1/100 eBioscience 
Rat anti-mouse IgD BV421 1/100 Biolegend 
Donkey anti-rat IgG Cy3 1/200 Jackson ImmunoResearch 
Donkey anti-rabbit IgG FITC 1/200 Jackson ImmunoResearch 
Donkey anti-rabbit IgG DyLight 405 1/200 Jackson ImmunoResearch 
Biotin anti-hamster IgG Biotin 1/200 Vector Laboratories 
Donkey anti-goat IgG AF 488 1/200 Jackson ImmunoResearch 
SA AF 647 1/200 Jackson ImmunoResearch 
SA AF 488 1/200 Jackson ImmunoResearch 
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2.3.3 Slide observation 
Fluorescent slides were observed in a Leica DM6000 (Leica Microsystems) controlled 
by LAS-AT software (Leica Microsystems) and pictures taken with a Leica DF350FX 
camera. Non-fluorescent slides were observed using a Leica DM6000 and pictures taken 
with a 5.ORTV camera with Q capture software. Whole spleen or whole lymph node 
section images were obtained with the Zeiss AxioScan Z1 equipment (Carl Zeiss, 
Germany) and processed with software ZEN, blue edition (Carl Zeiss).  
 
2.4 Enzyme-linked immunosorbent analysis (ELISA) 
Blood was collected by cardiac puncture from anaesthetised mice by isoflurane 
inhalation. Sera were obtained after clotting and centrifugation of blood samples. It was 
stored at -20˚C until analysis. Microtiter plates (Thermo Fisher Scientific, USA) were 
coated (5 µg/ml) overnight at 4ºC. NP15-BSA-coupled microtiter plates were used to 
detect NP-specific antibody. NP2-BSA-coupled microtiter plates were used to measure 
the high-affinity antibody fraction. CGG-coupled microtiter plates were used to measure 
antibodies coming from the memory response. Plates were washed in wash buffer and 
blocked with 200 μl of blocking buffer for 1 h at 37ºC. Serial tripling dilutions (1/30 
dilution at start) of serum samples were added into the plates and incubated for 1 h at 
37ºC. After this incubation, plates were washed and secondary AP-conjugated 
antibodies were added, specific for IgG, IgG1, IgG3 and IgM (Southern Biotech, USA) 
(Table iii). In adoptive transfer experiments, to detect antibodies produced from 




 (BD Pharmingen, USA) followed 
by incubation with streptavidin-conjugated Alkaline Phosphatase (Vector Laboratories, 
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USA) were used. Plates were incubated with secondary antibodies for 45 min at 37ºC 
and washed again. 
ELISA plates were developed using SIGMAFAST
TM
 (Sigma-Aldrich). Shortly, one p-
nitrophenyl phosphate (pNPP) tablet (1.0 mg/ml) and one Tris Buffer tablet (0.2 M Tris 
buffer and 5 mM magnesium chloride) were dissolved in 20 ml of ddH2O. Plate’s 
absorbance is read at 405 nm using Synergy HT Microplate Reader (BioTek, USA). 
Table iv provides a list of the reagents used. 
Negative and positive controls were included in each plate and antibody titres were 
calculated as a relative measure. Relative affinity was calculated as the fraction of NP2 
and NP15 relative antibody titres (NP2/NP15). 
 
Table iii: Antibodies used in ELISA 
Target Clone Dilution Manufacturer 
Goat anti-mouse IgM-AP 1020 1/2000 Southern Biotech 
Goat anti-mouse IgG3-AP 1100 1/1000 Southern Biotech 
Goat anti-mouse IgG1-AP 1070 1/1000 Southern Biotech 
Goat anti-mouse IgG-AP 1030 1/1000 Southern Biotech 
Biotin mouse anti-mouse 
IgMa  
DS-1 1/500 BD Pharmingen 
Biotin mouse anti-mouse 
IgMb  
AF6-78 1/500 BD Pharmingen 
 
Table iv: Reagents used in ELISA 
Reagent’s name Reagent’s ingredients 
Coating buffer Na2CO3 1.95g, NaHCO3 2.93g in 1 litre dH2O, pH=9.6 
Blocking/Dilution buffer 0.1M PBS + 0.05% Tween (Sigma) 
Wash buffer 0.1M PBS + 1% BSA (Sigma) 




2.5 Flow cytometry 
Spleens and lymph nodes were mashed and the cell suspensions were filtered using a 70 
µm cell strainer (Thermo Fisher Scientific) in RPMI 1641 culture media (Sigma-
Aldrich) supplemented with 5% foetal calf sera (FCS, Thermo Fisher Scientific, Gibco) 
and 1% penicillin/streptomycin (penicillin 10000 units/ml and streptomycin 10000 
µg/ml, Invitrogen) and stained for surface markers in a 96 well plate (Corning, USA).  
Bone marrow was extracted from femur and tibia bones. The cell suspension was 
filtered and stained for surface markers in a 96 well plate. 
Blood was collected by cardiac puncture from anaesthetised mice by isoflurane 
inhalation and incubated with Ethylenediaminetetraacetic acid (EDTA, Sigma-Aldrich) 
to avoid clotting. Red blood cells were lysated by several incubations with ACK lysing 
buffer (Gibco). Cells were stained for surface markers in a U-bottom 96 well plate 
(Thermo Fisher Scientific). 
Fc gamma II and III receptors were blocked (20 min at 4˚C) using an anti-CD16/32 
antibody diluted in FACS buffer (PBS supplemented with 1% FBS plus 5 mM EDTA). 
Surface antibodies were incubated diluted at the optimal concentrations (20 min at 4˚C) 
in FACS buffer and washed twice with FACS buffer prior to analysis (Table v).  
If required, 10000 counting beads (Spherotech, Inc) were added to the samples before 
analysis. Samples were analysed using CyAN FACS Analyser (Beckman Coulter) with 
the software Summit v4.3 (Beckman Coulter, USA) or with BD LSRFortessa Analyzer 
(BD Biosciences, USA) with the software BD FACSDiva (BD Biosciences). Data were 




2.5.1 Proliferation measure by injection of EdU  
Mice were injected intraperitoneally with 2 mg of the thymidine analog 5-ethynyl-2'-
deoxyuridine (EdU, Life Technologies) dissolved in PBS. EdU incorporation was 
analysed using the kit Click-iT Edu Alexa Fluor 647 for Flow cytometry (Life 
Technologies) following manufacturer’s instructions. This protocol is based on 
aldehyde fixation and detergent permeabilisation for antibody labelling. Once the cell 
suspension has been stained with surface antibodies (except BV510, PE and PE-
conjugated), they were washed with PBS-1% BSA. Then, they were incubated with 
Click-iT fixative and washed again. Afterwards, cells were incubated with Click-iT 
saponin-based permeabilisation and wash reagent. Following this incubation, cells were 
stained with Click-iT reaction cocktail (Table vi). Cells were washed again and 
incubated with the remaining surface markers. 
 
2.5.2 phospho-Akt staining by flow cytometry 
First, the cell suspension was stained with surface antibodies as described above. Cells 
were fixed in 4% freshly prepared PFA in PBS for 15 min at RT. Then, they were 
centrifuged and 1 ml of ice-cold acetone was added and incubated for 20 min on ice. 
After removing of the acetone by pipetting and wash with FACS buffer, the cell 
suspension was stained with anti-p-Akt-biotin in FACS buffer for 1 h at RT. Finally, 
cell suspension was stained using streptavidin and analysed in a flow cytometer. 
As this method destroys many antibody-epitopes, it was important to check if the other 
markers used are still working. B220 staining was found to be altered and appropriate 
controls were included. 
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Table v: Antibodies and chemicals used in FACS 
Target Clone Conjugation Dilution Manufacturer 
CD16/32 93 Purified 1/200 eBioscience 
CXCR4 (CD184) 2B11 biotin 1/100 BD Pharmingen 
PDL2 (CD273) TY25 biotin 1/200 Biolegend 
B220 (CD45R) RA3-6B2 FITC 1/200 BD Pharmingen 
B220 (CD45R) RA3-6B2 eFluor 450 1/100 eBioscience 
B220 (CD45R) RA3-6B2 BV510 1/200 Biolegend 
CD86 GL1 PE-Cy5 1/300 eBioscience 
CD86 GL1 BV650 1/200 Biolegend 
CD80 16-10A1 PE-Cy5 1/300 eBioscience 
Fas (CD95) Jo2 PE-Cy7 1/200 BD Pharmingen 
CD73 eBioTY PE-Cy7 1/300 eBioscience 
CD38 90 APC 1/1000 eBioscience 
CD38 90 FITC 1/100 eBioscience 
Syndecan-1 CD138 281-2 BV421 1/300 Biolegend 
GL7 GL-7 eFluor 450 1/200 eBioscience 
NP  PE  In house 
phospho-Akt (S473) D9E biotin 1/100 Cell Signalling 
Annexin V  APC 1/20 BD Pharmingen 
7-AAD   1/20 eBioscience 
SA  FITC 1/200 BD Pharmingen 
SA  PE-Cy5 1/200 BD Pharmingen 
SA  BV650 1/200 BD Horizon 
 
Table vi: Reagents included in Click-iT EdU reaction cocktail 
Reagent Amount for 1 sample (µl) 
PBS 43.8 
CuSO4 1 
AF 647 azide 0.25 
1x Click-iT EdU buffer 5 
Click-iT Wash buffer 10 
 
 
2.6 Adoptive transfer 
B cells were isolated from the spleen of unimmunised QM mice using the MACS 
system (Miltenyi Biotec GmbH, Germany). First, spleens were mashed and filter as 
described in section 2.5. Red cells were lysed by incubation with ACK lysis buffer 





 cells in 270 µl MACS buffer (degassed PBS without calcium and magnesium, 
0.5% BSA (Sigma-Aldrich), 2 mM EDTA (Sigma-Aldrich)). 30 µl CD43
+
 microbeads 
(Miltenyi Biotec) were added and incubated at 4ºC for 15 min. Then, splenocytes were 
washed and re-suspended in 500 µl MACS buffer before being applied to the LS 
column (Miltenyi Biotec) under the magnetic field. After pass through of 9 ml of 
MACS buffer, a purity of >90% B cells was generated. Eluted cells were counted using 





 cells was determined using flow cytometry.  






 B cells were injected 







 B cells were injected i.v. in 200 µl RPMI in the lateral tail vein. 






 B cells of each genotype 
respectively were injected i.v. One day after adoptive transfer mice were immunised 
with NP-CGG or NP-Ficoll, as described in the immunisations section.  
 
2.7 Fluorescence-activated cell sorting (FACs) 
Spleens, draining and distal lymph nodes were mashed, filtered and stained in a 100 µl 
volume. Fc gamma II and III receptors were blocked (30 min at 4˚C) using an anti-
CD16/32 antibody diluted in FACS buffer. Surface antibodies were incubated (30 min 
at 4˚C) in FACS buffer and washed twice with FACS buffer. Dead cells were excluded 
by Hoechst 33342 inclusion. Cells were sorted in MoFlo high-speed cell sorter 
(Beckman Coultier). Sorted cells were checked for purity using flow cytometry, 




2.8 mRNA detection 
2.8.1 Total mRNA extraction 
RNA was extracted from sorted cells (previously stored at -80˚C) using the RNeasy 
Mini kit or Micro kit (Qiagen, Crawley, UK) depending on the amount of cells, after 
homogenization of tissue using a QIAshredder column (Qiagen), following 
manufacturer’s instructions. mRNA was eluted in 15 or 30 µl of RNase free water and 
stored at -80ºC until further requirement.  
 
2.8.2 Production of cDNA 
cDNA was obtained by addition of random oligo-dN6 (1 μg/µl) (Promega Biosciences, 
USA) to the mRNA, denatured at 70˚C for 10 min and instantly cooled on ice. Reverse 
transcription mix was added to retrotranscribe the previously denatured mRNA. 
12 µl 5X first strand buffer (Invitrogen) 
6 µl DTT 0.1 M (Promega) 
3 µl dNTPs 10 mM (Invitrogen) 
3 µl Moloney murine leukaemia virus (M-MLV) reverse transcriptase 
(Invitrogen) 
1.5 µl RNasin RNase inhibitor (Promega) 
1.5 µl RNase free water (Qiagen) 
This mix was heated for 1 h at 41ºC and after for 10 min at 90ºC. cDNA was stored at -




2.8.3 Semi-quantitative real time PCR  
PCR was carried out in 384 well plates (Applied Biosystems, USA) with 1 µl of cDNA 
plus the optimal concentration of primers and probes, previously determined, and 
Taqman Universal PCR Master Mix (Applied Biosystems). The plate was covered with 
clear adhesive foil (Applied Biosystems) and centrifuged for a few seconds to eliminate 
any air bubble. Amplification of the internal housekeeping gene (β2-microglobulin, 
NED labelled) was done at the same time as the target gene. Ccr7 was FAM labelled. 
Ackr4 was detected using SYBR Green PCR Master mix (Thermo Fisher Scientific). 
PCRs were run using an ABI 7900 real-time PCR machine (Applied Biosystems): 
2 min at 50ºC 
10 min at 95ºC 
Followed by 40 cycles of: 
 15 s at 95ºC 
 1 min 60ºC 
SDS 2.2.2 (Applied Biosystems) software with manual determination of the threshold 
was used for the analysis of the fluorescence signals. The relative quantity of the 




Target Nucleotide sequence Concentration 
 
Ccr7 
Forward GGTGGCTCTCCTTGTCATTTTC 50 nM 
Reverse GTGGTATTCTCGCCGATGTAGTC 50 nM 
Probe TGCTTCTGCCAAGATGAGGTCACCG 150 nM 
β2-micro 
globulin 
Forward CTGCAGAGTTAAGCATGCCAGTAT 60 nM 
Reverse ATCACATGTCTCGATCCCAGTAGA 80 nM 
Probe CGAGCCCAAGACC 125 nM 
Ackr4 
Forward TGGATCCAAGATAAAGGCGGGGTGT 20 nM 





2.9 In vitro cell culture 
B cells were isolated from spleen as described in section 2.6 and labelled with CellTrace 
Violet Cell Proliferation kit (Invitrogen) following the manufacturers’ instructions. B 
cells were seeded in triplicates at 1x10
5
 cells/well into sterile flat-bottomed 96 well 
plates (Corning) and grown in 150 μl pre-warmed RPMI 1641 media supplemented with 
10% FCS, 1% pen/strep, 10 mM HEPES, 50 µM 2-mercaptoethanol and 1 mM sodium 
pyruvate (all from Sigma-Aldrich). At selected time points after stimulation, cell were 
harvested by centrifugation and further analysed by flow cytometry. 
 
2.9.1 NP-Ficoll-CCL19 stimulation 




cells were quantified by flow cytometry 






cells in 200 μl of culture media per well. Cells were 
stimulated with 2 ng/well NP-Ficoll and if necessary, with 200 ng/well mouse 
recombinant CCL19 (R&D Systems). p-Akt status was analysed 30 min after 
stimulation. 
 
2.10 Image analysis 
The images obtained from the microscope were analysed offline with the software Fiji 
(Fiji Is Just ImageJ). All analyses were performed blindly for the genotype of the 




2.10.1 Migration of NP
+
 B cells to the B-T zone interphase 
The region of interest (B follicle – T zone interphase) was marked manually with a 
thickness of 5-6 cells and converted into a mask. The original image was separated into 
Blue and Brown channels using the tool “Colour deconvolution” of ImageJ. The blue 
channel image, which corresponded with the NP staining, was thresholded with the 
“Default” method and the positive area for NP inside the mask area was measured. The 
fraction of positive area was represented graphically (Fig. 2.1). 
Figure 2.1: Technique for quantifying NP
+
 cells at the T-B border. Representative example 
of a spleen section 4h post NP-Ficoll immunisation where NP
+
 cells at the T zone-B follicle 
border were quantified. ImageJ was used to separate the blue and brown colours using colour 
deconvolution. The region of interest was drawn in the original image and converted into a 
Mask. The blue channel was thresholded using the “Default” Thresholding method and added 
using “Image calculator” to the Mask. The positive area in the resulting image was measured 
using “Analyze particles” and the % of the selected area covered by NP
+
 cells calculated. 
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2.10.2 Infiltration of IgD
+
 cells in the GC area 
GC areas were marked manually in the original images and these areas were converted 
into masks. Using the tool “Colour deconvolution” from ImageJ, the original image was 
separated into blue and brown channels. The brown channel image, which corresponded 
with the IgD staining, was thresholded using the “Default” thresholding method. The 
particles in the area of the mask from the Thresholded image were measured and the % 
of GC covered by IgD
+
 cells was calculated (Fig. 2.2). 
Figure 2.2: Technique for quantifying IgD
+
 cells in the GC area. Representative example of a 
spleen section 8 days post immunisation with NP-CGG where IgD
+
 cells invading the GC area 
were quantified. ImageJ was used to separate the blue and brown colours using colour 
deconvolution. The region of interest was drawn in the original image and converted into a Mask. 
The brown channel was thresholded using the “Default” Thresholding method and added using 
“Image calculator” to the Mask. The positive area of the resulting image between the mask and the 
brown thresholded image was measured using “Analyze particles” and the % of GC covered by 
IgD
+
 cells calculated. 
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2.10.3 PNA/IgD ratio 
The fraction of GC that was covered by naïve B cells was measured in 
immunofluorescence staining images from splenic sections of mice transferred with 
eYFP
+
 antigen-specific B cells 4 days post-immunisation with NP-Ficoll. GCs were 
identified as regions positive for PNA. The area positive for PNA and negative for IgD 





 areas were selected independently in each specific fluorescence channel. The 
areas of interest were measured using the option “Analyze; Measure”. Afterwards, the 
area in pixels was transformed to area in µm
2





 area *100). 
 
2.10.4 DZ/LZ ratio 
To investigate the intragerminal centre distribution, the fraction of GC that formed the 




 mice at different time 
points post-immunisation were stained for PNA, CXCR4 and IgD. GCs were identified 
as regions positive for PNA and negative for IgD and selected manually by drawing 
around the area. DZ/LZ distribution was determined by the CXCR4
+
 staining. DZ areas 









 cells in GC-T zone interphase 





 mice at different time points post-immunisation 
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were stained for PNA, CXCR4 and IgD. For this quantification only the GCs that were 
orientated appropriately were analysed. GCs had to be adjacent to the T zone, with a 
clear separation between LZ and DZ, denoted with CXCR4 staining. T cell areas were 
distinguished as IgD
-





that were positioned on the GC-T zone interphase were counted manually. The GC-T 
zone interphase was identified by the region were GCs were adjacent to the T zone with 
no IgD
+
 B cells in the middle and its length was measured using the tool “Analyze: 
Measure”. Numbers of CXCR4
+
 plasmablasts were represented in relation to the length 
of the interphase. 
 
2.10.6 Counts of CD3
+
 cells in GC areas 
In order to investigate the possibility of enlarged LZ areas due to increased numbers of 





 mice at different time points post-immunisation were stained for PNA, 
CD3 and IgD. GCs were identified as regions positive for PNA staining. CD3
+
 cells 
inside each GC were counted manually at 20x magnification.  CD3
+
 cell numbers were 
divided by PNA
+
 area, in order to represent the number of positive cells per unit of area.  
 
2.10.7 Counts of c-Myc
+
 cells in GC areas 
To explore the possibility of enlarged LZ areas due to increased expression of c-Myc by 





 mice at different time points post-immunisation 





 cells inside each GC were counted manually at 20x 
magnification.  c-Myc
+
 cell numbers were divided by PNA
+
 area, in order to represent 
the number of positive cells per unit of area.  
 
2.10.8 Counts of GFP
+
 MBCs in different distLN areas 
The distribution of GFP
+
 MBCs within the distant lymph nodes of Cγ1-Cre mTmG 
ACKR4
+/+
 and Cγ1-Cre mTmG ACKR4
-/-
 mice was analysed 8 days post-immunisation. 
GFP
+
 cells were counted manually from digital images of axillary lymph nodes stained 
for IgD and Lyve-1. The total area of the axillary LN and of the different areas were 
measured (vessels, follicles and T zone). The number of GFP
+
 MBCs was represented 
in relation to the area there were in. 
 
2.10.9 Counts of GFP
+
 MBCs in SCS 
The number of GFP
+
 MBCs that have migrated to the SCS was investigated in popliteal 
lymph node sections from Cγ1-Cre mTmG ACKR4
+/+
 and Cγ1-Cre mTmG ACKR4
-/-
 
mice at different time points post-immunisation stained for IgD and Lyve-1. GFP
+
 cells 
in the SCS were counted manually. The portion of the SCS analysed had to be intact, 
this is that the floor and ceiling LECs were present, marked by Lyve-1 staining and 
TdTomato expression, respectively. The length of the intact SCS was measured using 
the tool “Analyze: Measure”. The number of GFP
+
 MBCs was represented in relation to 




2.11 CCL19 injection 
Recombinant mouse CCL19 (R&D systems) was injected in the same footpad where 
antigen was injected at a concentration of 3 μg/ 20 μl PBS, 24 h or 6 h before lymph 
nodes were taken. 
 
2.12 Statistical analysis 
All statistical tests were performed using GraphPad Prism 6 software. Two-tailed 
Mann-Whitney non-parametric test was used to calculate significance.  
In Chapter 4, where 2 parameters coming from the same individual mouse are 
compared, Wilcoxon matched-pairs signed rank test (paired non-parametric test) was 
used to calculate significance. 
P values <0.05 were considered significant (*).   





Chapter 3. The role of ACKR4 in the murine splenic B cell 
responses  
3.1 Introduction and objectives 
3.1.1 Migration of GC B cells 
GC B cells are type of antigen-specific B cell that, although they are considered to be 
mature, they must differentiate further into high-affinity plasma cells or memory B 
cells. These cells have very distinct characteristics and a specific transcriptional 
programme. The signals that regulate this differentiation are far from being fully 
understood. In order for this differentiation to occur, GC B cells must migrate within the 
GC microenvironments and respond to different signals from FDCs and Tfh cells, 
which include cytokines and chemokines. 
Originally, GC B cells were considered to be a stage of non-migratory antigen-activated 
cells as they were unable to recognise and bind to HEVs, which normally mediate the 
entrance of lymphocytes to lymphoid tissues (Reichert, Gallatin et al. 1983). GC B cells 
are irresponsive in vitro to signals such as CXCL12, CCL19 and CXCL13, which drive 
migration of other B cells such as naïve and MBCs (Bleul, Schultze et al. 1998, Roy, 
Kim et al. 2002). Today, we know that GC B cells constitute a highly migratory 
population although they are confined to the local GC microenvironment. Two-photon 
microscopy imaging of the GC in vivo has allowed investigation of the movement of B 
cells within the GC (Allen, Okada et al. 2007, Hauser, Junt et al. 2007, Schwickert, 
Lindquist et al. 2007) and, together with mathematical modelling, demonstrated that GC 
B cells actively undergo chemotaxis to maintain GC zoning (LZ/DZ). Additionally, 
chemokine sensitivity is quickly downregulated (Figge, Garin et al. 2008). 
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Responsiveness to CXCL12 via CXCR4 is required for DZ/LZ segregation in the GC, 
while responsiveness to CXCL13 via CXCR5 helps to guide GC B cells towards the LZ 
(Allen, Ansel et al. 2004). CXCR4-deficient GC B cells are prevented from entering the 
DZ; but in the LZ cell-cycle progression occurs normally, they accumulate less 
mutations and PC development is normal. However, when GC B cells are restricted to 
the LZ there is increased generation of MBCs (Bannard, Horton et al. 2013). Therefore, 
responsiveness of GC B cells to chemokines and cytokines needs to be coordinated in 
order to balance proliferation versus differentiation. 
Moreover, once GC B cells differentiate to leave the GC and become PCs or MBCs, 
their responsiveness to chemokines needs to change so they are able to migrate to their 
respective niches. 
 
3.1.1a Regulation of chemokine receptor signalling 
Chemokine receptor signalling needs to be tightly regulated. Limitation and 
desensitization/resensitization of chemokine receptor signalling is important for the 
transzone migration frequencies, the re-entry into the cell cycle and the closure of the 
response in the GC (Meyer-Hermann, Mohr et al. 2012).  
GC B cells regulate their responsiveness to chemokines CXCL12 and CXCL13 by two 
Regulator of G protein signalling (RGS) molecules, the sensitizer RGS1 and the 
desensitizer RGS13. CD40 stimulation augments RGS13 while engagement of the B 
cell receptor (BCR) enhances the expression of RGS1 (Shi, Harrison et al. 2002). Mice 
deficient in RGS1, a GTPase that activates proteins for Gα subunits, have GCs in 
steady-state conditions and immunisation of these mice leads to exacerbated GC 
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formation and abnormal trafficking of plasma cells (Moratz, Hayman et al. 2004). As 
compared to WT B cells, a higher percentage of unstimulated RGS1-deficient B cells 
migrate towards CXCL12 (Moratz, Hayman et al. 2004). Despite the abnormalities in 
mice deficient in RGS1, affinity maturation is not altered (Moratz, Hayman et al. 2004). 
LZ GC B cells express high levels of RGS13 which desensitises chemokine signalling 
from CXCR4 and CXCR5 (Mountz, Wang et al. 2011). Furthermore, GC B cells also 
regulate their responsiveness in regard to fluctuating levels of chemokines in the GC 
zones, for example CXCL13 is expressed in the LZ and CXCL12 in the DZ (Allen, 
Ansel et al. 2004). 
Atypical chemokine receptors (ACKRs) also provide a way to regulate responsiveness 
to chemokines, as they are able to internalise chemokines to influence gradients 
(Ulvmar, Hub et al. 2011). The aim of this project has been to elucidate the role of 
atypical chemokine receptor 4 (ACKR4) which is able to regulate the responsiveness of 
cells to CCL19, CCL21 and CCL25, during the GC response.  
 
3.1.2 c-Myc in B cells and in the germinal centre 
In the case of human hepatocellular carcinoma, tumours that express ACKR4 have been 
shown to be less malignant. ACKR4 inhibited tumour progression by scavenging 
CCL19 and CCL21, reducing their binding to CCR7 and, therefore, the signalling 
driven by CCR7. CCR7 signals through the Akt-GSK3β pathway, and its 
downregulation leads to downregulation of c-Myc (Shi, Yang et al. 2015). In this 




The c-Myc oncogene was identified more than three decades ago and aberrant c-Myc 
has been associated with many cancers (Nie, Hu et al. 2012). As to B cells, c-Myc has 
also been found to be linked to chromosomal translocations in human GC-derived B cell 
lymphomas (Klein and Dalla-Favera 2008), such as in Burkitt lymphoma, where it 
collaborates with PI3K for its development (Sander and Rajewsky 2012). c-Myc is a 
transcription factor which acts as master regulator of cellular proliferation and apoptosis 
in haematopoietic and non-haematopoietic cells (Calado, Sasaki et al. 2012). The 
structure of c-Myc is a basic-loop-helix-leucine zipper and c-Myc binds to DNA in a 
sequence specific manner (E-boxes) when bound to Max (Perez-Roger, Kim et al. 
1999). Expression of c-Myc is associated with cell activation and is induced during the 
transition from G0-G1 to the S-phase of the cell cycle (Nie, Hu et al. 2012). c-Myc does 
not act as a global transcriptional amplifier but activates and represses transcription of 
discrete gene sets which then leads to changes in the cellular state that can increase the 
global production of RNA (Sabo, Kress et al. 2014). 
In the mouse, germline inactivation of c-Myc causes embryonic lethality at E10 (de 
Alboran, O'Hagan et al. 2001). Therefore, to study the role of cMyc in mature B cells, c-
Myc has been specifically deleted in CD19 B cells using the LoxP/Cre system. Using 
this system, it has been shown that c-Myc is required for normal B cell activation and 
proliferation, as c-Myc deficient B cells express low levels of CD95 (Fas) and CD95L 
(FasL) after activation (de Alboran, O'Hagan et al. 2001). c-Myc deficient B cells  
express normal surface levels of activation markers and are more resistant to CD95 and 
staurosporine-induced  and spontaneous cell death (de Alboran, Baena et al. 2004). The 
early stages of B cell differentiation in vivo require c-Myc which endows B cell identity 
via direct transcriptional regulation of Ebf-1 (Vallespinos, Fernandez et al. 2011) and 
amplification of calcium signalling (Habib, Park et al. 2007). In the B cell lymphoma 
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murine cell line WEHI 231, BCR-mediated apoptosis is linked with a reduction of c-
Myc expression resulting from a drop in NF-κB/Rel (Wu, Arsura et al. 1996). c-Myc 
has also been shown to play an important role in antibody secretion as c-Myc deficient 
B cells hyper-secrete IgM and cannot undergo CSR due to AID not being activated 
(Fernandez, Ortiz et al. 2013). 
Initially, c-Myc was considered to not to have a role in GC B cell proliferation (Klein, 
Tu et al. 2003) as GC B cells, compared to cells in the surrounding compartments, 
express very little c-Myc. Moreover, the master regulator of GC B cell phenotype, Bcl-
6, interacts with Miz-1, a transcription factor that, like c-Myc, represses CDK inhibitors 
(Phan, Saito et al. 2005). Therefore, GC B cells express high amounts of a transcription 
factor, Miz-1, that can act as an alternative to c-Myc. Bcl-6 can also repress the 
transcription of c-Myc  and of cyclin D2, a c-Myc target (Shaffer, Yu et al. 2000). 
Furthermore, GC B cells express mainly cyclin D3, which controls G1/S-phase 
transition and is not controlled by c-Myc (Perez-Roger, Kim et al. 1999).  
By using a c-Myc conditional KO, Calado and co-workers demonstrated that c-Myc is 
expressed in both mature and immature GCs and that c-Myc is indeed essential for the 
formation and maintenance of GCs (Calado, Sasaki et al. 2012). During the early stages 
of GC formation, GC B cells express both cyclin D2 and cyclin D3, which contribute to 
the hyper-proliferative characteristics of GC B cells. In mature GCs, c-Myc expressing 
cells were localised mostly in the LZ and these cells have the characteristics of activated 
cells (Calado, Sasaki et al. 2012). The authors suggested that GC B cells have a “cyclic 
dependence” on c-Myc for their proliferation, characterised by a very transient 
expression of c-Myc that is able to trigger competence for a GC B cell to enter a phase 
of proliferative expansion (Calado, Sasaki et al. 2012).  
62 
 
Using c-Myc GFP reporter mice, Dominguez-Sola and colleagues observed a transient 
expression of c-Myc in B cells that were engaging with T cells in the early phases of 
GC commitment (Dominguez-Sola, Victora et al. 2012). The authors further found that 
c-Myc expression in the GCs was restricted to a few cells in the LZ (around 10%) and 
that this expression may specify re-entry of cells into the DZ B cell pool. The few cells 
that express c-Myc may be the reason why other works have reported that GC B cells 
do not express c-Myc. (Dominguez-Sola, Victora et al. 2012). Dominguez-Sola and co-
workers hypothesised that repression of c-Myc expression in the DZ is important to 
limit the rounds of cell division each cell undergoes before each round of affinity-based 
selection to one division. This is important to allow the normal progression of somatic 
hyper-mutation (Dominguez-Sola, Victora et al. 2012). 
 
3.1.3 Objectives of this chapter 
The work presented in this chapter has investigated the response of ACKR4-deficient 
mice to T-dependent and T-independent antigens (NP-CGG, SRBC and NP-Ficoll) at 
various times after immunisation. The role of ACKR4 has been studied extensively in T 
cells and various cancer models. Despite specific expression of ACKR4 at the late 
stages of B cell differentiation, the role of ACKR4 has never been studied before in 
regard to the B cell response.  
The work has aimed to test whether ACKR4 deficiency in the B cells or in the 
surrounding environment has a role in the GC response, detailed as follows: 
1. Where are ACKR4 and related molecules expressed in the murine spleen and 
lymph nodes, in terms of both at the mRNA and protein? 
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2. Does ACKR4 deficiency have an effect on the germinal centre response? 
Specifically, on: 
a. GC B cell numbers and LZ/DZ differentiation 
b. GC output: plasma cells and memory B cells 
c. Expression of key signalling molecules 
d. Affinity maturation and antibody production 






3.2.1 Ackr4 expression at mRNA level  
In order to investigate the stages of mature B cell differentiation at which the atypical 
chemokine receptor 4, Ackr4 (previously known Ccrl1) is expressed, a search was 
performed using the Immunological Genome project (Immgen) dataset. Immgen is an 
online data base containing gene expression data from a large variety of cells types of 
the murine immune system (Heng and Painter 2008). A first overview of Immgen data 
for Ackr4 expression revealed that it is expressed in one population of B cells and two 
populations of stromal cells (green squares Fig. 3.1 upper). The stromal cells that 
express Ackr4 are lymphatic endothelial cells (LECs) from lymph nodes and cortical 
and medullary epithelial cells from the thymus. Within the forty key haematopoietic cell 
populations for which mRNA expression profiles are deposited in the Immgen database, 
Ackr4 mRNA was found to be specifically upregulated just in splenic GC B cells (Fig. 
3.1 lower). For the purposes of this project, expression of Ackr4 in the B cell population 
is of particular interest as the role of Ackr4 in the lymphatic endothelial cells of the 
lymph node subcapsular sinus has been previously studied (Ulvmar, Werth et al. 2014). 
Ackr4 shares the ligands CCL19 and CCL21 with Ccr7. Hence, expression of Ccr7 was 
also checked as to the database (Fig. 3.2). Contrary to Ackr4, Ccr7 expression was 
observed to be more abundant among the different haematological populations (green 
and red squares Fig. 3.2 upper), especially among the different T cell and DC 
subpopulations. Interestingly, Ccr7 mRNA level is greatly downregulated in GC B cells 
(Fig. 3.2 lower). 
Victora and co-workers (Victora, Dominguez-Sola et al. 2012) have performed a gene 
array analysis of murine and human LZ and DZ GC B cells. These data are available 
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online at the GEO (Gene Expression Omnibus) database, with accession numbers 
GSE38696 for Mus musculus and GSE38697 for Homo sapiens. Comparison of murine 
Ackr4 and Ccr7 levels for the above two cell types revealed an inverse expression 
pattern, with Ackr4 strongly up-regulated in the DZ and Ccr7 up-regulated in the LZ 
(Fig. 3.3). This pilot data encouraged further study of Ackr4 expression during the 
course of an immune response. Total RNA was isolated at different time points from 
splenic tissue sections of WT mice immunised with SRBC. Ackr4 expression was 
analysed by qPCR. Fig. 3.4a shows that Ackr4 expression increases at a constant rate 
from day 2 to day 3 post-immunisation (Fig. 3.4a). Ackr4 expression plateaus at its 
highest level around a week post primary immunisation. This indicates that Ackr4 may 
indeed be expressed specifically in structures that appear later in the immunological 
response, for example, the germinal centre. To confirm these results further, different 
populations of B cells were sorted from the draining and distant lymph nodes of WT 
mice that have received Cγ1-Cre x QM ROSAeYFP B cells and 8 days post-
immunisation in the hind feet with NP-CGG (Fig. 3.4b).  The qPCR analysis of the 
different FACS-sorted populations confirmed that Ackr4 was up-regulated up to a 
thousand times in GC B cells compared to naïve B cells, while memory B cells (MBCs), 
both from draining and distant LN, had intermediate levels of expression, 5-10 times 
higher than naïve B cells. In plasma cells, Ackr4 expression was found to be low (Fig. 
3.4c, left). Ccr7 expression was studied in the same sorted populations and revealed a 
constant level of Ccr7 mRNA expression among all B cell populations studied except 






Figure 3.1: Ackr4 is expressed by germinal centre B cells. Ackr4 (Ccrl1) gene expression in the 





Figure 3.2: Ccr7 is broadly expressed by cells of the haematopoietic system. Ccr7 gene expression 











Dark zone Light zone Dark zone Light zone 
Figure 3.3: Ackr4 and Ccr7 expression GC B cell subsets. Ccr7 (left) and Ackr4 (right) expression 




Figure 3.4: Ackr4 is expressed by GC B cells (2). a) Ackr4 expression was measured by qPCR from 
splenic sections during a time course response of WT mice immunised with SRBC. b) Representative 
sorting strategy for different B cell subsets sorted from lymph nodes of WT mice transferred with Cγ1-
Cre x QM ROSAeYFP B cells 8 days post-immunisation with NP-CGG. c) Ackr4 (left) and Ccr7 
(right) expression measured by qPCR in B cell subsets sorted in b).  
Each symbol represents one mouse. Horizontal line represents the median.  
Key: DrLN: draining lymph node; DistLN: distant lymph node; GC: germinal centre, MBCs: memory 






3.2.2 ACKR4 expression at protein level  
To determine the tissue distribution of ACKR4 expression at the protein level, 
immunofluorescence histology of splenic and popliteal lymph node sections was 
performed. For this purpose, mice were immunised with SRBC i.v. or with NP-CGG in 
the hind feet and the response analysed 8 days later. Immunofluorescence staining of 
spleen sections showed than ACKR4 is expressed on PNA
+
 B cells and levels expressed 
by DZ and LZ GC B cells were indistinguishable (Fig. 3.5a, 3.5b). In the spleen of 
ACKR4
+/GFP
 mice, where GFP replaces one copy of the Ackr4 gene (See Materials and 
Methods 2.1.3), GFP expression is also observable in the GCs (Fig. 3.5d, 3.5e). 
Antibody staining and ACKR4
+/GFP
 mice both revealed that ACKR4 is expressed by a 
thin layer of cells surrounding the marginal zone in the red pulp. Negative staining 
controls without primary antibody (Fig. 3.5c) or on ACKR4
-/-
 tissue (Fig. 3.5f, 3.5g) 
demonstrated the specificity of ACKR4 staining in the GC. However, a weak staining 
could be observed in the follicle area that may be due to un-specificity of the secondary 
antibody. In lymph nodes, ACKR4 expression corresponded with that seen in the 
spleen, with ACKR4 being homogenously expressed throughout the GC (Fig. 3.5h, 
3.5i). Additionally, as described by Ulvmar et al. (Ulvmar, Werth et al. 2014), ACKR4 
was observed to be expressed by the lymphatic endothelial cells in the subcapsular sinus 
of the lymph node independently of immunisation (Fig. 3.5h). This area of ACKR4 
expression may functionally correspond to the stroma staining found around white pulp 
in the spleen. The function of stromal ACKR4 in spleen has not been studied in detail 
(personal communication Antal Rot, University of York) 
The distribution of the chemokines that bind ACKR4 and CCR7 was studied by 
immunofluorescence histology. CCL19 and CCL21 are equipotent ligands of ACKR4. 
While CCL19 is soluble, CCL21 binds to the matrix and has stronger pro-migratory 
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properties than CCL19 (Ulvmar, Werth et al. 2014). Because CCL19 is soluble, it is 
almost undetectable in mouse tissues and its distribution is impossible to assess, but it 
can be speculated that, as CCL19 is produced at the same locations than CCL21, 
ACKR4 is able to form similar gradients of both of its ligands (Ulvmar, Werth et al. 
2014).  
CCL21 expression was investigated by antibody staining. In the spleen, CCL21 was 
observed to be expressed in the T zone areas and diffuses to the exterior of the white 
pulp. CCL21 was also highly expressed in HEVs, as previously described (Carlsen, 
Haraldsen et al. 2005) (Fig. 3.6a). There were no obvious differences in the distribution 





(Fig 3.6b). CCL21 expression was also analysed in draining LNs post-immunisation 
with NP-CGG. In ACKR4
+/+
 pLNs (Fig. 3.7a), CCL21 was mainly present in the SCS 
and in the T zone. A gradient of CCL21 from the T zone to the SCS was observed. This 
gradient is caused by the scavenging of CCL19/21 by the ACKR4 expressed in the 
lymphatic endothelial stroma in the SCS (Ulvmar, Werth et al. 2014). In ACKR4
-/-
 pLN 
(Fig. 3.7b), CCL21 was also observed to be present in the SCS and in the T zone, but 
there is no gradient between the T zone and the SCS. The positive staining for CCL21 
in the SCS can be explained by passive adhesion of CCL21 to ACKR4 and not by the 
production of CCL21 by lymphatic endothelial cells (personal communication Antal 
Rot, University of York). The presence of GCs was not seen to influence CCL21 
distribution, neither in ACKR4
+/+
 nor in ACKR4
-/-
 pLNs. 
As CCL19 is impossible to detect by antibody staining, CCL19-eYFP mice which 
express Cre after the Ccl19 promoter were examined as in these mice there is specific 
expression of eYFP in CCL19
+
 cells. Five days post SRBC immunisation (Fig. 3.8a), 
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the eYFP signal was mainly observed in the T zone and the outer follicle. Follicles were 
seen to be negative for CCL19. In GCs, low level of CCL19 production was observed 
which is comparable to the levels observed in the T zone. In non-immunised conditions 
(Fig. 3.8b), CCL19 was also observed to be produced in the T zone and in the outer 
follicles. 
CCR7 expression was studied at the protein level in different B cell subsets by flow 
cytometry. CD4 T cells are positive for CCR7 expression (Debes, Hopken et al. 2002) 
and these cells were used to gate a positive cell population. Eight days post NP-CGG 
immunisation, CCR7 was seen to be expressed in MBCs, both from the draining and 
distant lymph nodes and PCs, while GC B cells and naïve B cells had very low levels of 
CCR7 expression (Fig. 3.9a and 3.9b). Protein expression levels in the different B cell 
subsets did not correlate with the results obtained by qPCR (Fig. 3.4c), where mRNA 
expression was constant in all B cell subsets and lower in PCs. This difference may 
reflect post-translational modifications playing an important role in regulating protein 
surface levels. 
Outcomes from the above studies have revealed the expression of chemokine receptors 
ACKR4 and CCR7, and of their shared ligands CCL19 and CCL21, in the spleen and 
lymph nodes. While CCR7 is broadly expressed by T lymphocytes, B lymphocytes do 
not express it at high levels. ACKR4 is only expressed in GC B cells and in a layer of 
LECs in the SCS or stroma surrounding MZ. This differential expression may indicate 
that CCR7-dependent responses are regulated by fluctuating levels of ACKR4 
expression in the SLOs, which creates gradients of their ligands from the T zone, where 





Figure 3.5 (1): ACKR4 is expressed by GC B cells. a-e) Representative splenic immunofluorescence 
images of ACKR4 (green), PNA (red), IgD (blue). a-b) ACKR4
+/-
 spleen 8 days post-immunisation 
with SRBC i.v. c) Negative control for secondary antibody in ACKR4
+/-
 spleen 8 days post-
immunisation with SRBC i.v. d-e) ACKR4-GFP (green), PNA (red), IgD (blue) from ACKR4
+/GFP
 
spleen 8 days post-immunisation with SRBC i.v.  
Key: F: B follicle; TZ: T zone; RP: red pulp; GC: germinal centre; PNA: peanut agglutinin; SCS: 




Figure 3.5 (2): ACKR4 is expressed by GC B cells. f-g) Representative immunofluorescence images 
of ACKR4
-/- 
spleen 8 days post-immunisation with SRBC i.v. h-i) Representative immunofluorescence 
images of CXCR4 (red), ACKR4 (green), IgD (blue) of WT popliteal lymph node 8 days post-
immunisation with NP-CGG s.c. in the hind feet. 
Key: F: B follicle; TZ: T zone; RP: red pulp; GC: germinal centre; PNA: peanut agglutinin; SCS: 




Figure 3.6: CCL21 expression in the spleen. a-b) Representative splenic immunofluorescence 
images for CCL21 (green), IgD (blue). a) WT spleen 8 days post-immunisation with NP-CGG i.p. b) 
ACKR4
-/-
 spleen 8 days post-immunisation with NP-CGG i.p. Upper: lower magnification images. 
Lower: higher magnification images. 




Figure 3.7: CCL21 expression in the draining lymph nodes. a-b) Representative 
immunofluorescence images of popliteal LNs for CCL21 (green), PNA (red), IgD (blue). a) WT pLN 
8 days post-immunisation with NP-CGG s.c. in the hind feet. b) ACKR4
-/-
 LN 8 days post-
immunisation with NP-CGG s.c. in the hind feet. Images were thresholded using the “Moments” 
Thresholding method. 
Key: F: B follicle; TZ: T zone; GC: germinal centre; PNA: peanut agglutinin; SCS: subcapsular sinus.  




Figure 3.8: CCL19-eYFP expression in the spleen. a-b) Representative splenic immunofluorescence 
images for CCL19-eYFP (green), PNA (magenta), IgD (red) and CD4 (blue). a) CCL19-eYFP mice, 5 
days post-immunisation with SRBC i.v. b) CCL19-eYFP mice, non-immunised.  
Key: F: B follicle; TZ: T zone; RP: red pulp; GC: germinal centre; PNA: peanut agglutinin; SCS: 
subcapsular sinus.  






Figure 3.9: CCR7 expression in lymph nodes of immunised mice. a) Different B cell subsets were 
gated by flow cytometry from lymph nodes of WT mice transferred with Cγ1-Cre x QM ROSAeYFP 
B cells 8 days post-immunisation with NP-CGG and CCR7 surface expression analysed. b) 
Quantification of the % of CCR7
+
 cells in each B cell subset. 
Each symbol represents one mouse. Horizontal line represents the median.  






 mice present normal T and B cell populations 
To test whether ACKR4 affects the differentiation and/or survival of T and B cells 





 mice were analysed by flow cytometry. The gating strategy is 
shown in Fig. 3.10a for T cells and Fig. 3.10b for B cells. T cells were gated as CD3
+
 




. Each of these populations 
was further subdivided according to the expression of CD44 and CD62L into memory, 
































) were analysed for both CD4
+
 (Fig. 3.11a) and 
CD8
+ 
populations (Fig. 3.11b). ACKR4
-/-
 mice had normal splenic T cell populations 
when compared to ACKR4
+/-
 mice. B cells were gated on the basis of their expression 
of B220 and CD19 and were further subdivided into marginal zone, follicular (B2) and 
B1 B cells according to the expression of CD21/35 and CD23. B1 B cells were further 
subdivided into B1a and B1b B cells according to their expression of CD5. As to 
unimmunised ACKR4
-/-
 mice significant differences were not detected as to any of the 





















), follicular B cells (CD23
+





3.12a). In addition, histological analysis of spleen sections was performed following 





 sections were comparable as to the 
distribution and volumes of cells observed in the B cell follicles (IgD
+
 areas, brown) 
and T cell zones (CD3
+
 areas, blue) (Fig. 3.12b). These findings confirm that ACKR4 





 mice have similar numbers of B cells and T cells in resting 
conditions as compared to ACKR4
+/-
 mice. It might, therefore, be assumed that any 
effect of ACKR4 deficiency post-immunisation is due to an effect on B cell activation 




Figure 3.10: Representative gating strategy for splenic T and B cell populations in non-
immunised mice. a) Flow cytometry gating strategy for splenic T cells from non-immunised mice. b) 
Flow cytometry gating strategy for splenic B cells from non-immunised mice. 





Figure 3.11: Splenic T and B cell populations in non-immunised ACKR4
-/- 
mice are similar to 
ACKR4
+/-
 (1). a-b) Absolute splenic cell numbers in the different T cell populations depicted in Fig. 
3.10a. a) CD4
+
 T cells. b) CD8
+
 T cells. 
1 independent experiment with 4 mice per group. Each symbol represents one mouse. Horizontal line 







Figure 3.12: Splenic T and B cell populations in non-immunised ACKR4
-/-
mice are similar to 
ACKR4
+/-
 (2). a) Absolute splenic cell numbers in the different B cell populations depicted in Fig. 
3.10b. b) Representative immunohistochemistry staining for CD3 (blue) and IgD (brown) of non-
immunised spleens from ACKR4
+/-
 (left) and ACKR4
-/- 
(right) mice.  
1 independent experiment with 4 mice per group. Each symbol represents one mouse. Horizontal line 
represents the median.  





 B cells migrate normally to T-B borders 4 hours post-immunisation 
Activated B cells encounter antigen in the splenic marginal zone and they then migrate 
in a CCR7-dependent manner to the T cell zone- B cell follicle border within 4-48h 





 mice were immunised with the TI-II antigen 
NP-Ficoll and the response was analysed by immunohistological staining 4h after 
immunisation (Fig. 3.13). QM B cells are hemizygous for a rearranged V(D)J segment 
at the Ig heavy chain locus, the other allele being non-functional. They also have a non-
functional kappa light chain allele. The heavy chain, when paired with any lambda light 





 mice did not show any differences in the distribution of 
NP
+
 B cells, which were located mainly around the follicular areas (Fig. 3.13a). NP-
Ficoll immunisation of QM mice causes strong mobilisation of activated B cells to the 
T-B border (Marshall, Zhang et al. 2011). NP
+
 B cells (blue) were observed at both the 
marginal zones and the T cell- B follicle borders 4 h post-immunisation (Fig. 3.13b). No 
differences were observed when the area of NP
+
 cells at the T zone –B follicle 




mice (Fig. 3.13c). Therefore, 
ACKR4 deficiency does not have an effect during the early B cell activation nor 
influences the migration of activated B cells to the T-B zone border in regard to the 






Figure 3.13: Initial antigen-induced migration of B cells to the T-B zone border occurs normally 
in the absence of ACKR4. a) Representative examples of immunohistochemistry images for NP 
(blue) and IgD (brown) of non-immunised QM ACKR4
+/-
 (upper) and QM ACKR4
-/-
 (lower) spleens. 





 (lower) spleens 4 h post-immunisation with NP-Ficoll. c) Quantification of % of NP
+
 
cells at the T zone –B follicle interphase.   
Each symbol represent the median of 4-5 different areas in one individual mouse. 
Arrow heads indicate NP
+
 B cells that have migrated to the T-B interphase. 





 GC counts are normal but GCs show abnormal histology 8 days post- 
immunisation 
As outlined above, non-immunised ACKR4
-/-
 mice do not have detectable alterations in 
their T cell or B cell populations and the initial migration of activated ACKR4
-/-
 B cells 
to the T-B border after immunisation with TI-II antigen is normal. To test whether the 
germinal centre stages of B cell differentiation are normal in ACKR4
-/-





 mice with the TD antigen NP-CGG i.p. was 
performed. The response was analysed by flow cytometry. The gating strategy is shown 













) numbers and LZ/DZ 
distribution in the GC were observed to be similar when ACKR4
-/-
 mice were compared 
to ACKR4
+/-
 (Fig. 3.14b). 
Interestingly, while cell numbers were normal, immunohistological staining of spleen 
sections revealed that the shape of GCs in ACKR4
-/-
 mice was different (Fig. 3.15a). In 
WT mice (ACKR4
+/-
), GCs are compact assemblies of IgD
-
 B cells in the centre of the 
B cell follicle with a well-defined border (Fig. 3.15a left). However, GCs from ACKR4
-
/-
 splenic sections presented irregular borders and the perimeter was not well defined. 
Naïve B cells were observed to intermingle with GC B cells at the GC border and 
infiltrate the GC area more (Fig. 3.14a right). These differences were quantified in GCs 
from splenic sections. GCs from ACKR4
-/-
 mice contained a larger proportion of IgD
+
 
cells than GCs of ACKR4
+/-
, both 8 days post primary immunisation (Fig. 3.15b) and 14 
days post primary immunisation (Fig. 3.15c).  
While ACKR4
-/-
 mice have normal numbers of GC B cells and plasma cells after 
primary immunisation, ACKR4
-/-
 GCs have fuzzy borders with IgD
+
 cells intermingling 
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with the GC B cells. This dysregulated shape of the GCs may have an important bearing 




 B cells infiltrate the GC area when the environment is ACKR4
-/-
 














host mice. This experiment allows dissection of the effect of absence of ACKR4 
expression by the B cells, that take part in the response (transferred B cells) and absence 
in regard to the stromal environment (stroma plus B cells that do not take part in the 
response, e.g. naïve B cells NP
-
).  
Adoptive transfer of QM B cells into host mice and immunisation with NP-Ficoll results 
in strong plasma cell differentiation and the development of T independent GCs by day 
4 of the response (Marshall, Zhang et al. 2011). This set up was chosen as it is ideal to 
study GC formation in the spleen without carrier priming. The response was analysed 
by immunohistological staining 4 days post-immunisation, before GCs start to abort (de 
Vinuesa, Cook et al. 2000) (Fig. 3.16). 
In order to identify GCs, splenic sections were stained for PNA (GC B cells) and IgD 
(naïve B cells). Transferred cells were distinguished by their expression of eYFP. 
Analysis of these tissue sections confirmed the results obtained by flow cytometry as 
there was no difference in the spleen area covered by GCs, measured as PNA
+
 area (in 
µm
2
), in any of the conditions (Fig. 3.16b and 3.16e).  




 QM B cells into a wt environment (Fig. 3.16a-





 area divided by the IgD
-
 area (Fig. 3.16c). However, when ACKR4
+/+
 B cells 
were transferred into an ACKR4
-/-
 environment (Fig. 3.16d-f), despite there not being a 
difference in the size of GCs, the fraction of GC area that had been infiltrated by naïve 
B cells was significantly increased when compared to the control conditions (Fig. 
3.16f). These findings have demonstrated that the differences observed after TD 




 mice are caused by ACKR4 expression in 
the host and emphasise the importance of the expression of ACKR4 in the splenic 
stroma to the maintenance of GC shape. There are potential implications to the GC 
response as to affinity maturation and entry and exit of cells. 





 (QM ACKR4-ko into) NP-specific B cells were transferred into 
ACKR4
+/+
 (wt) or ACKR4
-/-
 (ko) hosts, mice were immunised with NP-Ficoll one day 
after and the response was analysed 4 days post-immunisation. The above experiments 
confirmed that the absence of ACKR4 from B cells or from the environment does not 
lead to changes to the numbers or percentages of lymphocytes of NP-specific GC B 
cells per spleen (Fig. 3.17a). Furthermore, changes in GC DZ or GC LZ B cell numbers 
and proportions were not observed (Fig. 3.17b and 3.17c). The DZ/LZ ratio was also 
analysed and no differences were observed (Fig. 3.17d). ACKR4 deficiency also had no 










 MBCs, which reached significance when absolute numbers of 
CD80
+




In summary, the GC fuzziness observed by immunohistology in ACKR4-deficient 
environments appears to have no major consequences as to the differentiation of B cell 
subsets 4 days post NP-Ficoll immunisation.  
Figure 3.14: GCs B cells from ACKR4
-/-
 mice 8 days post NP-CGG are normal. a) Flow 





mice. b) % of lymphocytes of GC B cells and plasma cells (upper) and % of GC B cells of dark zone 
and light zone (lower) on day 8 post-immunisation with NP-CGG.  
In section b upper, data were combined from 2 independent experiments with 3-6 mice per group. In 
section b lower, data is representative from 1 out of 2 independent experiments. Each symbol 
represents one mouse. Horizontal line represents the median.  




Figure 3.15: GCs from ACKR4
-/-
 mice 8 days post NP-CGG show abnormal histology. a) 
Representative immunohistochemistry staining images for NP (blue) and IgD (brown) of splenic 
sections from ACKR4
+/-
 (left) and ACKR4
-/-
 (right) 8 days post-immunisation with NP-CGG. b) 
Quantification of the % of GC covered by IgD
+
 cells 8 days post-immunisation with NP-CGG. c) 14 
days post-immunisation.  
GCs were counted from 2 independent experiments with 3-4 mice per group. Individual circles 
represent GCs. Individual triangles represent the median of 4-5 different GCs in one individual mouse. 
Horizontal line represents the median. Arrow heads indicate IgD
+
 cells that have infiltrated the GC 
area. 
Key: F: B follicle; TZ: T zone; RP: red pulp; GC: germinal centre 
Scale bar: 100 µm. 






 cells infiltrate GC area when the environment is ACKR4
-/-
. a-c) WT and 
ACKR4
-/-
 QM B cells were transferred into WT mice, immunised with NP-Ficoll i.p. and the response 
studied 4 days later. a) Representative example of immunofluorescence staining for eYFP (transferred 
QM B cells), PNA (red) and IgD (blue). b) GC area. c) Fraction of GC infiltrated by naïve B cells. d-f) 
WT QM B cells were transferred into WT and ACKR4
-/-
 mice, immunised with NP-Ficoll i.p. and the 
response studied 4 days later. d) Representative example of immunofluorescence staining for eYFP 
(transferred QM B cells), PNA and IgD (blue). e) GC area. f) Fraction of GC infiltrated by naïve B 
cells.  
Each symbol represents one GC. 18-23 GCs in total were counted from 4 mice. Horizontal line 
represents the median.  
Key: TZ: T zone; F: B follicle; GC: germinal centre; RP: red pulp. Scale bar: 100 μm. 













 environments 4 days post-immunisation 
with NP-Ficoll. a-d) WT or ACKR4
-/-
 QM B cells were transferred into WT or ACKR4
-/-
 recipients and 
cell populations were analysed by flow cytometry 4 days post immunisation with NP-Ficoll. Absolute 


































). d) DZ/LZ ratio. 
ACKR4
+/+




host comparisons were performed in 2 
independent experiments with 4-5 mice per group. ACKR4
+/+
 into WT host vs ACKR4
-/-
 into WT host 
comparisons were performed in 2 independent experiments with 3-4 mice per group. Comparison of the 
3 groups was performed in 1 independent experiment with 4-5 mice per group. Each symbol represents 
one mouse. Horizontal line represents the median.  
Key: GC: germinal centre; LZ: light zone; DZ: dark zone. 















 environments 4 days post-immunisation 
with NP-Ficoll (2). a-c) WT or ACKR4
-/-
 QM B cells were transferred into WT or ACKR4
-/-
 recipients 
and cell populations were analysed by flow cytometry 4 days post immunisation with NP-Ficoll. 










































host comparisons were performed in 2 
independent experiments with 4-5 mice per group. ACKR4
+/+
 into WT host vs ACKR4
-/-
 into WT host 
comparisons were performed in 2 independent experiments with 3-4 mice per group. Comparison of the 
3 groups was performed in 1 independent experiment with 4-5 mice per group. Each symbol represents 
one mouse. Horizontal line represents the median.  
Key: MBC: memory B cell. 
Non-parametric Mann-Whitney test **p<0.01 
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3.2.7 At later stages of the GC response, DZ/LZ ratio is altered in ACKR4
-/-
 mice  
To test whether the changes to the shape of GCs in ACKR4
-/-
 mice have a functional 




 mice were 
immunised with NP-CGG and the splenic response studied 14 days post-immunisation 
(Fig. 3.19). As seen on day 8 post NP-CGG immunisation, GC B cell numbers per 
spleen or percentages were unaltered (Fig. 3.19a). Plasma cells as well as memory B 





(Fig. 3.19b, 3.19c). Intriguingly, ACKR4
-/-
 mice had reduced percentage of DZ GC B 
cells and a higher percentage of LZ GC B cells (Fig. 3.19d), resulting in a reduced 
DZ/LZ ratio in ACKR4
-/-
 mice (Fig. 3.19e).  
This altered ratio could have profound effects in the later stages of the GC response. 
Therefore, experiments were undertaken to verify that this effect was also observable 




 mice were immunised 
with SRBC and the response was analysed 8, 14 and 21 days post-immunisation by flow 
cytometry. The gating strategy is shown in Fig. 3.20. After SRBC immunisation, 
antigen-specific B cells were indistinguishable and they were gated in relation to their 
expression of B220. Subsequently, B cells were gated for PCs, GCs and for GC 
subpopulations LZ B cells and DZ B cells. As expected from the results obtained after 
NP-CGG primary immunisation, 8 days post-immunisation, a difference was not 
observed as to GC B cells or in DZ/LZ distribution for ACKR4
-/-
 mice versus ACKR4
+/-
 
mice (Fig. 3.21a). At later time points, 14 days (Fig. 3.21b) and 21 days (Fig. 3.21c) 
post-immunisation, GC B cell percentages were unaltered but the LZ/DZ ratio was 
skewed towards LZ in ACKR4
-/-
 spleens. These results confirm that the effect observed 
after NP-CGG immunisation occurs also in regard to immunisation with SRBC. 
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 mice taken at day 8, 14 and 21, were stained 
with PNA (to denote GCs), CXCR4 (to denote DZ) and IgD (to denote follicles) (Fig. 
3.22). As observed 8 days post primary immunisation, the perimeters in ACKR4
-/-
 GCs 
were also altered and less defined 14 days after SRBC immunisation (Fig. 3.22a). GC 
and DZ areas were measured on splenic sections using digital image analysis. The 
fraction of GC occupied by DZ (Fig. 3.22b) and the GC area (Fig. 3.22c) were analysed. 
Consistent with flow cytometry results, 8 days post-immunisation, there was no 
differences in the GC area or in DZ area when ACKR4
-/-
 mice were compared with 
ACKR4
+/-
 mice (Fig. 3.22b upper, 3.22c upper). Furthermore, 14 days (Fig. 3.22b 
middle, 3.22c middle) and 21 days post-immunisation (Fig. 3.22b lower, 3.22c lower), 
while GC area was unchanged, DZ fraction was reduced. 
The findings described above have revealed that ACKR4
-/-
 mice have an altered 
distribution of GC B cell subpopulations, with bigger LZ and smaller DZ, while GC B 
cell numbers are normal. This skewed ratio may have functional consequences such as 






Figure 3.19: DZ/LZ ratio is altered in ACKR4
-/-





 mice were immunised with NP-CGG and B cell populations analysed on day 14 by flow 
















































) GC B cells. e) DZ/LZ ratio. 
2 independent experiments with 4 mice per group. Each symbol represents one mouse. Horizontal line 
represents the median.  
Key: GC: germinal centre; LZ: light zone; DZ: dark zone. 









 mice to SRBC. 





immunised with SRBC. The response was studied 8, 14 and 21 days post immunisation. 






Figure 3.21: DZ/LZ ratio is altered in ACKR4
-/-
































) GC B cells  were 
analysed on a) day 8, b) day 14 and c) day 21 post-immunisation.  
For gating strategy see Figure 3.20. 
In section a, data were combined from 2 independent experiments with 4 mice per group. In section b, 
data were combined from 2 independent experiments with 4-5 mice per group, except for GC B cells 
were plot is representative of 2 independent experiments. In section c, plots are representative of 2 
independent experiments with 4 mice per group. Each symbol represents one mouse. Horizontal line 
represents the median.  
Key: GC: germinal centre; LZ: light zone; DZ: dark zone; D: day. 




Figure 3.22: DZ/LZ ratio is altered in ACKR4
-/-





 mice were immunised with SRBC and spleens were stained by immunofluorescence. a) 
Representative example of immunofluorescence staining from 14 days post-immunisation. b) 
Percentage of DZ per GC from days 8, 14 and 21 post-immunisation. c) GC area, in µm
2
, as measured 
in immunofluorescence staining sections from 8, 14 and 21 days post-immunisation.  
GCs from whole splenic sections from 2 independent experiments with 4-5 mice per group. Each 
symbol represents one GC. Horizontal line represents the median.  
Key: TZ: T zone; F: B follicle; GC: germinal centre; RP: red pulp; DZ: dark zone; LZ: light zone.  
Scale bar: 100 µm. 
Box and whiskers plot with 5-95 percentile. Non-parametric Mann-Whitney test **p<0.01 
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3.2.8 GC B cell proliferation is not altered in ACKR4
-/-
 mice  
One reason for enlarged LZ and smaller DZ areas in ACKR4
-/-
 mice versus ACKR4
+/-
 
mice could be a reduced cell proliferation. To test this, proliferation rates were 
examined by using EdU (5-ethynyl-2'-deoxyuridine) incorporation. EdU is a thymidine 
analogue that is incorporated in the DNA during the S phase of cell cycle and can be 




 mice were 
immunised with NP-CGG and injected with EdU 1 h prior to sacrifice at days 8, 14 and 
21 days post-immunisation. The response was studied by flow cytometry and the gating 
strategy is shown in Fig. 3.23a. The EdU
+
 gate was set up according to naïve B cells, 
which should be mainly negative for EdU. GC B cell, LZ GC B cell and DZ GC B cell 
EdU incorporation was measured at the different time points and a difference was not 
observed between ACKR4
-/-
 mice versus ACKR4
+/-
 (Fig. 3.23b). Fourteen days post-
immunisation, there was a tendency towards higher cell proliferation in ACKR4
-/-
 GCs. 
This difference was reproducible in independent experiments, but statistically not 
significant (Fig. 3.23b middle). Furthermore, this tendency had disappeared by day 21 
(Fig. 3.23b lower). MFI values for EdU were also studied at the different time points 
and a difference was not observed (data not shown).  
A difference in cell proliferation, as measured by EdU incorporation does not appear to 











According to the analysis undertaken of GEO data for gene expression by DZ/LZ GC B 
cell subsets (Victora, Dominguez-Sola et al. 2012) (Fig. 3.3), ACKR4 is specifically 
upregulated in DZ GC B cells. Plasmablasts are exiting the GC from the GC-dark zone 
interface (Meyer-Hermann, Mohr et al. 2012) (Yang Zhang, unpublished). To test 
whether ACKR4 expression in the dark zone is influencing the exit of plasmablasts 





 mice immunised with SRBC and 8, 14 and 21 days post-
immunisation were stained for CXCR4 (to denote plasmablasts), PNA (to denote GCs) 
and IgD (to denote follicles) (Fig. 3.24a). CXCR4
+ 
plasmablasts leaving the GC through 
the DZ were counted in GCs when the GC-T zone interphase was visible. To ensure that 
the sections through GCs were oriented such that they represented the entire GC, GCs 
were chosen that showed a clear differentiation between LZ and DZ based on CXCR4 





 mice, differences were not observed when CXCR4
+
 plasmablasts 
numbers were expressed in relation to the length of the GC-T zone interphase, neither 8 
days after SRBC (Fig. 3.24b upper)  nor 14 days (Fig. 3.24b lower). Therefore, it can be 
concluded that ACKR4 specific expression in the DZ is not influencing the movement 
of plasmablasts out of the GC through the DZ and GC-T zone interphase. 
 
3.2.10 The number of CD3
+
 cells in GCs is not altered in ACKR4
-/-
 mice 
To test the possibility of enlargement of the LZ because of the presence of a higher 
number of T follicular helper (Tfh) cells, CD3
+
 cells inside GCs were counted in 
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 mice immunised with SRBC 
8, 14 and 21 days post-immunisation (Fig. 3.24c). Tfh cells express Bcl6 and CXCR5 
and are important for the maintenance of GCs as they provide signals for the selection 
of high-affinity GC B cells and that regulate GC B cell differentiation into PCs or 
MBCs (Crotty 2011). Though CD3 will also label non-Tfh GC T cells, it does provide a 
good approximation for Tfh cells, as only 10-12% of GC T cells are Tfr cells (Sage, Tan 
et al. 2015). Fourteen days post-immunisation, ACKR4
-/-
 GCs had lower number of Tfh 
cells (Fig. 3.24c middle). However, this difference was minimal and was not 
reproducible either 8 (Fig. 3.24c upper) or 21 days post-immunisation (Fig. 3.24c 
lower). Moreover, this change cannot account for the skewed LZ/DZ ratio, as less T 
cells in the LZ would mean smaller LZ areas. It has been shown that the altered LZ/DZ 
distribution in ACKR4
-/-
 mice at later stages of the GC response is not caused by 
differences in proliferation, nor by increased PC exit in the GC-T zone interphase, nor 
by increased numbers of T cells in the LZ. Further events that can cause an alteration to 
the LZ/DZ distribution are differences in the expression of key molecules that are 






Figure 3.23: Proliferation is not altered in GCs from ACKR4
-/-





 mice were immunised with NP-CGG and EdU incorporation was assessed by flow cytometry. a) 
Flow cytometry gating strategy for EdU
+
 B cell populations. b) EdU
+
 GC B cells at day 8 (upper), 14 
(middle) and 21 (lower) post-immunisation. EdU was injected 1 h prior to death. 
Plots are representative of 2 independent experiments with 4-5 mice per group. Each symbol 
represents one mouse. Horizontal line represents the median.  





Figure 3.24: Output of PCs (CXCR4
high
) at GC-TZ interphase and CD3
+
 cell numbers per GC 
are normal in ACKR4
-/-




 mice were immunised with SRBC and 
spleens were stained by immunofluorescence. a) Representative example of immunofluorescence 
staining for CXCR4 (red), PNA (green) and IgD (blue) 8 days post-immunisation. b) Counts for 
CXCR4
+
 plasmablasts per GC-T zone interphase length in 8 days (left) and 14 days (right) post-
immunisation. c) Counts for CD3
+
 cells per GC area, in µm
2
, 8 (left), 14 (middle) and 21 (right) days 
post-immunisation.  
GCs from whole splenic sections from 2 independent experiments with 4-5 mice with per group. Each 
symbol represents one GC. Horizontal line represents the median.  
Key: TZ: T zone; F: B follicle; GC: germinal centre; RP: red pulp. PC: plasma cell. Scale bar: 100 
µm. 
Box and whiskers plot with 5-95 percentile. Non-parametric Mann-Whitney test *p<0.05 
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3.2.11 GCs from ACKR4
-/-
 mice express more c-Myc and p-Akt at later stages of GC 
response 
A recent publication has linked the expression of ACKR4 with reduced expression of 
the transcription factor c-Myc in hepatocellular carcinoma (Shi, Yang et al. 2015). 
Importantly, c-Myc is a major regulator of B cell differentiation and proliferation in the 
GC (Dominguez-Sola, Victora et al. 2012). In the absence of ACKR4, more ligand 
binds to CCR7 and in consequence, there is higher activation of the downstream 
signalling components. Signalling downstream of CCR7 towards c-Myc includes 
phosphorylation of the Akt-GSK3β pathway (Shi, Yang et al. 2015). To test the effect 





 mice 8, 14 and 21 days post SRBC immunisation were stained for c-Myc, 
PNA (to denote GCs) and IgD (to denote follicles) (Fig. 3.25a). c-Myc
+
 cells were 
counted manually using the same contrast and brightness settings for all images. The 
numbers of c-Myc
+
 nuclei were analysed in relation to PNA
+
 area. As previously 
described, GCs expressed lower levels of c-Myc compared to their adjacent cells. Eight 
days post-immunisation with SRBC, ACKR4
+/-
 mice had more c-Myc
+





 (Fig. 3.25b left). Fourteen days post-immunisation, this ratio was 
inverted and ACKR4
-/-
 mice had more c-Myc
+
 cells per PNA
+
 area than ACKR4
+/-
 mice 
(Fig. 3.25b middle). 21 days post-immunisation, ACKR4
-/- 
GCs continue to have more 
c-Myc
+
 cells per PNA
+
 area than ACKR4
+/-
 GCs (Fig. 3.25b right, 3.25c). It is 
important to note that at day 14 and 21, the differences are statistically more significant 
(lower p value) and the medians are respectively 1.2 and 1.7 times increased in ACKR4
-
/-
 GCs. An increase of 1.2-1.7 times in c-Myc
+
 cells may not appear at first sight to be 
an elevated number, but may constitute a substantial difference as to cells that 
recirculate from LZ to DZ and post-GC effects. More B cells that are expressing c-Myc 
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in the LZ of ACKR4
-/-
 GCs may imply the accumulation of GC B cells in the LZ, as 
they require downregulation of c-Myc in order to migrate back to the DZ, leading to 
dysregulated LZ/DZ distribution. 
To investigate whether the increase in c-Myc
+
 cells was caused by signalling through 
the Akt-GSK3β pathway, the phosphorylation status of p-Akt (Ser473) was examined in 




 mice were 
immunised with NP-CGG and the response analysed 8 and 14 days later. p-Akt levels 
were higher than naïve B cells (filled grey, Fig. 3.26a) in all of the B cell populations 
studied, including GC B cells (blue, Fig. 3.26a), memory B cells (green, Fig. 3.26a). 
Plasma cells expressed the highest levels of p-Akt (red, Fig. 3.26a). In the GC 
subpopulations, LZ GC B cells (orange, Fig. 3.26a) expressed higher levels than DZ GC 
B cells (purple, Fig. 3.26a). The gate indicates numbers of p-Akt
+
 cells. When ACKR4
-/-
 
mice were compared with ACKR4
+/-
 mice there were no differences in number of p-
Akt
+
 cells at any of the time points studied (data not shown). 





 mice in regard to GC B cells, LZ GC B cells and DZ GC B 
cells (Fig. 3.26b, 3.26c). Fourteen days post-immunisation, p-Akt levels, measured as 
MFI, were elevated in ACKR4
-/-
 GCs (Fig. 3.27a left, 3.27b left). Dissection of p-Akt 
levels as to DZ and LZ, revealed that the differences were due to increased 
phosphorylation levels in LZ GC B cells (Fig. 3.27a right, 3.27b right) and not related to 
differences in DZ GC B cells (Fig. 3.27a middle, 3.27b middle).  Plasma cell p-Akt 
phosphorylation levels were the same as to both genotypes (Fig. 3.27b lower) and. 
Therefore, the effect is GC-specific. 
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To further confirm that the effect observed is generated due to activation of the pathway 
CCL19/21-CCR7-p-Akt-c-Myc in absence of the scavenging receptor ACKR4, 




mice were stimulated for 30 min 
in vitro with NP-Ficoll and CCL19. Akt phosphorylation levels were measured by flow 
cytometry and represented as to their MFI (Fig. 3.28). When splenocytes were 
stimulated only with NP-Ficoll, no differences could be observed among the three 
genotypes analysed. However, after stimulation of splenocytes with NP-Ficoll and 
CCL19, p-Akt levels were significantly elevated in ACKR4
-/-
 splenocytes compared to 
CCR7
-/-
, whose levels remained lower than WT splenocytes. 
The above results have confirmed that when ACKR4 is absent, there is more ligand 
binding to CCR7 and, therefore, more signalling via the Akt-c-Myc pathway, resulting 










 mice were immunised with SRBC and spleens were stained by 
immunofluorescence. a) Representative example of immunofluorescence staining for c-Myc (red), 
PNA (green) and IgD (blue) 8 days post-immunisation. b) Counts for c-Myc+ cells per GC area, in 
µm
2
, 8 (left), 14 (middle) and 21 (right) days post-immunisation. c) Representative example of 
immunofluorescence staining for c-Myc (red), PNA (green) and IgD (blue) 21 days post-immunisation 
(see next page). 
GCs from whole splenic sections from 2 independent experiments with 4-5 mice per group. Each 
symbol represents one GC. Horizontal line represents the median.  
Key: TZ: T zone; F: B follicle; GC: germinal centre; DZ: dark zone; LZ: light zone; RP: red pulp.  
Scale bar: 100 µm. 





Figure 3.25 (2): GCs from ACKR4
-/-
 mice have more c-Myc
+
 cells 14 and 21 days after SRBC. c) 
Representative example of immunofluorescence staining for c-Myc (red), PNA (green) and IgD 
(blue) 21 days post-immunisation. 
GCs from whole splenic sections from 2 independent experiments with 4-5 mice per group. Each 
symbol represents one GC. Horizontal line represents the median.  
Key: TZ: T zone; F: B follicle; GC: germinal centre; DZ: dark zone; LZ: light zone; RP: red pulp.  
Scale bar: 100 µm. 





Figure 3.26: GCs from ACKR4
-/-
 mice express same levels of p-Akt 8 days post NP-CGG. a) Flow 
cytometry gating strategy for p-Akt
+
 (Ser473) in different B cell populations. b) Flow cytometry 




 mice at day 8 post-immunisation 
with NP-CGG. c) MFI flow cytometry data for p-Akt
+
 GC B cells, DZ GC B cells, LZ GC B cells and 
plasma cells at day 8 post-immunisation.  
Data were normalised for each experiment. Plots are representative of 2 independent experiments with 
3-4 mice per group. Each symbol represents one mouse. Horizontal line represents the median.  




Figure 3.27: GCs from ACKR4
-/-
 mice express higher levels of p-Akt at day 14 after NP-CGG. a) 




 mice at day 14 
post-immunisation with NP-CGG. c) MFI flow cytometry data for p-Akt
+
 GC B cells, DZ GC B cells, 
LZ GC B cells and plasma cells 14 days post-immunisation.  
Data were normalised for each experiment. Data were combined from 2 independent experiments with 
4 mice per group, except for Plasma cells, where plot is representative of 2 independent experiments. 
Each symbol represents one mouse. Horizontal line represents the median.  
Key: GC: germinal centre; DZ: dark zone; LZ: light zone; MFI: mean fluorescent intensity. 




Figure 3.28: In vitro stimulation of ACKR4
-/-
 splenocytes with CCL19 causes elevated Akt 
phosphorylation. p-Akt (Ser473) levels were measured by flow cytometry in splenocytes from QM, 
QM CCR7
-/-
 and QM ACKR4
-/-
 mice stimulated in vitro with NP-Ficoll +/- CCL19. 
1 independent experiment. Each symbol represents one mouse. Horizontal line represents the 
median.  
Key: WT: wild type; MFI: mean fluorescent intensity 





3.2.12 Secondary response to NP-CGG is normal in ACKR4
-/-
 mice 
To investigate if enlarged LZ areas and reduced DZ areas had any relevance in the 




 mice were primed with CGG 
and boosted 5 weeks later with NP-CGG. Five days after boosting, spleens were 
analysed by flow cytometry. There was no difference when differentiation into NP-
specific plasma cells, GC B cells and memory B cells was studied (Fig. 3.29). 
Moreover, LZ/DZ distribution was normal in ACKR4
-/-
 mice compared to ACKR4
+/-
 
mice (Fig. 3.29). These results indicate that ACKR4
-/-
 mice are able mount an effective 
secondary response. The skewed LZ/DZ distribution does not seem to have an effect in 
the generation of competent memory B cells, as these are able to mount secondary 
responses to the same extent as ACKR4
+/-
 mice.  
 




One consequence of enlarged LZ areas and reduced DZ areas could be an alteration to 
affinity maturation and antibody titres of the GC-derived plasma cells. In order to 





 mice were immunised with NP-CGG and the serum was 
collected at different time points post immunisation. NP-CGG immunisation causes the 
induction of Cγ1 switch transcript production from the third day after immunisation and 
also IL-4 and IFN-γ production (Toellner, Luther et al. 1998). Eight days post-
immunisation, differences were not observed as to any of the antibody isotypes analysed 
in the case of ACKR4
-/-
 mice (Fig. 3.30a). Fourteen days post-immunisation, an 
increase was observed in the relative antibody titres to NP15-IgG that was not seen in 
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regard to in IgG1 titres (Fig. 3.30b). However, 21 days post-immunisation, there was no 
difference in relative antibody titres (Fig. 3.30c). When relative affinity of IgG1 was 
examined (Fig. 3.30d), there was a reduction in affinity 14 days post-immunisation in 
ACKR4
-/-
 mice (Fig. 3.30d middle) that was not noticeable 21 days post-immunisation 
(Fig. 3.30d right). 
Antibody affinities were also measured during the secondary response. Mice were 
primed with CGG, boosted 5 weeks later with NP-CGG and the response analysed 5 





 mice (Fig. 3.30e).  
These results have shown that the skewed LZ/DZ distribution in ACKR4
-/-
 mice that 
seems to be a result of increased p-Akt-c-Myc expression does not have a major effect 














 mice were primed with CGG, boosted 5 weeks later NP-CGG and the response studied 5 days after 
boosting. % of lymphocytes of plasma cells, GC B cells and memory B cells (upper). % of GC B cells 
of dark zone and light zone GC B cells (lower). 
Data were combined from 2 independent experiments with 4 mice per group. Each symbol represents 
one mouse. Horizontal line represents the median.  




Figure 3.30: No major changes in antibody titres and antibody affinity in ACKR4
-/-
 mice after 




 mice  immunised with NP-CGG 





 mice immunised with NP-CGG 8 days (left), 14 days (middle) 21 days (right) post-




 mice when they were primed 
with CGG and boosted 5 weeks later with NP-CGG and the response studied 5 days after boosting. 
Plots from days 8 and 21 post primary and day 5 post secondary immunisation are representative of 2 
independent experiments with 3-6 mice. Data from day 14 post primary immunisation were combined 
from 2 independent experiments with 4 mice per group. Each symbol represents one mouse. 
Horizontal line represents the median.  




3.3.1 ACKR4 expression in B cells 
The findings from experiments described in this chapter revealed that ACKR4 is 
expressed both at the mRNA and protein level in germinal centre B cells from spleen 
and lymph nodes. This was predicted from the analysis of the data deposited in Immgen 
(Heng and Painter 2008) and by a large scale gene expression analysis of GC B cell 
subpopulations (Victora, Dominguez-Sola et al. 2012). Moreover, findings have 
confirmed the expression of ACKR4 in a layer of lymphatic endothelial cells of the 
lymph node subcapsular sinus (Ulvmar, Werth et al. 2014) and around the splenic 
marginal zone (Antal Rot, University of York, unpublished). Experiments have further 
shown that ACKR4 is also expressed at intermediate levels in memory B cells, from 
their generation in draining LN to their arrival in distant LN, while ACKR4 is 
downregulated to levels similar to levels found in naïve B cells in plasma cells.  
Contrary to CCR7, ACKR4 expression levels vary through the different stages of 
antigen-induced B cell differentiation. For this reason, the work focused on ACKR4 
expression. ACKR4 is able to modulate CCR7 responsiveness by scavenging CCR7 
ligands CCL19 and CCL21 (Comerford, Milasta et al. 2006). Interestingly, ACKR4 and 
CCR7 are differentially expressed between the GC subpopulations of centrocytes in the 
LZ and centroblasts in the DZ. ACKR4 is expressed at higher levels in the DZ while 
CCR7 is expressed stronger in the LZ (Victora, Dominguez-Sola et al. 2012). This 
dichotomy in expression levels opens up the possibility of a role of their shared ligands, 
CCL19 and CCL21 (Comerford, Harata-Lee et al. 2013) in regulating migration and 
differentiation of B cells during the germinal centre response.  
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ACKR4 deficiency in non-immunised mice does not lead to a change in the 
composition of B cell or T cell subpopulations or their anatomical locations regarding 
their recirculation through spleen and lymph nodes. An absence of effects on B cell 
development was expected, as ACKR4 is not expressed during the early stages of B cell 
development or by the stroma that interacts with developing B cells (Immgen). Due to 
the absence of effects on mature B cell differentiation stages, it is safe to assume that 
any difference observed during antigen-induced immune responses are due to the effects 
of ACKR4 deficiency during the response itself. Therefore, antigen-induced responses 
were studied directly in ACKR4 deficient mice. This is different from CCR7-deficient 
mice, which have profound alterations as to migration of naïve lymphocytes into 
secondary lymphoid organs and also altered lymph node microarchitecture (Forster, 




 cell infiltration in the GC area 
For studies of antigen-induced response, all of the mice used were males and ACKR4
+/-
 
mice were used as control mice. In a previous publication that has examined the role of 





 littermates and there were slight differences between males 
and females (Lucas, White et al. 2015). Moreover, preliminary results in antigen-
induced responses showed similar results to those published (S. Cook, personal 





 mice are subjected to NP-CGG immunisation and at the 
peak of the GC response, day 8 post-immunisation (Toellner, Gulbranson-Judge et al. 





 GCs have an abnormal shape, with poorly delimited borders and 
fuzzy perimeters.  
To investigate the reason for the fuzzy shape, particularly if it was caused by ACKR4 





, were transferred to wt or ko hosts. Under such conditions, it was observed 
that the fuzziness was not caused by GC B cells spreading out (same PNA
+
 area) but by 
the infiltration of IgD
+
 cells (naïve B cells) into the GC area. This effect is dependent on 
the expression of ACKR4 in the environment and not on the expression of ACKR4 by 
the transferred B cells. 
Despite the above severe effect, when the chimeras were analysed at early stages of the 
GC response by flow cytometry there were no effects other than a small increase in 
memory B cell numbers. Classically, memory B cells were thought to be produced only 
via the germinal centre pathway (McHeyzer-Williams and McHeyzer-Williams 2005). 
However, in past years it has been demonstrated that memory B cells can also be 
produced via a GC-independent pathway (Dogan, Bertocci et al. 2009) (Pape, Taylor et 
al. 2011) (Taylor, Pape et al. 2012). CD73
+
 MBCs are generated independently of GCs 
and express IgM
+
 (Taylor, Pape et al. 2012). CD80
+
 has been described as a 
differentiation marker that identifies memory B cells differentiating from the GC 







 MBCs are considered more 
memory-like cells as they also have higher mutation rates and are generally switched 
(Tomayko, Steinel et al. 2010) (Anderson, Tomayko et al. 2007). The increase in CD80
+
 
memory B cells observed in ACKR4
-/-
 B cells suggests that B cell selection is de-
regulated during GC differentiation. 
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In regard to the fuzziness of the GC perimeters in absence of ACKR4, the following 
hypothesis was tested. ACKR4 expression in the surroundings of the GC, by either 
LECs in the subcapsular sinus or stroma cells in the red pulp of the spleen or even by 
naïve B cells, might fix naïve B cells in the follicles and prevents them for accessing to 
the GC area. This would help to create two distinct microenvironments within the B cell 
areas: the follicle and the GC. In the absence of ACKR4 these microenvironments are 
intermingled, as follicular B cells are no longer anchored to follicular areas and are able 
to access the GC areas, where CCL19/CCL21 are available at the same concentration 
than in the follicle. Accordingly, the borders become diffuse. 
The functional consequences of the infiltration of naïve B cells 8 days post-
immunisation are not so clear. Increased numbers of naïve B cells in the GC area may 
restrict the accessibility of GC B cells to other cells such as FDCs and Tfh cells, with 
which they need to interact. This restricted access may have functional consequences as 
to the recirculation capacity of cells and the output of cells from GCs. 
 
3.3.3 Skewed LZ/DZ distribution 
As to the GC itself, an altered LZ/DZ distribution was observed from 14 days post-
immunisation, though GC size was unchanged. This skewed distribution was persistent 
at least until day 21 post-immunisation and was detected both by flow cytometry and 
histology and also post-immunisation with different TD antigens, NP-CGG and SRBC. 
During the first 8 days B cells are activated by T cells present in the T zone- B follicle 
border. They then, migrate back into follicles where they expand (MacLennan, Liu et al. 
1988, Toellner 2014). The fact that no changes were observed 8 days post-immunisation 
means that ACKR4 is not relevant during the expansion phase of the GC. This was 
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expected as mature GC B cells are the only B cell subset that expresses ACKR4. 
However, the increase in LZ GC B cells and the increase in c-Myc-expressing GC B 
cells 14 days post-immunisation may indicate that the later stages of B cell 
differentiation, recirculation and migration in the GC, induction of c-Myc and/or 
proliferation of B cells become regulated by ACKR4 and/or CCR7. 
Analysis of GEO data from an earlier publication on genes that are differentially 
expressed between the light and dark zones (Victora, Dominguez-Sola et al. 2012) 
showed that ACKR4 is differentially expressed in the DZ of the GC. The transition 
from centroblast to centrocyte appears to be governed by a timed program that works 
independently of signals emanating in the DZ (Bannard, Horton et al. 2013). According 
to this model, the decrease in CXCR4 surface expression, of pro-proliferative genes and 
of SHM-related genes associated with the transition from DZ to LZ differentiation stage 
is not a consequence of the phenotype transition but the cause of it. On the other hand, 
re-entry into centroblast status from LZ requires B cells to examine the new mutated 
BCRs. B cells do not compete for adhesion to FDC-bounded antigen but high-affinity B 
cells may be able to capture more antigen from FDCs and also able to remove antigen 
from the surface of low-affinity B cells (Allen, Okada et al. 2007, Zhang, Meyer-
Hermann et al. 2013). Long contacts with T cells should be established but these 
contacts are infrequent, so it is possible that T cell help restricts selection of clones with 
high-affinity BCRs (Allen, Okada et al. 2007). 
The differential expression of ACKR4 between the LZ and the DZ would make it a 
candidate gene as to involvement in GC recirculation and fits with the results obtained 
that the inability to express ACKR4 prevents cells from cycling back to the DZ leading 
to the accumulation of cells in the LZ at later stages of the GC response. In this case, as 
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seen, the size of the GC B cell population is unaltered.  There are other reasons why 
ACKR4 deficiency could be causing an increase in LZ B cells which include 
differences in proliferation, increased numbers of T cells in the LZ and/or increased 
output of plasma cells from the DZ. ACKR4
-/-
 mice have normal levels of cell 
proliferation, as measured by EdU incorporation. Moreover, smaller DZ areas are not 
caused by an increased plasmablast exit towards the T cell area. Additionally, enlarged 
LZ are not caused by an increased accumulation of Tfh cells. 
c-Myc is a master regulator of proliferation and differentiation and its role in GC 
biology  has been very controversial as c-Myc was previously proposed not to have a 
role in GC biology (Klein, Tu et al. 2003).  In a recent publication, c-Myc expression 
was shown to be triggered by the CCR7-CCL19/CCL21 axis in hepatocellular 
carcinoma (Shi, Yang et al. 2015). c-Myc expression is reduced when ACKR4 is 
expressed, as ACKR4 competes with CCR7 and represses CCR7-dependent chemotaxis 
(Shi, Yang et al. 2015). Accordingly, results presented in this chapter on c-Myc 
expression have revealed an increase in c-Myc protein expression by day 14 post-
immunisation that persisted at least until day 21 which were not present at day 8. GEO 
data analysis from a previous study (Dominguez-Sola, Victora et al. 2012) (Fig. 3.31) 





from the GC showed that ACKR4 expression negatively correlates with c-Myc 
expression. 
To test whether the increased c-Myc expression is caused by increased signalling 
through CCR7 via the Akt/GSKβ pathway when ACKR4 is absent, p-Akt status was 
analysed. In parallel to c-Myc expression, Akt phosphorylation (Ser473) was increased 
in LZ GC B cells 14 days post NP-CGG but not 8 days post-immunisation, where p-Akt 
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 GC B cells. To further 
substantiate that this effect is due to more CCL19/21 binding to CCR7 when ACKR4 is 




 splenocytes were 
stimulated in vitro and p-Akt levels measured. In CCR7
-/-
 splenocytes p-Akt levels 
remained constant after CCL19 stimulation, whereas ACKR4
-/-
 splenocytes expressed 
higher p-Akt levels and WT splenocytes expressed intermediate levels. 
Akt has not been linked to c-Myc previously in the physiological GC response. 
However, synergy between Akt and c-Myc has been previously described in the case of 
Burkitt’s lymphoma, which is a GC-derived malignancy (Spender and Inman 2014). 
Moreover, in GC-derived diffuse large B cell lymphoma (DLBCL), inhibition of 
signalling PI3K/Akt axis induces down-regulation of the transcription of Myc and 
rescues the tumorigenic phenotype in DLBCL cell lines (Pfeifer, Grau et al. 2013). 
Overall, the findings described support a role for ACKR4 in recirculation of cells within 
the GC and in the distribution of B cell subpopulations within the GC. ACKR4 is linked 
to the CCR7-p-Akt-c-Myc axis in the GC response, although the relevance of ACKR4 
to the whole GC response is still not clear as the effects observed are very subtle. A 
small but significant decrease in the affinity of NP-specific antibodies was observed 14 
days post-immunisation but this effect was not seen by day 21. Affinity maturation to 
NP is robustly increased by a few dominant mutations (Jacob, Przylepa et al. 1993) and 
it is possible that using the NP-system, subtle differences in affinity maturation have 
gone unnoticed. ACKR4
-/-
 GC B cells have restricted access to the DZ and this may 
have influenced their chances of undergoing effective somatic hypermutation. It is 
possible that studies of responses to complex antigens may reveal these subtle 
differences, as affinity maturation to complex antigens requires sequential accumulation 
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of many mutations during GC reaction and multiple entries to the DZ (Kuraoka, 
Schmidt et al. 2016) and this possibility needs to be investigated. It has been shown here 
that ACKR4-deficiency increases c-Myc expression in the GC. Most DLBCL tumours 
do not have Myc translocations but they continuously express c-Myc, although 
dysregulation of c-Myc is not sufficient to cause lymphoma, as the constitutive 
activation of c-Myc does not cause tumours (Shaffer, Young et al. 2012). It is possible 
that ACKR4
-/-
 mice are more susceptible to the development of GC-derived lymphomas 
such as DLBCL, though other hits, such as p53 dysregulation, are highly likely to be 
required. This possible susceptibility needs to be investigated.  
 
Figure 3.31: Ackr4 expression in GC Myc positive and negative cells. Ackr4 expression measured 




Chapter 4. The CCL19/CCL21 axis regulates memory B cell 
migration 
4.1 Introduction and objectives 
4.1.1 Memory B cell generation 
Memory B cells are mostly generated in response to T-cell dependent antigens. Two 
stages of MBC generation have been described accordingly to their T cell requirements. 
After antigenic challenge, a first wave of T cell-independent MBCs occurs followed by 
a T cell-dependent wave (Okumura, Metzler et al. 1976). More recently, it has been 
shown that some IgM
+
 MBCs can be generated in response to TI antigens (Good-
Jacobson and Tarlinton 2012), but these cells are not the focus of this section. TD-
generated MBCs can be the result of the GC reaction or can develop independently of 
the GC reaction. Both classes of MBCs can persist in a quiescent state over a long 
period and are equally capable of producing greater amounts of recall antibody 
responses than naïve B cells (Takemori, Kaji et al. 2014). GC-independent and –
dependent MBCs express MBC markers CD80, PDL1, PDL2, CD35, MHC class II and 
CD40 at comparable level (Anderson, Tomayko et al. 2007) (Takemori, Kaji et al. 
2014). In the spleen, MBCs are equally distributed among the follicles and the marginal 
zones (Anderson, Tomayko et al. 2007). Moreover, IgM
+
 MBCs and switched MBCs 
localise in distinct areas of the spleen. Switched MBCs localise preferentially close to 




4.1.1a GC-independent MBCs 
MBCs generated independently of GCs are detected as early as 3 days post-
immunisation and do not carry somatic mutations (Takemori, Kaji et al. 2014). They 
originate from a precursor which is GL7 and CD38 positive (Taylor, Pape et al. 2012). 
CD40, which is provided by T cells, can by itself cause MBC differentiation. In culture, 
CD40 signals from T cells induce the differentiation of human GC B cells towards a 
MBC phenotype (Casamayor-Palleja, Feuillard et al. 1996).  In mice, MBC 
development is impaired by blockade of the interaction between CD40 and CD40L 
(Siepmann, Skok et al. 2001). 
At the initial T-B cell interaction, in the border between the T zone and the follicle there 
are two possibilities: if the duration of the contact between a T cell and a B cell is long, 
meaning that B cell has high antigen affinity, B cells will then enter the GC pathway. If 
the duration is relatively short, B cells are more prone to enter the GC-independent 
memory pool (Kurosaki, Kometani et al. 2015). Moreover, if ICOS is blocked in the 
early stages of the immune response, there is no reduction in the total numbers of 
MBCs, although there are fewer mutated MBCs (Inamine, Takahashi et al. 2005), 
further demonstrating that MBCs can be generated independently of GCs.  MBCs can 
express IgM or other antibody isotypes (IgG, IgE). However, IgM MBCs do not 
contribute much to the secondary response (Pape, Taylor et al. 2011). IgE MBCs are 
generated mainly in response to membrane IgD cross-linking and their generation 
requires a limited duration of cognate T cell interaction (Le Gros, Schultze et al. 1996). 
The generation of MBCs by the GC-independent pathway is dedicated to preserving 
germ line antibody specificities and prepares the body to elicit rapid responses to 
variants of the invading antigen (Kaji, Ishige et al. 2012). GC-independently generated 
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MBCs provide protection against pathogens with antigens and epitopes that are related 
to the initial invading pathogen. 
 
4.1.1b GC-dependent MBCs 
GC-derived MBCs are thought to be dedicated to generate high affinity somatic 
antibody mutants (Kaji, Ishige et al. 2012). Mutated MBCs are not generated in the 
absence of Tfh cells, which has been demonstrated in Bcl-6 deficient mice (Kaji, Ishige 
et al. 2012). CD80 expression identifies the MBCs mutated compartment. CD80 
deletion in B cells has shown that CD80 has a role in Tfh maturation and the 
maintenance of late GC responses and differentiation of MBCs and long-lived plasma 
cells (Good-Jacobson, Song et al. 2012). 
There are two hypotheses regarding the generation of GC-dependent MBCs. The first 
postulates a master regulator of transcription that guides GC B cells towards the 
memory pool compartment, as Blimp-1 does for plasma cells (Shaffer, Lin et al. 2002). 
However, this transcription factor is still to be identified. The second hypothesis is that 
MBCs differentiate from GC stochastically if they receive survival signals (Kurosaki, 
Kometani et al. 2015). In support of the last hypothesis is that it has been shown that 
overexpression of the pro-survival factor Bcl2 or downregulation of pro-apoptotic 
signals such as Bim, leads to an increase in the memory compartment (Fischer, Bouillet 
et al. 2007). Quantitative modelling of terminal differentiation of GC B cells has 
showed that abrogation of IRF4-mediated Blimp-1 activation leads to a steady state 
resembling MBC phenotype (Martinez, Corradin et al. 2012). In keeping with this 
model is that IRF4 is not required for MBC generation, though it may have a role in 
long-term survival (Klein, Casola et al. 2006). 
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High affinity GC B cells are selected for differentiation into plasma cells. Low-affinity 
B cells survive in the GC without undergoing plasma cell differentiation, so the 
mechanism that regulates plasma cell differentiation is independent of the regulation of 
GC B cell survival (Phan, Paus et al. 2006). Lymphoid tissues have a limited capacity to 
sustain plasma cells (Sze, Toellner et al. 2000) and it is uncertain whether they also 
have a limited capacity to sustain MBCs. Nonetheless, and contrary to what it has been 
described for plasma cells, low affinity LZ GC B cells are actively selected into the 
MBC pool (Shinnakasu, Inoue et al. 2016). These low affinity B cells specifically 
express Bach2, a transcriptional repressor that is expressed when B cells receive weak T 
cell help (Shinnakasu, Inoue et al. 2016). Recently it has been shown that as the GC 
matures it undergoes a switch in its output (Weisel, Zuccarino-Catania et al. 2016). 
BrdU pulse labelling was used to show that non-switched MBCs are produced first in 
the response, followed by switched MBCs and followed by switched long lived PCs. 
The persistence of MBCs, contrary to their generation, has been shown to require little, 
if any, T cell help (Vieira and Rajewsky 1990). IgM
+
 MBCs have been shown to live 
longer than switched MBCs (Pape, Taylor et al. 2011). However, there is controversy 
on this matter. Schittek and Rajewsky have shown that switched MBCs survive in the 
order of 0.01% cells of the spleen for at least 200 days (Schittek and Rajewsky 1990). 




 MBCs, utilising a non-




 MBCs survived in 
a similar manner and with a half-life even greater than the 2 years life span of the mouse 
(Jones, Wilmore et al. 2015). Further studies are needed to clarify this matter.  
Upon re-challenge, MBCs have the capacity to respond quickly and to mount effective 
antibody responses in a shorter time than naïve B cells (Kurosaki, Kometani et al. 
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2015). According to several reports, switched MBCs are responsible of the potent 
antibody response, by differentiating rapidly to plasmablasts. IgM
+
 MBCs only 
contribute to the secondary reaction after the disappearance of switched MBCs and 
enter the GC reaction (Pape, Taylor et al. 2011). Class-switched MBCs diversify their 
BCRs in the secondary GC reaction (McHeyzer-Williams, Milpied et al. 2015). There is 
disagreement about whether IgM
+
 MBCs undergo CSR after re-stimulation. When the 
antigen is PE, IgM
+
 MBCs do not undergo CSR (Pape, Taylor et al. 2011), but SRBC-
specific IgM
+
 MBCs do undergo CSR and produce IgG
+
 secreting plasma cells (Dogan, 
Bertocci et al. 2009). Gitlin and colleagues (Gitlin, von Boehmer et al. 2016) designed a 
very clever way to dissect the role of AID for SHM and CSR in immune responses. 
Switching to IgG1 favoured B cell differentiation towards the PC compartment, 
whereas SHM reduced the longevity of MBCs. This correlates with IgM
+
 MBCs having 
longer life spams (Pape, Taylor et al. 2011) as typically only a small proportion of IgM
+
 
MBCs will have accumulated mutations, while IgG
+
 MBCs, as they have been produced 
in the GC, will have expressed AID and, therefore, accumulated mutations. 
There are conflicting reports regarding a major role for switched-MBCs upon re-
challenge. In a murine model for ehrlichiosis, which is caused by a bacterial infection 
transmitted by ticks, IgM
+
 MBCs are generated in high numbers and are essential to the 
mouse mounting a secondary response (Yates, Racine et al. 2013). Moreover, 





 and un-mutated IgD
+
, but upon re-challenge, IgM
+
 MBCs dominated the 
response and gave rise to plasmablasts faster than IgG
+
 MBCs (Krishnamurty, 





 MBCs are induced and both populations respond rapidly to secondary 
immunisation producing high amounts of high affinity antibodies (Zabel, Mohanan et 
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al. 2014). These controversial results demonstrate the importance of the antigen, 
pathogen and vector that is transmitting the pathogen and it is becoming more and more 
apparent that different pathogens cause different types of memory responses. 
 
4.1.2 Human MBCs 
In humans, the signals and pathways that lead to the generation of MBCs are even less 
clear. Presently, six MBCs subsets have been defined based on their antigen-
experienced phenotype and the differential expression of CD27 and IgH isotypes 
(Berkowska, Driessen et al. 2011). Human MBCs can also originate from three different 



























 MBCs are similar, but these two populations of cells have different functional 
capacities (Seifert, Przekopowitz et al. 2015).  
 
4.1.3 Memory B cell migration 
The exit of PCs and MBCs from the GC is not very well understood. PCs that leave the 
GC up-regulate CXCR4 and are attracted towards CXCL12 to a greater extent than their 
precursors in the GC. CXCL12 is expressed in the splenic red pulp, lymphatic 
medullary cords and bone marrow. PCs leaving the GC also downregulate CXCR5 and 
CCR7 (Hargreaves, Hyman et al. 2001). CXCR4-deficient PCs accumulate in the blood, 
emphasising the importance of CXCL12-directed migration to entrance of PCs to the 
bone marrow (Hargreaves, Hyman et al. 2001). Emigration of PC from secondary 
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lymphoid organs also requires signalling through S1P1. S1P1 ligand, S1P, is plentiful in 
the blood as it is produced by red blood cells (Roth, Oehme et al. 2014). 
It has been clear for a long time that there is a population of B cells, defined as memory 
B cells, that has migratory properties and that is functionally different from GC B cells, 
as they are long-lived and able to enter the recirculating pool (Kraal, Weissman et al. 
1988). In vitro GC B cells do not chemotax to chemokines, such as CXCL13, CXCL12 
or CCL19, and in vivo the GC B cells are confined to the GC area and do not express 
adhesion factors such as L-Selectin and CLA, whereas MBCs do. This shift in the 
migratory phenotype takes place in the GC under the control of cytokines such as IL-2, 
IL-4 and IL-10 (Roy, Kim et al. 2002). Specifically, IL-4 is able to modulate and 
abbrogate responses to CXCL12 and CXCL13. Once human GC B cells mature to 
MBCs and plasmablasts, they downregulate CXCR5 surface expression and upregulate 
ACKR3 (CXCR7) expression, an atypical chemokine receptor that binds CXCL12 and 
CXCL11. This is a transient expression and regulates exit from the GC to the follicle, as 
ACKR3-expression ensures that cells are not retained by CXCL12 in the GC, thus 
limiting CXCR4-associated migratory capacity (Humpert, Pinto et al. 2014). 
Memory T cell generation and migration is much better understood (Mueller, Gebhardt 
et al. 2013). Memory T cells are sub-divided into Central Memory (Tcm), Effector 
Memory (Tem) and tissue-resident memory (Trm) (Sallusto, Langenkamp et al. 2000). 
Although Tcm express CCR7, it is known that their migration back to lymph nodes is 
CCR7-independent (Vander Lugt, Tubo et al. 2013). CD4 memory T cells have been 
shown to localise to the bone marrow at the end of an immune response, and they 




4.1.4 Objectives of this chapter 
The experiments described in this chapter have investigated the role of ACKR4 in the 
generation and migration of MBCs. As described in Chapter 3, ACKR4 is specifically 
expressed on GC B cells and on lymphatic endothelial cells of the subcapsular sinus 
(SCS). This restricted pattern of expression suggests a role for ACKR4 in regulating the 
migration of GC B cells as to output. It has been shown before that ACKR4 expression 
in the SCS causes a CCL19/21 gradient from the T zone to the capsule that influences 
the migration of DCs inwards (Ulvmar, Werth et al. 2014). As MBCs exit the GC from 
the LZ and migrate towards the SCS (Y. Zhang, unpublished), the CCL19/21 gradient 
may also be influencing MBC migration towards the capsule and their appearance in 
distant lymphoid organs, as MBCs express CCR7 and ACKR4. The areas investigated 
are as follows: 
1. MBC generation in ACKR4-/- mice during TD response to NP-CGG. 




3. The importance of ACKR4 expression by MBCs and stromal cells. 
4. The relation to CCR7-/- MBCs. MBC generation and migration in CCR7-/- B 
cells 






4.2.1 Memory B cells from Cγ1-Cre mTmG ACKR4
-/-
 appear in higher numbers in the 
distant LN from 8 days after NP-CGG  
Chapter 3 has documented that ACKR4 is expressed by GC B cells (Fig. 3.4, 3.5) and 
has a minor role in intra-GC migration at the mature stage of the GC response (Fig. 
3.19). ACKR4 does not seem to have a role in GC output generation in the spleen (Fig. 
3.14, 3.19). In order to investigate whether this is true also in the case of LN and if 
ACKR4 has a role in the migration of MBCs from the draining LN to other non-reactive 
sites, Cγ1-Cre x mTmG mice that were backcrossed into the ACKR4
-/-
 strain were used 
for experiments.  
mTmG is a double-fluorescent reporter system whereby all of the body cells initially 
express the membrane-bound tandem-dimer Tomato (TdTomato) protein (mT) under 
the control of CMV β-actin enhancer promoter. After Cre expression, TdTomato is 
deleted and this leads to the expression of membrane-bound GFP protein (mG) 
(Muzumdar, Tasic et al. 2007). Cγ1-Cre mice (See 2.1.5) express Cre recombinase after 
transcription of the Iγ1-Cg1 constant region gene germline transcript, expressed during 
the initiation of IgG1 class-switch recombination (Casola, Cattoretti et al. 2006). Cg1 
germline transcripts are expressed after cognate Th2-B cell interaction, for example: 
during initial the T-B interaction after T cell priming has taken place (Toellner, Luther 
et al. 1998), or during Tfh cell- B cell interaction in the GC (Liu, Malisan et al. 1996). 
Limitations of the Cγ1-Cre mice include: (i) 2% of the IgM
+
 B cells pre-immunisation 
shows Cre-mediated recombination, (ii) Cre-mediated recombination labels 85-95% of 
the GC B cell population and 70-80% of the memory B cell population, (iii) Cre-
mediated recombination involves most IgG1-, but also a fraction of IgG3-, IgG2a-, 
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IgG2b- and IgA-expressing GC and post-GC B cells (Casola, Cattoretti et al. 2006). 
These limitations imply that some of the antigen-specific B cells that are involved in the 
immune response are not detected. 
 F1 crosses of these two strains (Cγ1-Cre x mTmG) produce mice where B cells that 
have interacted with T cells and expressed the Cγ1 gene will be GFP
+
. This includes 
most GC B cells and their descendants, plasma cells and T-dependent MBCs. Therefore, 
MBCs derived from GC, but also from the initial T-B interactions (GC-independent 
MBCs) will be detectable by flow cytometry. Because the fluorescent reporters are 
membrane anchored, they are also suitable for immunofluorescence histology.  
In Cγ1-Cre eYFP mice, post NP-CGG immunisation subcutaneously in the hind feet, 
eYFP
+
 GC B cells peaked at day 7 post-immunisation in the drLN, as analysed by flow 
cytometry (Y. Zhang, unpublished, Fig. 4.1a). eYFP
+
 MBCs in the drLN peaked slightly 
later, between day 7 and day 10, and numbers were maintained until day 14. By day 21, 
MBCs were imperceptible. In the distLN, MBCs peaked parallelly to the drLN (Y. 
Zhang, unpublished, Fig. 4.1b and 4.1c). These preliminary results indicated the best 
time points to study T-dependent MBC generation. 





 mice was analysed 5, 8 and 14 days post subcutaneous 
immunisation in the hind feet. The popliteal lymph node drains immunisation in the foot 
(Harrell, Iritani et al. 2008). The primary response and GC development are restricted to 
the popliteal LN (from now on, draining LN or drLN). From there, MBCs will migrate 
to other sites, while PCs will home to the bone marrow (Tellier and Kallies 2014). 
Different B cell subpopulations in the drLN of Cγ1-Cre mTmG ACKR4
+/+
 and Cγ1-Cre 
mTmG ACKR4
-/-
 mice were analysed by flow cytometry. The gating strategy is shown 
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in Fig. 4.2. Cγ1-expressing B cells were gated according to the expression of GFP and 
further subdivided in plasma cells (CD138
+








). GC B cells were further subdivided into DZ and LZ on the basis of 
their expression of CXCR4 and CD86. MBCs were gated from the GFP
+





, in keeping with naïve B cell expression of these markers (gate 2, Fig. 
4.2), but as these are GFP
+
 this indicates that they have seen the antigen and interacted 






 MBCs. These 
subpopulations of MBCs have been previously described (Anderson, Tomayko et al. 
2007). 
Five days post-immunisation, Cγ1-Cre mTmG ACKR4
-/- 
mice had numbers of GFP
+
 
cells, plasma cells, GC B cells and a distribution of GC in LZ and DZ comparable to 
Cγ1-Cre mTmG ACKR4
+/+
 mice (Fig. 4.3). MBCs were not analysed in the drLN at this 
time point due to their low numbers (Fig. 4.1) and that they might be recently activated 
B cells. At the peak of the GC response to NP-CGG, which was 8 days post-
immunisation, Cγ1-Cre mTmG ACKR4
-/- 
mice presented comparable numbers than 
Cγ1-Cre mTmG ACKR4
+/+
 mice of all the B cell subpopulations analysed, which 
included GFP
+












 mice to NP-CGG immunisation was also studied in the drLN 
14 days post-immunisation. GFP
+
 cell, plasma cell and GC B cell populations were 
similar in Cγ1-Cre mTmG ACKR4
+/+
 and Cγ1-Cre mTmG ACKR4
-/-
 mice (Fig. 4.5). 
As previously observed for the splenic response to NP-CGG (Fig. 3.19), GCs from 
ACKR4
-/-
 mice presented a skewed LZ/DZ distribution, with elevated LZ GC B cell 
numbers and reduced DZ GC B cell numbers (Fig. 4.5). MBCs and the different MBCs 
subpopulations analysed were comparable for both mice (Fig. 4.5). 
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Analysis of the distant lymph nodes (axillary and brachial, distLN) from Cγ1-Cre 
mTmG ACKR4
+/+
 and Cγ1-Cre mTmG ACKR4
-/-
 mice showed an increased 
appearance of GFP
+
 cells in the ACKR4
-/-
 distLNs (Fig. 4.6a). The expression of mGFP 
showed that these cells had seen antigen and undergone T-dependent activation. The 
expression of CD38 confirmed that these cells were not GC B cells, and the absence of 
CD138 expression indicated that they were not PCs. Before immunisation, there were 
barely any GFP
+
 cells in the distLN, indicating that the cells that appeared afterwards 
had been generated specifically in the immune response provoked by the immunisation 
(Day 0, Fig. 4.6a and 4.6b). At early stages of the immune response, there were no 
difference in the numbers of GFP
+
MBCs in the distLN from Cγ1-Cre mTmG ACKR4
+/+
 
and Cγ1-Cre mTmG ACKR4
-/-
 mice (Day 5, Fig. 4.6b). Strikingly, from day 8 post-
immunisation onwards, in ACKR4
-/-
 distLN there were significantly more GFP
+
MBCs 
(Day 8, Day 14, Fig. 4.6b).  
Several reasons might account for the increased appearance of MBCs in distant 
lymphoid sites. For example: increased differentiation of B cells into MBCs in the drLN 
will lead to elevated MBC migration out of the drLN and, therefore, increased 
appearance in distant sites; preference of MBCs to leave the drLN in ACKR4
-/-
 mice; or 
preference of MBCs to enter distLN in ACKR4
-/-
 mice can also lead to an increased 
appearance of MBCs in distLN; increased retention of MBCs in distLN from ACKR4
-/-
 
mice can also lead to elevated numbers of MBCs in distLN. The results showed in Fig. 
4.4 and 4.5 indicated that ACKR4
-/-
 mice did not seem to have an increased level of 






Figure 4.1: MBCs numbers reach the maximum in draining lymph node and distant lymph 
node in parallel to GC B cells. Cγ1-Cre eYFP mice were immunised with NP-CGG s.c. in the 
rear feet and the response studied at different time points post-immunisation in the drLN and 
distLN by flow cytometry. a) GC B cells, as to the % of total number of cells in the drLN. b) 
MBCs, as to the % of total number of cells in the drLN. c) MBCs, as to the % of total number of 
cells in the distLN.  
1 independent experiment. Each symbol represents one mouse. Horizontal line represents the 
median. 
Key: GC: germinal centre; MBCs: memory B cells; drLN: draining lymph node; distLN: distant 




Figure 4.2: Representative gating strategy for antigen-specific B cell populations in the 
draining lymph node of Cγ1-Cre mTmG mice 8 days post-immunisation with NP-CGG. Cγ1-
Cre mTmG ACKR4
+/+
 and Cγ1-Cre mTmG ACKR4
-/-
 mice were immunised with NP-CGG s.c. in 
the rear feet and the response was studied at different times post-immunisation. The figure shows 
the flow cytometry gating strategy for different B cell subsets from drLN 8 days post-immunisation.   
Key: GFP: green fluorescent protein; GC: germinal centre; DZ: dark zone; LZ: light zone; MBCs: 




Figure 4.3: Cγ1-Cre mTmG ACKR4
-/-
 mice have a normal response in the draining lymph 
node to NP-CGG, 5 days post-immunisation. Cγ1-Cre mTmG ACKR4
+/+
 and Cγ1-Cre 
mTmG ACKR4
-/-
 mice were immunised with NP-CGG s.c. in the rear feet and the was response 













). Quantification as to the % of GC B 




















) from pLN (draining LN) 5 days post-immunisation.  
Data were combined from 2 independent experiments with 5 mice per group, except for DZ and 
LZ GC B cells, where plots are representative of 2 independent experiments. Each symbol 
represents one mouse. Horizontal line represents the median. 
Key: GFP: green fluorescent protein; GC: germinal centre; DZ: dark zone; LZ: light zone; s.c: 








Figure 4.4: Cγ1-Cre mTmG ACKR4
-/-
 mice have a normal response in the draining lymph node 
to NP-CGG, 8 days post-immunisation. Cγ1-Cre mTmG ACKR4
+/+
 and Cγ1-Cre mTmG ACKR4
-/-
 
mice were immunised with NP-CGG s.c. in the rear feet and the response was studied 8 days post-
immunisation.  Quantification, as to the % of lymphocytes, of GFP
+

















). Quantification, as to 




























 MBCs from pLN (draining LN) 8 days post-immunisation.  
Data were combined from 3 independent experiments with 4 mice per group, except for DZ, LZ GC 
B cells and CD80
+
 MBCs, where data were combined from 2 independent experiments. Each symbol 
represents one mouse. Horizontal line represents the median. 
Key: GFP: green fluorescent protein; GC: germinal centre; DZ: dark zone; LZ: light zone; MBCs: 





Figure 4.5: Cγ1-Cre mTmG ACKR4
-/-
 mice have a normal response in the draining lymph node 
to NP-CGG, 14 days post-immunisation. Cγ1-Cre mTmG ACKR4
+/+
 and Cγ1-Cre mTmG ACKR4
-
/-
 mice were immunised with NP-CGG s.c. in the rear feet and the response studied 14 days post-
immunisation. a) Quantification, as to the % of lymphocytes, of GFP
+














































 MBCs from pLN (draining LN)  14 days post-immunisation.  
Data were combined from 2 independent experiments with 3-4 mice per group, except for CD80
+
 
MBCs, where data were representative from 2 independent experiments. Each symbol represents one 
mouse. Horizontal line represents the median. 
Key: GFP: green fluorescent protein; GC: germinal centre; DZ: dark zone; LZ: light zone; MBC: 






 memory B cells from Cγ1-Cre mTmG ACKR4
-/-
 appear in higher numbers in 
the distant LN from 8 days after NP-CGG. Cγ1-Cre mTmG ACKR4
+/+
 and Cγ1-Cre mTmG 
ACKR4
-/-
 mice were immunised with NP-CGG s.c. in the rear feet and the response was studied at 
different times post-immunisation. a) Flow cytometry gating strategy for memory B cells from axillary 
lymph nodes (distant LN) 8 days post-immunisation.  b) Quantification, as to the % of lymphocytes, of 






) from axillary lymph nodes (distant LN) 0, 5, 8 and 14 days 
post-immunisation.  
Data were combined from 2 (day 5 and day 14) or 3 (day 8) independent experiments with 3-5 mice 
per group. Each symbol represents one mouse. Horizontal line represents the median. 
Key: GFP: green fluorescent protein; s.c: subcutaneously; LN: lymph node. 
Non-parametric Mann-Whitney test *p<0.05; **p<0.01 
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4.2.2 Memory B cells from Cγ1-Cre mTmG ACKR4
-/-
 mice exit the drLN in increased 
numbers than in Cγ1-Cre mTmG ACKR4
+/+
 mice 
To explore the possibilities listed above regarding the elevated number of MBCs in the 
distant lymph nodes of ACKR4
-/-
 mice, the GFP
+
MBCs that appeared in the distLN 













 MBCs were viewed as recent arrivals from the drLN, because 




 MBCs were viewed as cells 
that had been activated longer ago and, therefore, they may had left the GC response 
and the drLN longer ago. Re-analysis of the data from Fig. 4.6 as to this further 





 MBCs (Fig. 4.8a), while 14 days post-immunisation, the 
differences were not statistically significant (Fig. 4.8b). These results are compatible 
with the hypothesis that MBCs in ACKR4
-/-
 mice leave the drLN or enter the distLN in 
higher numbers. These new entrants in distant lymph nodes were detected throughout 
the response.  
To further test the hypothesis that MBCs in ACKR4
-/-
 mice leave the drLN or enter the 
distLN better, Cγ1-Cre mTmG ACKR4
+/+
 and Cγ1-Cre mTmG ACKR4
-/-
 mice 
immunised with NP-CGG were injected with EdU 8 days post-immunisation. Twelve 
hours later the tissues were taken. MBCs that have proliferated in the drLN in the last 
12 h and arrived in the distLN will be EdU
+
, while the MBCs that were in the distLN 
for longer than 12 h will be EdU
-





mice there were more EdU
+




 subpopulation (Fig. 4.9a). 
This was true for all the mice analysed (Fig. 4.9b), independent of their genotype, 
confirming that double positive MBCs may be recent emigrants, as there is a larger 





mice had a trend to higher percentages of EdU
+
 cells, confirming that in ACKR4
-/-
 mice 
emigration from the draining LN is increased. Pulsing with EdU with one i.p. injection 
and measurement of the response 12 h later may present some inconveniences for the 
detection of MBCs. It may prevent the detection of some GC B cells that were initially 
labelled but have proliferated and differentiated into MBCs between the injection and 
detection time, and therefore, diluted the EdU that was previously incorporated. 
MBC accumulation in certain areas of the distant LNs would indicate a defect in MBC 
recirculation throughout the body and, therefore, increased retention of MBCs in 
ACKR4
-/-
 mice. An equal distribution of MBCs would be further evidence to support 
the viewpoint that ACKR4 does not play a role in MBC retention in distLN and instead 





 distLN, axillary LNs from Cγ1-Cre mTmG ACKR4
+/+
 and Cγ1-Cre 
mTmG ACKR4
-/-
 mice 8 days post-immunisation with NP-CGG in the rear feet were 
collected, sectioned and stained by immunofluorescence. A representative example of 
an axillary LN can be seen in Fig. 4.10. Because there is no antigen-dependent 
activation, axillary LNs do not have GCs or PCs. GFP
+
MBCs can be seen in three 
different areas: most of the MBCs are in the follicles (IgD
+
 areas) or in the vessels 
(Lyve-1
+





and they are probably transiting from the vessels to the follicles, as MBCs continuously 
recirculate between blood and tissue, entering secondary lymphoid organs through HEV 
in a CD62L-dependent manner (Rasmussen, Lodahl et al. 2004).  
MBCs were quantified in the three different areas mentioned previously and the data 
obtained are presented graphically (Fig. 4.11). As expected from the flow cytometry 
results, ACKR4
-/-
 mice had significantly more MBCs per total LN area (Fig. 4.11a, left) 
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and also in the different areas analysed: vessels (Fig. 4.11a, middle), follicles (Fig. 
4.11a, right) and T cell zones (Fig. 4.11a, lower). Nevertheless, when the percentage of 
MBCs was represented in relation to the zone in which they were located (Fig. 4.11b), 
no difference could be observed, indicating that even if ACKR4
-/-
 distLN do have more 
MBCs, these distribute in the same way in the different areas. Around 50% of MBCs 
were seen to be spread randomly throughout the follicular B cell areas, 45% were in 
lymphatic vessels and only about 5-10% was seen to be disseminated in the T cell areas. 
Before immunisation (day 0), GFP
+
MBCs were not detectable by immunofluorescence 
histology (Fig. 4.12). 
In summary, distLN from ACKR4
-/-
 mice contain more MBCs from day 8 post-
immunisation. The data are compatible with the notion that these differences are caused 
by increased migration from the draining LN towards the distLN. Additionally, in 
ACKR4
-/-
 distLN, MBCs distribute similarly to MBCs in ACKR4
+/+
 distLN. This is in 
line with the hypothesis that ACKR4 does not have an effect on entrance of MBCs into 
the distLN, nor on their retention in this site. In conclusion, MBCs appear in higher 
number in distLN of ACKR4
-/-
 mice due to an increased exit from the draining LN. 
 
4.2.3 In the draining LN, memory B cells from Cγ1-Cre mTmG ACKR4
-/-
 mice appear 
in higher numbers in the subcapsular sinus  
How MBCs leave the GC in the drLN and migrate to other LNs is still not very well 
understood. It is possible that MBCs leave the GC from the LZ towards the outside of 
the follicle and the SCS (Y. Zhang unpublished), where they would join a net of 
lymphatic vessels that connects with the medullary sinus and the efferent lymphatics 
that would drive them out of the drLN (Girard, Moussion et al. 2012). In a mouse model 
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where B cells in cell cycle (Cdt-1
+





 MBCs were observed by intravital microscopy to migrate to the SCS 
of the drLN, from day 6 post-immunisation (Y. Zhang unpublished, Fig. 4.13). Further 
evidence showing that MBCs appear in the SCS of Cγ1-Cre mTmG mice is the 
visualisation of their movement by light-sheet microscopy (Fig. 4.14a). The movement 
of MBCs was observed ex vivo in an explanted popliteal lymph node from a Cγ1-Cre 
mTmG mice 8 days post-immunisation with NP-CGG s.c. in the hind feet. In focus 
appears the capsule and SCS of the lymph node (TdTomato
+
) and some GFP
+
 individual 
cells, which are MBCs. Out of focus, which means the cells are deeper in the tissue, 
there are two GCs (GFP
+




 MBCs were 
observed to sit and crawl under the capsule of the drLN (Fig. 4.14b). 
Further analysis of immunised drLN from Cγ1-Cre mTmG ACKR4
+/+
 and Cγ1-Cre 
mTmG ACKR4
-/-
 mice by immunofluorescence histology showed that GFP
+
 MBCs 
spread throughout the follicles around GCs and also some of them located in the SCS 
(Fig. 4.15). These MBCs are in the Lyve-1
+
 area (Fig. 4.15a), which corresponds with 





 (Fig. 4.15b). Plasma cells are also GFP
+
 and there is a possibility that 
these GFP
+
 cells in the SCS may be PCs. However, PCs leave the GC through the DZ 
towards the T zone and they are unlikely to have migrated towards the SCS (Y. Zhang, 
unpublished). GFP
+
 cells in the SCS were counted and represented as the number of 
cells in relation to the length of the SCS analysed (Fig. 4.16a). Only intact SCS was 
analysed, meaning that the floor and the ceiling LECs are present, as determined by 
Lyve-1 and TdTomato expression. Coinciding with the increased appearance of MBCs 
in distant LN (Fig. 4.6), 8 days post-immunisation there was an increase in GFP
+
 MBCs 
in the SCS of ACKR4
-/-
 drLN compared to drLN from ACKR4
+/+
 mice (Fig. 4.16b), 
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 mice were similar (Fig. 
4.4). Although GFP
+
 MBCs were observable in the SCS from day 5 post-immunisation, 
there were not obvious differences in the numbers of GFP
+
 MBCs in the SCS of drLN 
neither 5 days nor 14 days post-immunisation (Fig. 4.16b).  




 mice 8 
days post-immunisation have revealed that MBCs appear in higher numbers in the SCS 
of drLNs in ACKR4
-/-
 mice. This may explain why MBCs appear in higher numbers in 




Figure 4.7: Representative gating strategy for GFP
+
 memory B cells from the distant lymph 
nodes of Cγ1-Cre mTmG ACKR4
+/+
 and Cγ1-Cre mTmG ACKR4
-/-
 mice according to 
TdTomato level and EdU incorporation 8 days after NP-CGG. The figure shows the flow 
cytometry gating strategy for memory B cells from axillary lymph nodes (distant LN) from Cγ1-Cre 
mTmG ACKR4
+/+
 and Cγ1-Cre mTmG ACKR4
-/-
 mice 8 days post-immunisation with NP-CGG s.c. in 
the rear feet. EdU was injected i.p. 12 h prior to sacrifice. 
Key: GFP: green fluorescent protein; s.c: subcutaneously; LN: lymph node; EdU: 5-ethynyl-2′-








 memory B cells are the fraction that causes higher appearance of 
memory B cells in Cγ1-Cre mTmG ACKR4
-/-
 mice 8 days after NP-CGG. Cγ1-Cre mTmG 
ACKR4
+/+
 and Cγ1-Cre mTmG ACKR4
-/-
 mice were immunised with NP-CGG s.c. in the rear feet 
and the response studied at different times post-immunisation. a) Quantification, as to the % of 








) from axillary lymph nodes (distant 









) from axillary lymph nodes (distant LN) 0, 5, 8 and 14 days 
post-immunisation. For gating see Figure 4.7. 
Data were combined from 2 (day 5 and day 14) or 3 (day 8) independent experiments with 3-5 mice 
per group..Each symbol represents one mouse. Horizontal line represents the median. 
Key: GFP: green fluorescent protein; s.c: subcutaneously; LN: lymph node. 





Figure 4.9: Memory B cells from Cγ1-Cre mTmG ACKR4
-/-
 appear in higher numbers in the 
distant LN from 8 days after NP-CGG due to increased exit from drLN. Cγ1-Cre mTmG 
ACKR4
+/+
 and Cγ1-Cre mTmG ACKR4
-/-
 mice were immunised with NP-CGG s.c. in the rear feet and 
the response studied 8 days post-immunisation. EdU was injected i.p. 12h prior to sacrifice. a) 
Quantification, as to the % of MBCs, of EdU
+






) cells from 









 MBCs. See gating in Figure 4.7. 
1 independent experiment with 5 mice per group. Each symbol represents one mouse. Horizontal line 
represents the median. 
Key: GFP: green fluorescent protein; MBC: memory B cell; s.c: subcutaneously; LN: lymph node; 
EdU: 5-ethynyl-2′-deoxyuridine; i.p: intraperitoneally. 




Figure 4.10: Memory B cells from Cγ1-Cre mTmG ACKR4
-/-





 areas. Representative example of immunofluorescence staining image 
for Tomato (red), Lyve-1 (pink), GFP (green) and IgD (blue) from axillary LN (distant LN) from 
Cγ1-Cre mTmG ACKR4
-/-
 mouse 8 days post-immunisation with NP-CGG s.c. in the rear feet. Green 
marked areas denote IgD
+
 areas, orange marked areas denote Lyve-1
+
 areas, interarea space 
corresponds to CD3
+
 areas. Yellow arrows indicate GFP
+
 MBCs. 
Scale bar: 200 µm 




Figure 4.11: Memory B cells in Cγ1-Cre mTmG ACKR4
-/-
 distant lymph nodes distribute as in 
Cγ1-Cre mTmG ACKR4
+/+
 mice. Cγ1-Cre mTmG ACKR4
+/+ 
and Cγ1-Cre mTmG ACKR4
-/-
 mice 
were immunised with NP-CGG s.c. in the rear feet and the response studied 8 days post-immunisation. 




 MBCs that have 
migrated to distant LN. Upper left, total MBC numbers in whole LN. Upper middle, MBC numbers in 
Lyve-1
+
 areas. Upper right, MBC numbers in IgD
+
 areas. Lower left, MBC numbers in CD3
+
 areas. b) 
Quantification of immunofluorescence staining images, in % of cells, of GFP+ MBCs. Left, % of 
MBCs in Lyve-1
+
 areas. Middle, % of MBCs in IgD
+
 areas. Right, % of MBCs in CD3
+
 areas. See 
Figure 4.10 for explanation of different areas. 
Data were combined from 2 independent experiments with 4-5 mice per group. Each symbol 
represents one lymph node. Horizontal line represents the median. 
Key: GFP: green fluorescent protein; s.c: subcutaneously; LN: lymph node; MBCs: memory B cell. 






 memory B cells are absent in Cγ1-Cre mTmG ACKR4
+/+
 and Cγ1-Cre 
mTmG ACKR4
-/-
 mice before immunisation. Representative examples of 
immunofluorescence staining images and higher magnification for Tomato (red), GFP (green), 
CD4 (blue) and IgD (white) from axillary lymph nodes (distant LN) from non-immunised Cγ1-
Cre mTmG ACKR4+/+ and Cγ1-Cre mTmG ACKR4-/- mice.  
Scale bar: 100 μm  





Figure 4.13: Memory B cells leave the GC from the LZ and migrate towards the subcapsular 
sinus. Representative example of immunofluorescence staining images for Cdt-1 (red), Blimp-1 
(green) and CD4 (blue) from popliteal lymph node (draining LN) 6 days post-immunisation with NP-
CGG s.c. in the rear feet from Fucci x Blimp-1-GFP mice.  








 memory B cells appear and move in the SCS of drLN. Cγ1-Cre mTmG 
ACKR4
+/+
 mice were immunised with NP-CGG s.c. in the rear feet and the response was analysed 8 
days post-immunisation. Explanted drLN were observed under light sheet microscope ex vivo. A total 
of 60 footages in 40 min were captured. TdTomato (red), GFP (green). a) Representative maximum 
intensity projection of one independent footage. b) Sequential footage. Arrow heads indicate the 
different positions of three GFP
+
 MBCs in their movement under the capsule. c) Tracking of the 
migration in the SCS of three different GFP
+
 MBCs for the complete lenght of the observation. 
Key: GFP: green fluorescent protein; GC: germinal centre; PC: plasma cells; MBC: memory B cell; 





Figure 4.15: Trafficking of memory B cells in the subcapsular sinus of draining lymph node 
from Cγ1-Cre mTmG mice 8 days after NP-CGG. Representative examples of immunofluorescence 
staining images from popliteal lymph nodes (draining LN) from Cγ1-Cre mTmG ACKR4
-/-
 mice 8 
days post-immunisation with NP-CGG s.c. in the rear feet. Yellow arrows denote GFP
+
 MBCs in the 
SCS. White arrows denote GFP
+
 PCs. a) TdTomato (red), GFP (green), IgD (blue) and Lyve-1 (cyan) 
and higher magnification Lyve-1 (red), GFP (green). b) TdTomato (red), GFP (green), IgD (blue) and 
Ki67 (cyan) and higher magnification Ki67 (red) and GFP (green). 
Key: GFP: green fluorescent protein; PC: plasma cells; MBC: memory B cell; SCS: subcapsular sinus; 
s.c: subcutaneously. 




Figure 4.16: In the draining LN, memory B cells from Cγ1-Cre mTmG ACKR4
-/-
 appear in 
higher numbers in the subcapsular sinus from 8 days after NP-CGG. Cγ1-Cre mTmG ACKR4
+/+
 
and Cγ1-Cre mTmG ACKR4
-/-
 mice were immunised with NP-CGG s.c. in the rear feet and the 
response studied at different time points post-immunisation. a) Representative example of 
immunofluorescence staining images for TdTomato (red) and GFP (green) from popliteal lymph node 
(draining LN) from Cγ1-Cre mTmG ACKR4
-/-
 mice 8 days post-immunisation. Yellow arrows denote 
GFP
+
 MBCs. b) Quantification, as to cells per mm of subcapsular sinus, of GFP
+
 MBCs that have 
migrated to the subcapsular sinus 5, 8 and 14 days post-immunisation.  
Data were combined from 2 (day 5 and day 14) or 3 (day 8) independent experiments with 3-5 mice 
per group. Each symbol represents one mouse. Horizontal line represents the median.  
Key: GFP: green fluorescent protein; s.c: subcutaneously; LN: lymph node; MBCs: memory B cell. 





hosts had reduced numbers of MBCs in the drLN independently of the 
MBC genotype  
So far it has been shown that in ACKR4
-/-
 mice, MBCs appear in higher numbers in 
distLN from 8 days post-immunisation due to increased exit through the SCS in the 
drLN. There are two possible explanations. The effect might have been caused by a B 
cell intrinsic deficiency of ACKR4. Alternatively, loss of ACKR4 expression by cells in 
the surrounding environment (host), for example by naïve follicular B cells, stroma or 
SCS endothelium, might be important.  
In order to examine the role of ACKR4 expression in the MBCs or in the host for the 
migration of MBCs towards distant sites, chimeric mice were produced by transferring 




 and QM ACKR4
-/-





 recipients (Fig. 4.17a). Due to the general expression of the 2 different 





specific B cells could be co-transferred into the same host and their response to NP-
CGG be studied in direct competition.  Mice were given primary immunisation with 
NP-CGG into the rear feet subcutaneously and lymph nodes were taken for analysis 8 
days post-immunisation. When LNs from mice that were not immunised were analysed 
barely any transferred cell survived for 8 days (Fig. 4.17b). Therefore, it is safe to 
assume that the fluorescent cells detected in the distLN 8 days post-immunisation are 
MBCs and not naïve B cells.  
Flow cytometry was used to detect different immunisation-induced B cell 
subpopulations in the drLN. A representative example of the gating strategy for GC B 
cells and PCs from drLN 8 days post-immunisation is shown in Fig. 4.18. There were 




 antigen-specific B 
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), with on average 80% of the transferred cells differentiating 
into GC B cells by day 8 (Fig. 4.19a, left). There was also not a major difference in the 
percentages of GC B cells of lymphocytes (Fig. 4.19a, right), with 0.5% of the total 
lymphocyte cell population becoming GC B cells from each of the genotypes 





 B cells in the same hosts (Fig. 4.19b) allows the study of B cell intrinsic 
effects. Absence of ACKR4 in B cells led to slightly higher numbers of GC B cells 
compared to ACKR4
+/+
 B cells when placed in the same ACKR4
-/-
 environment (Fig. 
4.19b right). So, it can be presumed that ACKR4
-/-
 B cells differentiate slightly better 
into GC B cells only when they are placed into an ACKR4-deficient environment.  
Next, LZ/DZ distribution was investigated. As seen in the later stages of the splenic GC 
response (Fig. 3.19), the LZ/DZ distribution is skewed towards LZ. (Fig. 4.20). This 
effect is dependent on the expression of ACKR4 in B cells and independent of ACKR4-
expression in the environment (Fig. 4.20a). These differences are clearer when data 
from the same mice are linked (Fig. 4.20b). ACKR4
+/+
 B cells enter preferably the DZ 
compartment while ACKR4
-/-
 B cells go into the LZ GC B cell subpopulation. This 
result was to be expected as ACKR4 is differentially expressed in DZ GC B cells. It is 
interesting that the skewed distribution is observable earlier in pLN than in the case of 
the splenic response. This may indicate that the time course in spleen and in LN is 
slightly different, that the changes are more pronounced in the LN response, or that the 
route of administration of the antigen marks the time point at which some differences 





) were also analysed in the drLN. Neither in percentage of 
transferred cells (Fig. 4.21a, left) nor in the percentage of lymphocytes (Fig. 4.21a, 
right) was any difference observed. Moreover, when the data from the same hosts was 
linked, there was not a difference (Fig. 4.21b). Therefore, it can be concluded that 
ACKR4 expression, neither on B cells nor on the environment, has an appreciable role 
in PC generation 8 days after NP-CGG immunisation.  
Analysis of MBCs numbers in the drLN (the gating strategy is shown in Fig. 4.22) 
showed that, both the percentage of MBCs developing within transferred B cells (Fig. 
4.23a, left) and the percentage of MBCs within all lymphocytes, which corresponds to 
the absolute number of MBCs (Fig. 4.23a, right) were lower when the host was 
ACKR4
-/-
. ACKR4 deficiency in B cells did not have an effect (Fig. 4.23b). This 
finding reveals that when ACKR4 is expressed in the lymph node environment, B cells 
differentiate into MBCs better. In order to study subpopulations of MBCs, CD73, CD80 
and PDL2 were stained on drLN MBCs. CD80 and/or PDL2-high expression identify 
the more memory-like population that accumulates a higher number of mutations. 
MBCs that express CD73 are the more naïve-like, have a lower rate of mutation and are 
infrequently isotype switched (Tomayko, Steinel et al. 2010, Zuccarino-Catania, 
Sadanand et al. 2014). There was no difference in the percentage of MBCs that 
expressed CD73 (Fig. 4.24a, b upper). Surprisingly, in the GC-dependent CD80
+
 
subpopulation, there was a major reduction in the percentage of CD80
+
 MBCs, if B cells 
were deficient for ACKR4 (Fig. 4.24a, b middle). In the PDL2
+
 subpopulation there was 
a minor difference when ACKR4
-/-
 B cells were placed in a WT environment (Fig. 
4.24a, b lower). 
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In summary, when the drLNs of chimeric mice were analysed, the major differences 
were found in the MBC compartment. There are less MBCs when the host is ACKR4
-/-
 . 
There was a reduction of GC-derived CD80
+





Figure 4.17: Transfer of QM ACKR4
+/+






 cells into WT or ACKR4
-/-
 




 cells from QM 
ACKR4
+/+








 cells from each genotype were co-transferred 
into the same hosts i.v. and immunised 24 h later with 20 µg NP-CGG alum precipitated with 1x10
5
 







 cells from each genotype. 






















 cells from QM 
ACKR4
+/+
 and same number from QM ACKR4
-/-
 were co-transferred to WT or ACKR4
-/-
 hosts i.v. 
and immunised 24 h later with NP-CGG s.c. in the rear feet. The response was studied 8 days post-
immunisation. Representative diagram for flow cytometry gating of plasma cells, GC B cells, DZ GC 
B cells and LZ GC B cells.  
Key: KO: knock-out; WT: wild type; PCs: plasma cells; GC: germinal centre; DZ: dark zone; LZ: 





















 differentiate better 
into GCs when the host does not express ACKR4. WT or ACKR4
-/-







 cells from QM ACKR4
+/+
 and same number from QM ACKR4
-/-
 i.v. and immunised 
24 h later with NP-CGG s.c. in the rear feet. The response was studied 8 days post-immunisation in the 
drLN. a) Flow cytometry data, as to the % of transferred cells (left) or % of lymphocytes (right), of GC 
B cells from b) Linked flow cytometry data from the same hosts for GC B cells.  
Data were combined from 3 independent experiments with 5-6 mice per group. Each pair of symbols 
represents one mouse. Horizontal line represents the median.  
Key: WT: wild type; i.v: intravenously; s.c: subcutaneously; drLN: draining lymph node; GC: 
germinal centre. 
Same host compared using Wilcoxon matched-pairs signed rank test *p<0.05  
a) 
b) 
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Figure 4.20: In the draining LN, QM ACKR4
-/-
 form smaller DZ and bigger LZ, independently 
of the host. WT or ACKR4
-/-






 cells from QM 
ACKR4
+/+
 and same number from QM ACKR4
-/-
 i.v. and immunised 24 h later with NP-CGG s.c. in 
the rear feet. The response was studied 8 days post-immunisation in the drLN. a) Flow cytometry data, 
as to the % of GC B cells, of LZ GC B cells (left) and DZ GC B cells (right). b) Linked flow 
cytometry data from the same hosts for LZ GC B cells (left) and DZ GC B cells (right).  
Data were combined from 3 independent experiments with 5-6 mice per group. Each pair of symbols 
represents one mouse. Horizontal line represents the median.  
Key: WT: wild type; i.v: intravenously; s.c: subcutaneously; drLN: draining lymph node; GC: 
germinal centre; LZ: light zone; DZ: dark zone. 
Same host compared using Wilcoxon matched-pairs signed rank test *p<0.05; **p<0.01 
a) 
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Figure 4.21: In the draining LN, QM ACKR4
+/+







equally into plasma cells, independently of the host. WT or ACKR4
-/-







 cells from QM ACKR4
+/+
 and same number from QM ACKR4
-/-
 i.v. and immunised 
24 h later with NP-CGG s.c. in the rear feet. The response was studied 8 days post-immunisation in the 
drLN. a) Flow cytometry data, as to the % of transferred cells (left) or % of lymphocytes (right), of 
plasma cells. b) Linked flow cytometry data from the same hosts for plasma cells.  
Data were combined from 3 independent experiments with 5-6 mice per group. Each pair of symbols 
represents one mouse. Horizontal line represents the median.  
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Figure 4.22: Gating strategy for memory B cells after transfer of QM ACKR4
+/+















 cells from QM ACKR4
+/+
 
and same number from QM ACKR4
-/-
 were co-transferred to WT or ACKR4
-/-
 hosts i.v. and 
immunised 24 h later with NP-CGG s.c. in the rear feet. The response was studied 8 days post-
immunisation in the drLN. The figure shows representative diagrams for flow cytometry gating of 




 MBCs and PDL2
+
 MBCs. 
Key: eYFP: enhanced yellow fluorescent protein; i.v: intravenously; s.c: subcutaneously; drLN: 






Figure 4.23: In the draining lymph node, there are more memory B cells when the host 
expresses ACKR4. WT or ACKR4
-/-






 cells from QM 
ACKR4
+/+
 and same number from QM ACKR4
-/-
 i.v. and immunised 24 h later with NP-CGG s.c. in 
the rear feet. The response was studied 8 days post-immunisation in the drLN. a) Flow cytometry 
data, as to the % of transferred cells (left) or % of lymphocytes (right), of memory B cells. b) Linked 
flow cytometry data from the same hosts for MBCs.  
Data were combined from 3 independent experiments with 5-6 mice per group. Each pair of symbols 
represents one mouse. Horizontal line represents the median.  
Key: WT: wild type; i.v: intravenously; s.c: subcutaneously; drLN: draining lymph node; MBC: 
memory B cells. 
Different hosts compared using Mann-Whitney test *p<0.05; **p<0.01 
Same host compared using Wilcoxon matched-pairs signed rank test **p<0.01 
a) 
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Figure 4.24: In the draining lymph node, CD80
+
 memory B cells are reduced in ACKR4
-/- 
memory B cells, independently of the host. WT or ACKR4
-/-







 cells from QM ACKR4
+/+
 and same number from QM ACKR4
-/-
 i.v. and immunised 24 h 
later with NP-CGG s.c. in the rear feet. The response was studied 8 days post-immunisation in the 
drLN. a) Flow cytometry data, in % of MBCs, of CD73
+
 MBCs (upper), CD80
+
 MBCs (middle) and 
PDL2
+
 MBCs (lower). b) Linked flow cytometry data from the same hosts for CD73
+
 MBCs (upper), 
CD80
+
 MBCs (middle) and PDL2
+
 MBCs (lower).  
Data were combined from 3 independent experiments with 5-6 mice per group. Each pair of symbols 
represents one mouse. Horizontal line represents the median.  
Key: WT: wild type; i.v: intravenously; s.c: subcutaneously; drLN: draining lymph node; MBC: 
memory B cells. 
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 MBCs migrate in higher proportion to distant LN 
The above experiments have shown that MBCs appear in higher numbers in distLN in 
mice completely deficient for ACKR4 compared to WT animals (4.2.1). In order to test 
whether MBC migration depends on ACKR4 expression on B cells or in the 
environment, MBC migration was studied in chimeric mice, in which ACKR4 was 
absent either in antigen-specific B cells or in the host environment. Analysis of the 
distLN from the chimeric mice (described in 4.2.4) by flow cytometry was undertaken 8 
days post primary immunisation in the hind feet. Eight days post-immunisation is the 
time when the number of MBCs reach the maximum in the distLN (Fig. 4.1). It is also 
the time when there is the biggest difference between WT and complete ACKR4-





 cells was about 50 times lower than in the drLN. A vast 




) (Fig. 4.25a). It has been 
previously discussed that CD38
+
 cells that express either eYFP or TdTomato cannot be 
naïve B cells as these do not survive for 8 days without encountering antigen (Fig. 
4.17b). 
Contrary to what was seen in the drLN, more MBCs appeared in the distLN when the B 
cells were ACKR4
-/-
. This was independent of whether ACKR4 was expressed in the 
environment or not (Fig. 4.25b). This result indicates that the appearance of elevated 
number of MBCs in the distant LN of Cγ1-Cre mTmG mice completely deficient in 
ACKR4 was due to the absence of ACKR4 on the B cells. To test whether the result is 
an artefact caused by an inhibitory effect due to the expression of TdTomato or eYFP in 
the different MBC populations, the experiment was repeated with the fluorescent 




 populations.  The experiment 
showed that, independent of the fluorescent protein expressed, ACKR4
-/-
 MBCs appear 
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in higher number than ACKR4
+/+
 MBCs in distLN (Fig. 4.25c). Different MBC 
subpopulations in the distLN were analysed on the basis of their expression of CD73, 
CD80 and PDL2 (Fig. 4.26). This analysis showed no significant differences in the 
frequencies of the different MBC subpopulations arriving in distLN. However, a 
reduced number of samples made it difficult to draw any conclusion. There is a 
tendency to a lower frequency of PDL2
+
 MBCs in the distLN when B cells are ACKR4
-
/-
. It is relevant to note that while in the drLN almost 100% of MBCs expressed PDL2, 
only 50-80% expressed PDL2 in the distLN. The frequency of CD80
+
 MBCs had 
increased as to comparing MBCs in the drLN and in the distLN. It is unknown whether 
these MBCs shift PDL2 and CD80 expression during their migration or whether only 
MBCs that express a lower level of PDL2 and/or high level of CD80 are able to migrate 
to distLN. The frequency of CD73
+
 MBCs did not seem to be altered when MBCs in the 
drLN and distLNs were compared. These differences in the frequencies of MBCs 
appearing in distLN can be explained by the selective migration of specific subsets of 





 cells were naïve B cells for the reasons mentioned above (Fig. 
4.17b) and these cells are not GC B cells or PCs, as activation of axillary LNs was not 
observed post-immunisation in the hind feet (Fig. 4.10). 
 




It has been shown that MBCs appear in the blood within one week post-immunisation 
(Blink, Light et al. 2005). Presumably, MBCs leave the drLN via the SCS that 
communicates through the trabecular sinus with the efferent lymphatics (von Andrian 
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and Mempel 2003) from where they transit into the blood circulation. From the blood 
stream they may enter other LNs via HEVs (Rasmussen, Lodahl et al. 2004). Memory T 
cells have been shown to migrate with the same pattern than naïve T cells. Memory T 
cells enter the LNs via HEVs and migrate into the T cell area of LN with similar 
kinetics than naïve T cells. They also enter non-lymphoid organs (Westermann, Ehlers 
et al. 2001). 
Peripheral blood mononuclear cells (PBMC) from chimeric mice (described in 4.2.4) 










), as naïve B cells do not survive for 8 days without antigen 
encounter. In stark contrast to what was observed in drLN, there were significantly 
more MBCs in the blood of ACKR4
-/-
 hosts compared to ACKR4
+/+
 hosts and this was 
not dependent on ACKR4 expression on the antigen-specific B cells (Fig. 4.27b).  
ACKR4
-/-
 hosts had reduced numbers of MBCs in the drLN, independently of the 
genotype of the B cells, compared to ACKR4
+/+
 hosts. However, in the blood of 
ACKR4
-/-
 hosts there were more MBCs, independently of the genotype of the B cells. 
This increased number of MBCs in the blood of ACKR4
-/-
 hosts indicates that the 
reduced number of MBCs in the drLN of ACKR4
-/-
 hosts was not due to deficient 
generation but due to increased exit of MBCs from the drLN, as these MBCs seem to be 
appearing in the blood. This result also agrees with increased migration of MBCs to the 
SCS of ACKR4
-/-
 mice (4.2.3). 
MBCs in ACKR4
-/-
 environment leave the drLN in higher number, as indicated by their 
reduced number in the drLN and their increased number in blood. However, ACKR4
-/-
 






 memory B cells migrate in higher proportion to distant lymph nodes. WT 
or ACKR4
-/-






 cells from QM ACKR4
+/+
 and same 
number from QM ACKR4
-/-
 i.v. and immunised 24 h later with NP-CGG s.c. in the rear feet. The 
response was studied 8 days post-immunisation in distLN. a) Representative diagram for flow 
cytometry gating for memory B cells from distant LN (axillary LN). b) Flow cytometry data, as to the 
% of lymphocytes, of MBCs from distant LN. c) Flow cytometry data, as to the % of lymphocytes, 
linking data points from the same mice. Also, fluorescent proteins were interchanged in order to 
eliminate the possibility of an effect caused by them. 
Data were combined from 3 independent experiments with 5-6 mice per group. Each pair of symbols 
represents one mouse. Horizontal line represents the median.  
Key: WT: wild type; i.v: intravenously; s.c: subcutaneously; distLN: distant lymph node; MBC: 
memory B cell. 






 MBC subpopulations migrate in similar proportions to distant LN. WT or 
ACKR4
-/-






 cells from QM ACKR4
+/+
 and same number 
from QM ACKR4
-/-
 i.v. and immunised 24 h later with NP-CGG s.c. in the rear feet. The response was 





 MBCs (middle) and PDL2
+
 MBCs (lower). 
Plots are representative from 3 independent experiments with 5-6 mice per group. Each pair of 
symbols represents one mouse. Horizontal line represents the median.  
Key: WT: wild type; i.v: intravenously; s.c: subcutaneously; distLN: distant lymph node; MBC: 
memory B cell. 
Same host compared using Wilcoxon matched-pairs signed rank test ***p<0.001 
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Figure 4.27: Memory B cells leave from draining lymph node in higher proportion when the 
host is ACKR4
-/-
. WT or ACKR4
-/-






 cells from QM 
ACKR4
+/+
 and same number from QM ACKR4
-/-
 i.v. and immunised 24 h later with NP-CGG s.c. in 
the rear feet. The response was studied 8 days post-immunisation. a) Representative diagram for flow 
cytometry gating for memory B cells from blood. b) Flow cytometry data, in % of lymphocytes, for 
MBCs from blood. 
Data were combined from 3 independent experiments with 5-6 mice per group. Each pair of symbols 
represents one mouse. Horizontal line represents the median.  
Key: WT: wild type; i.v: intravenously; s.c: subcutaneously; MBC: memory B cell. 
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 B cells are selected negatively when they compete with CCR7
+/+
 B cells 
in WT hosts 
ACKR4 and CCR7 share the ligands CCL19/CCL21. In order to test whether the 
increased migration from drLN of ACKR4
-/-
 hosts is a process that is dependent on 
CCL19/CCL21, the generation and migration of CCR7
-/-
 MBCs was studied. 
The primary response to NP-CGG in the lymph nodes draining the rear feet of chimeric 
mice with NP-specific B cells from QM CCR7
+/+
 and QM CCR7
-/-
 mice into WT hosts 
was studied 8 days post-immunisation. In this series of experiments, B cells could not 
be transferred to CCR7
-/-
 hosts, as they develop defective secondary lymphoid tissues. 
CCR7
-/-
 mice have enlarged spleen with increased number of lymphocytes, 
accumulation of T cells within the red pulp and reduced lymphocyte counts in 
mesenteric LNs (Ohl, Henning et al. 2003). When drLN were analysed, all of the 
populations studied (GC B cells, PCs and MBCs) appeared in lower numbers when the 
transferred antigen-specific B cells were CCR7-deficient (Fig. 4.28a). Despite the lower 
numbers of CCR7
-/-
 cells differentiating, analysis of the frequencies of different B cell 




 population showed that the extent to 
which CCR7
-/-
 B cells differentiated into the different B cell populations was the same 
for PCs and MBCs (Fig. 4.28b). However, CCR7
-/-
 B cells differentiated into GC B 
cells with a lower frequency compared to CCR7
+/+
 B cells. The generally lower 
numbers of CCR7
-/-
 B cells that appeared on day 8 is most likely due to the importance 
of CCR7 during the initial B cell activation, when antigen-activated B cells migrate in a 
CCR7-dependent manner to the border between the follicle and the T zone to interact 
and obtain further activation signals from CD4 antigen-specific T cells (Reif, Ekland et 
al. 2002) (Okada, Miller et al. 2005). The reduced numbers of CCR7
-/-
 antigen-specific 





B cell into the LN through the HEVs. It has been previously shown that CCR7
-/-
 B cells 
bound preferentially to larger HEVs than WT B cells and localised in follicles located 
closer to the LN medullary region, perhaps because they had used CXCR4 for entrance 
(Park, Hwang et al. 2012). After adhesion, WT and CCR7
-/-
 naïve B cells behaved 
similarly and presented same transendothelial migration times (Park, Hwang et al. 
2012). It would be interesting to further investigate if same numbers of WT and CCR7
-/-
 
B cells are present in the LN before immunisation. The similar propensities of the 
different subpopulations to differentiate into PC and MBCs indicate that, if a CCR7
-/-
 B 
cell manages to enter the LN, get activated and enter the GC B cell compartment, CCR7 
has no significant role in the downstream differentiation processes to PC or MBC. 
Moreover, analysis of GC subpopulations showed that CCR7
-/-
 GC B cells entered the 
LZ in a lower frequency than CCR7
+/+
 GC B cells (Fig. 4.29a). The LZ/DZ ratio was 
shifted towards the LZ for CCR7
+/+
 GC B cells while CCR7
-/-
 GC B cells had a ratio 
shifted towards the DZ. When the different MBC subpopulations in the drLN were 
analysed, there was a significant reduction in PDL2
+
 MBCs while no significant 
difference could be observed in the CD73
+
 MBC subpopulation. There was a slight but 
not significant reduction in the CD80
+
 MBC subpopulation (Fig. 4.29c). 
In summary, despite CCR7 being important for initial activation, as demonstrated by a 
generally lower number of CCR7
-/-
 antigen-specific B cells and lower frequency of 
CCR7
-/-
 GC B cells, it does not play a role in the subsequent differentiation into PCs or 
MBCs. These results are in concordance with those observed in ACKR4-deficient 
animals, as ACKR4 expression on B cells did not play a major role in antigen-induced 
B cell differentiation. CCR7
-/-
 GC B cells enter preferentially the DZ GC B cell 
compartment and this is expected as CCR7 is preferentially expressed in LZ GC B cells 
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(Fig. 3.3) and confirms the role of chemokines CCL19/21 in intra-germinal centre 




 MBCs appear in higher proportion in distant lymphoid sites 
To test the migratory capacity of CCR7
-/-
 MBCs, appearance of MBCs was analysed in 
distant LNs of chimeric mice (described in 4.2.7). In the distLN, CCR7
-/-
 MBCs 
appeared in higher proportion than WT MBCs (Fig. 4.30b). Due to the very low 
numbers of MBCs detectable, this difference was not noticeable in the blood (Fig. 
4.30a). CCR7
-/-
 MBCs appeared in higher numbers in the bone marrow (Fig. 4.30c) and 
in the spleen (Fig. 4.30d) 8 days post-immunisation. It is important to note here that the 
number of CCR7
-/-
 MBCs is lower in the drLN compared to CCR7
+/+
 MBCs (Fig. 4.28), 
where these cells are being generated, so an increased appearance of CCR7
-/-
 MBCs in 
distLNs, spleen and bone marrow, implies a major advantage of CCR7
-/- 
MBCs during 
their migration to other sites. It is likely that CCR7 is involved in the exit of MBCs 
from the drLN, as it is unlikely that the entrance to such different microenvironments as 
bone marrow, spleen and LN is controlled by a single receptor. In the bone marrow B 
cells are localised to an extravascular location, recirculate freely and cluster around 
vascular sinusoids (Pillai and Cariappa 2009). Entry into LN is mediated by L-selectin 
binding to ligands on HEV and triggering a chemokine-mediated integrin activation and 
adhesion (Butcher, Williams et al. 1999). Entry into the white pulp of the spleen has 
some redundancies with LNs in terms of integrin involvement, but lymphocytes entry 
the spleen through follicular arterioles that terminate in the marginal zone (van Ewijk 
and Nieuwenhuis 1985). 
178 
 
ACKR4-deficiency in the environment of antigen-specific B cells (destroying the 
CCL19/21 gradient from the T zone to the SCS in the LN) and CCR7-deficiency in the 
antigen-specific B cells themselves (making them irresponsive to CCL19/21) causes the 
same effect on the emigration of MBCs from the drLN. Both increase the emigration of 
MBCs and, therefore, favour MBC appearance in other lymphoid tissues. We 
hypothesise that migration of MBCs from the GC in the B cell follicle centre to the SCS 
is inhibited by CCL19/21 gradient, with the highest concentrations of CCL19/21 close 
to the T zone in the centre of the LN and the lowest in the SCS. When this gradient is 
disrupted or MBCs are CCR7
-/-
, MBCs are able to overcome the CCL19/21 attracting 
effect, migrating to the SCS better and appearing in distant sites in higher number. 
Moreover, ACKR4 has an added effect during entrance of MBCs into distant LN. 
ACKR4
-/-
 MBCs enter in higher frequency to distLN, independently of the presence or 
absence of ACKR4 in the host environment. It is hypothesised that ACKR4
-/-
 MBCs are 
able to bind CCL21-expressing HEV (Carlsen, Haraldsen et al. 2005) better and 
therefore they enter distLN in a higher number. Increased binding to CCL21-HEV and, 
therefore, increased signalling through CCR7, correlates with the effect previously 
described in 3.2.11, where ACKR4
-/-
 B cells showed increased signalling through 
CCR7, including phosphorylation of Akt. However, ACKR4 does not play a role in the 
localisation of MBCs throughout the distLN, as ACKR4
-/-
 MBCs distribute as 
ACKR4
+/+
 in the different zones of the distLN (Fig. 4.10, 4.11). 
 
4.2.9 CCL19/21 do not have a major effect on MBC proliferation 
In order to confirm that the differences observed in the model of double transfer of QM 
CCR7
+/+
 and QM CCR7
-/-
 antigen-specific B cells were due to actual differences in 
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 NP-binding B cells were separately 
transferred to WT hosts. The primary response in drLN to NP-CGG injected into the 
hind feet was studied 8 days later. One hour prior to sacrifice, mice were injected with 
EdU in order to study cell proliferation by flow cytometry. 
Transferred cells in drLN were gated according to the expression of TdTomato 
fluorescent protein and GC B cells, plasma cells and MBCs as previously shown (Fig. 





a reduced proliferation compared to WT B cells. This reduced proliferation correlated 
with reduced CCR7
-/-
 GC B cell numbers and PCs (Fig. 4.28). MBCs (Fig. 4.31c) did 
not show any detectable differences in proliferation. Although MBCs by definition are 
quiescent cells (McHeyzer-Williams, Okitsu et al. 2012), they need T cell help and 
recognition of the antigen to enter cell division and differentiate into effector cells 
(Tangye, Avery et al. 2003), a substantial percentage of the cells here (30%) are still in 
cell cycle, which may reflect their very recent differentiation from GC B cells. This is 
confirmed by their expression of Ki67 (Fig. 4.15b). The absence of differences in MBC 
proliferation between WT, CCR7
-/-
  and ACKR4
-/-
 MBCs in the drLN  makes it unlikely 
that the increased number seen in distLN is due to anything else than an effect on the 
migration of MBCs. 
 
4.2.10 In the draining LN, CCR7
-/-
 MBCs migrate in larger number than CCR7
+/+
 
MBCs to the subcapsular sinus 
The data shown above are compatible with the hypothesis that CCR7
-/-
 MBCs overcome 
the retention by CCL19/21 more easily and migrate better to the SCS. In order to 
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examine the exit of MBCs from the LN into the SCS, numbers of MBCs present in the 
SCS of the drLN of chimeric mice (described in 4.2.9) were quantified by microscopy 
(Fig. 4.32a).  
Transferred antigen-specific B cells can be identified in histology by the expression of 
TdTomato. GCs are formed mainly by antigen-specific transferred cells. Lyve-1 
staining allows the recognition of LECs in the SCS. IgD and CD4 allow the delimitation 
of follicles and T zone, respectively. MBCs were observed sitting in the Lyve-1
+
 SCS, 
as seen previously (Fig. 4.16). Differences between the number of CCR7
-/-
 MBCs and 
WT MBCs that have migrated to the SCS were not statistically significant (Fig. 4.32b). 
However, this result suggests that CCR7
-/-
 MBCs have done better in migrating towards 
the SCS than WT MBCs given the reduced number of CCR7
-/-
 MBCs in the drLN 
compared to WT MBC numbers (Fig. 4.28). Surprisingly, ACKR4
-/-
 MBCs migrated in 
an even higher number to the SCS than CCR7
-/-
 MBCs. This finding indicates that the 
absence of ACKR4 in the MBCs prevents the retention of cells by CCL19/21 gradients. 
A similar effect from B cell intrinsic deficiency and from ACKR4 deficiency in the 
environment on B cell migration appears counterintuitive. A likely explanation is that 
ACKR4 expression on individual B cells creates a microenvironment surrounding the 
cell that enables B cells to sense and be retained by CCL19/21 gradients. A similar 
mechanism of action has been demonstrated for ACKR3 (CXCR7) (Dona, Barry et al. 
2013, Venkiteswaran, Lewellis et al. 2013). During zebrafish embryogenesis, the 
primordium epithelial cells have to migrate collectively along the body of the fish until 
they reach the tip end. ACKR3 expression on the rear primordium reduces the 
concentration of CXCL12 through protein scavenging, generating a gradient of 
CXCL12 that is able to self-direct tissue migration (Dona, Barry et al. 2013, 
Venkiteswaran, Lewellis et al. 2013). 
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 MBCs are present 
in same numbers than WT MBCs in distant LN 
In order to test the consequences of the increased migration of CCR7
-/-
 MBCs towards 
other lymphoid sites to the long-term survival of the MBCs and their response to 
secondary challenges, chimeric mice (described in 4.2.9) were analysed 5 weeks post-
primary immunisation and 5 days post-secondary immunisation.  
In order to establish that the results from the double transfer of WT and ACKR4
-/- 
NP-
specific B cells (4.2.4) or WT and CCR7
-/-
 NP-specific B cells (4.2.7) into WT hosts 
were reproducible by separated transfers, the response was also analysed 8 days post-
immunisation. Transferred cells were gated in base of their expression of the fluorescent 
protein TdTomato (Fig. 4.33). As expected, in the drLN, CCR7
-/-
 MBCs were less 
abundant while numbers of WT and ACKR4
-/-
 MBCs were comparable (Fig. 4.33a). 





 MBCs compared to WT MBCs were not statistically significant 
(Fig. 4.33a). However, these results correlated to those observed previously during the 




 MBCs that had 
migrated into the distLN was comparable, and correlated with the affinity of both 
receptors for the ligands (Forster, Davalos-Misslitz et al. 2008). Interestingly, in the 





 MBC numbers (Fig. 4.33c). This may indicate that distLNs have 
a limited capacity to sustain MBC survival long-term and accumulation of WT MBCs 





have some intrinsic defects that reduce their survival rate. 
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Five weeks after primary immunisation mice were boosted with soluble antigen in the 
contralateral feet in order to stimulate the pLN in the opposite side from the primary 
immunisation. In the contralateral LN, the only cells that will be able to respond to the 
soluble antigen will be the MBCs that have migrated there from the primary response. 
Naïve transferred cells did not survive in the host for 5 weeks without antigen 
encounter. The secondary response was analysed 5 days post-boosting. The gating 
strategy is shown in Fig. 4.34a. There was no significant difference in the numbers of 
GC B cells (Fig. 4.34b left) or plasma cells (Fig. 4.34b right) that had differentiated 
after boosting from each genotype. There was a tendency to higher numbers of CCR7
-/-
 




 MBCs do 
not have any defect or advantage to mount effective secondary responses, compared to 





 MBCs survive to the same extent than WT MBCs 
and absence of CCR7 or ACKR4 expression in MBCs does not have a negative nor 







 B cells are negatively selected when they compete with CCR7
+/+
 B cells in 






 cells from QM CCR7
+/+
 and same 
number from QM CCR7
-/-
  i.v. and immunised 24 h later with NP-CGG s.c. in the rear feet. The 
response was studied 8 days post-immunisation in the drLN. a) Flow cytometry data, as to the % of 
lymphocytes (upper) and % of lymphocytes (lower) with linked data from same host of GC B cells 
(left), plasma cells (middle) and MBCs (right). b) Flow cytometry data, as to the % of transferred cells 
(upper) and % of transferred cells (lower) with linked data from same host of GC B cells (left), plasma 
cells (middle) and MBCs (right). 
Data were combined from 2 independent experiments with 5-6 mice per group. Each pair of symbols 
represents one mouse. Horizontal line represents the median.  
Key: i.v: intravenously; s.c: subcutaneously; drLN: draining lymph node; GC: germinal centre; MBC: 
memory B cell. 
Unlinked data compared using Mann-Whitney test *p<0.05; **p<0.01; ****p<0.0001 






 B cells enter preferentially the DZ when they compete with CCR7
+/+
 B cells 






 cells from QM CCR7
+/+
 and same 
number from QM CCR7
-/-
  i.v. and immunised 24 h later with NP-CGG s.c. in the rear feet. The 
response was studied 8 days post-immunisation in the drLN. a) Flow cytometry data, as to the % of GC 
B cells (upper) and % of GC B cells with linked data from the same host (lower) of LZ GC B cells 
(left), DZ GC B cells (middle) and LZ/DZ ratio (right). b) Flow cytometry data, as to the % of MBCs 







 MBCs.  
Data were combined from 2 independent experiments with 5-6 mice per group. Each pair of symbols 
represents one mouse. Horizontal line represents the median.  
Key: i.v: intravenously; s.c: subcutaneously; drLN: draining lymph node; GC: germinal centre; LZ: 
light zone; DZ: dark zone; MBC: memory B cell.  
Unlinked data compared using Mann-Whitney test *p<0.05  













cells from QM CCR7
+/+
 and same number from QM CCR7
-/-
  i.v. 
and immunised 24 h later with NP-CGG s.c. in the rear feet. The response was studied 8 days post-
immunisation in different secondary organs. a) Representative diagram for flow cytometry gating for 
memory B cells from distant LN for QM CCR7
+/+
 and QM CCR7
-/-
 MBCs (left). Flow cytometry data, 
as to the % of lymphocytes, for MBCs from distant LNs (right). b) Representative flow cytometry 
graph for MBCs from blood (left). Flow cytometry data, as to the % of lymphocytes, of MBCs from 
blood (right). c) Representative flow cytometry graph for MBCs from the bone marrow (left). Flow 
cytometry data, as to the % of lymphocytes, of MBCs from bone marrow (right). d) Representative 
flow cytometry graph for MBCs from the spleen (left). Flow cytometry data, as to the % of 
lymphocytes, of MBCs from spleen (right).  
Data were combined from 2 independent experiments with 5-6 mice per group. Each pair of symbols 
represents one mouse. Horizontal line represents the median.  
Key: i.v: intravenously; s.c: subcutaneously; LN: lymph node; MBC: memory B cell. 




Figure 4.31: CCL19/21 does not have a major effect on memory B cell proliferation. WT hosts 



















 i.v. and immunised 24 h later with NP-CGG s.c. in the rear feet. 
The response was studied 8 days post-immunisation in the drLN. EdU was injected 1 h prior to 
sacrifice. a) Flow cytometry data, as to the % of GC B cells, for EdU
+
 GC B cells. b) Flow cytometry 
data, as to the % of PCs, for EdU
+




1 independent experiment. Each symbol represents one mouse. Horizontal line represents the median.  
Key: i.v: intravenously; s.c: subcutaneously; drLN: draining lymph node; GC: germinal centre; MBC: 
memory B cell; PC: plasma cell; EdU: 5-ethynyl-2′-deoxyuridine. 




Figure 4.32: In the draining lymph node, CCR7
-/-
 memory B cells appear in higher numbers 




















 i.v. and immunised 24 h later with NP-CGG s.c. in the rear feet. The response was studied 
8 days post-immunisation in the drLN. a) Representative example for immunofluorescence staining 
images of drLN for Lyve-1 (green), TdTomato (transferred cells) (red), IgD (grey) and CD4 (blue). 
Yellow arrows denote TdTomato
+
 MBCs that have migrated to the subcapsular sinus. b) 
Quantification, as to the cells per mm of subcapsular sinus, of TdTomato
+
 MBCs that have migrated 
to the subcapsular sinus. 
1 independent experiment. Each symbol represents one mouse. Horizontal line represents the median.  








 MBCs are present in 



















 i.v. and 
immunised 24 h later with NP-CGG s.c. in the rear feet. The response was studied at different times 
post-immunisation. a) The response was studied 8 days post-immunisation. Flow cytometry gating 
example and data, as to the % of lymphocytes, for MBCs from drLN. b) The response was studied 8 
days post-immunisation. Flow cytometry gating example and data, as to the % of lymphocytes, for 
MBCs from distant LNs. c) The response was studied 5 weeks post primary immunisation. Flow 
cytometry gating example and data, as to the % of lymphocytes, for MBCs from distant LNs. 
1 independent experiment. Each symbol represents one mouse. Horizontal line represents the median.  








 memory B cells mount normal secondary responses. WT hosts 



















 and immunised 24 h later with NP-CGG s.c. in the rear feet. 5 
weeks post primary immunisation, mice were boosted in the contralateral footpad with soluble NP-
CGG and the response studied 5 days post-boosting. a) Representative diagram for flow cytometry 
gating of PCs, GC B cells and MBCs. b) Flow cytometry data, as to the % of transferred cells, for GC 
B cells, plasma cells and MBCs from draining LN.  
1 independent experiment. Each symbol represents one mouse. Horizontal line represents the median.  
Key: i.v: intravenously; s.c: subcutaneously; drLN: draining lymph node; GC: germinal centre; MBC: 
memory B cell; PC: plasma cell. 
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4.2.12 Disruption of CCL19/21 gradients in drLN by CCL19 injection causes increased 
MBC migration 
The data shown above have indicated that the increased appearance of CCR7
-/-
 MBCs in 
distant lymphoid sites may be caused through a lack of MBCs being attracted towards 
CCL19/21 gradients in the drLN. Similarly, disruption of the CCL19/21 gradient 
through ACKR4-deficiency in the host environment causes a similar effect. In order to 
further test the role of the CCL19/21 gradient in the drLN, chimeric mice for WT and 
CCR7
-/-
 (described in 4.2.7) were immunised with NP-CGG in the rear feet. In order to 
disrupt the CCL19 gradient, mice were injected with 3 µg of CCL19 or PBS in the same 
feet of immunisation 6 h prior to sacrificing the mice on day 8 post-immunisation. 
It has been shown previously that disruption of the CCL19/21 gradient by CCL21-
overexpression disturbs T cell migration, T cell subpopulations and lymph node 
microarchitecture, demonstrating that chemotaxis caused by CCL19/21 is firmly 
regulated and can be altered easily (Christopherson, Campbell et al. 2001). Injection of 
3 µg of CCL19 is enough to disturb the gradient. Injection of 1 µg of CCL19 s.c. altered 
the regular distribution of CCR7 ligands in the pLN and was enough to modify basal 
CD4
+
 T cell motility from T zones to subcapsular areas (Worbs, Mempel et al. 2007). 
Preliminary experiments showed that the injection of CCL19 24 h prior to sacrifice had 
a profound effect in the GC B cell differentiation and differentiation of PCs and MBCs. 
Both WT and CCR7
-/-
 GC B cell numbers were reduced after CCL19 incubation for 24h 
(Fig. 4.35a). Interestingly, CCL19 injection had an effect in the differentiation of cells 
and after 24 h, PC numbers are increased (Fig. 4.35b) while MBC numbers are reduced 
(Fig. 4.35c) both from the WT and CCR7
-/-
 genotype. Therefore, it is difficult to 
distinguish if the effects observed in appearance of MBCs in distant sites were caused 
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by differences in the migration or in the generation of MBCs. In order to minimise the 
effects of output of MBCs from GCs, a short incubation of 6 h with CCL19 was chosen. 
When the drLNs were analysed by flow cytometry, it could be observed that short term 
administration of CCL19 had no major effects on the number of GC B cells as to the 
percentage of transferred cells (Fig. 4.36a). CCR7
-/-
 GC B cell numbers were reduced in 
both conditions as previously observed (Fig. 4.28). PCs and MBC numbers as to the 
percentage of transferred cells were comparable between genotypes and in both 
conditions (Fig. 4.36b, 4.36c). The expression of Fas by MBCs is a matter of 
controversy in the literature. Fas has been shown to be required for MBC generation 
(Takahashi, Ohta et al. 2001) and in humans, Fas is expressed in activated MBCs 
(Jacobi, Reiter et al. 2008). For this reason, MBCs were gated only in basis of their 
expression of CD38 and negative expression for CD138. As MBCs were not gated 
according to their Fas expression, this gate included also some cells that were 
previously included in the GC B cell gate, making the total of transferred cells higher 
than 100% when GC B cells, PCs and MBCs were added together. 
However, in this particular experiment lower numbers of CCR7
-/- 
NP-specific B cells 
than CCR7
+/+
 NP-specific B cells were transferred. When antigen-differentiated cells 
were analysed as to the percentage of lymphocytes, it was observed that WT B cell 
numbers were at least 5 times higher than CCR7
-/-
 B cells, including GC B cells (Fig. 
4.37a), PCs (4.37b) and MBCs (Fig. 4.37c), while in previous experiments the ratio 
between WT and CCR7
-/-
 B cells in the same host was only double (Fig. 4.28). This 
explains why CCR7
-/-
 appeared in lower numbers than WT MBCs in distLN in control 
conditions (Fig. 4.38). In this experiment, injection of CCL19 led to a strong appearance 
of WT MBCs in the blood (Fig. 4.38a) and in the distLN (Fig. 4.38b), confirming that 
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the disruption of the gradient facilitates the exit of WT MBCs from the drLN. Further, 
the gradient disruption did not have an effect in the CCR7
-/-
 population. However, in the 
spleen (Fig. 4.38c left) and in the bone marrow (Fig. 4.38d right), the effect of the 
CCL19 injection was not detectable. This may be due to an inefficient inhibition by 
CCL19, for example, because higher concentrations are necessary, a different route of 
injection should have been chosen or the incubation period was too short. 
When MBCs that have migrated to the SCS were quantified in immunofluorescence 
images from drLN (Fig. 4.38e), it could be observed that in control conditions, CCR7
-/-
 
MBCs appeared in the SCS to the same extent as WT MBCs or even in higher numbers. 
However, when CCL19 was injected and the gradient disturbed, this scenario was 
reversed and more WT than CCR7
-/-
 MBCs migrated to the SCS. This result supports 
the idea that the body, specifically the drLNs and the SCS, have a limited capacity to 
sustain MBCs and that is why the injection of CCL19 reverses the migration towards 





Figure 4.35: CCL19 injection in the drLN for 24 h affects antigen-stimulated B cell 






 cells from QM CCR7
+/+
 and same 
number from QM CCR7
-/-
 i.v. and immunised 24 h later with NP-CGG s.c. in the rear feet. The 
response was studied 8 days post-immunisation in the drLN. 3 µg of CCL19 were injected in the same 
foot 24 h prior to sacrifice. a) Flow cytometry data, as to the % of transferred cells, for GC B cells. b) 
Flow cytometry data, as to the % of transferred cells, for PCs. c) Flow cytometry data, as to the % of 
transferred cells, for MBCs. 1 independent experiment. Each pair of symbols represents one mouse. 
Horizontal line represents the median.  
Key: i.v: intravenously; s.c: subcutaneously; drLN: draining lymph node; GC: germinal centre; MBC: 
memory B cell; PC: plasma cell; PBS: phosphate buffer saline. 
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Figure 4.36: CCL19 injection in the drLN for 6 h has no effect in antigen-stimulated B cell 






 cells from QM 
CCR7
+/+
 and same number from QM CCR7
-/-
 i.v. and immunised 24 h later with NP-CGG s.c. in the 
rear feet. The response was studied 8 days post-immunisation in the drLN. 3 µg of CCL19 were 
injected in the same foot 6 h prior to sacrifice. a) Flow cytometry data, as to the % of transferred cells, 
for GC B cells. b) Flow cytometry data, as to the % of transferred cells, for PCs. c) Flow cytometry 
data, as to the % of transferred cells, for MBCs. 1 independent experiment. Each pair of symbols 
represents one mouse. Horizontal line represents the median.  
Key: i.v: intravenously; s.c: subcutaneously; drLN: draining lymph node; GC: germinal centre; MBC: 
memory B cell; PC: plasma cell; PBS: phosphate buffer saline 
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Figure 4.37: CCL19 injection in the drLN for 6 h has no effect in antigen-stimulated B cell 




 cells from QM CCR7
+/+
 and QM 
CCR7
-/-
 and immunised 24 h later with NP-CGG s.c. in the rear feet. The response was studied 8 days 
post-immunisation in the drLN. 3 µg of CCL19 were injected in the same foot 6 h prior to sacrifice. a) 
Flow cytometry data, as to the % of lymphocytes, for GC B cells. b) Flow cytometry data, as to the % 
of lymphocytes, for PCs. c) Flow cytometry data, as to the % of lymphocytes, for MBCs. 
1 independent experiment. Each pair of symbols represents one mouse. Horizontal line represents the 
median.  
Key: i.v: intravenously; s.c: subcutaneously; drLN: draining lymph node; GC: germinal centre; MBC: 
memory B cell; PC: plasma cell; PBS: phosphate buffer saline 
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Figure 4.38: CCL19 injection in the drLN affects memory B cell migration to the distant sites. 




 cells from QM CCR7
+/+
 and QM CCR7
-/-
 and 
immunised 24 h later with NP-CGG s.c. in the rear feet. The response was studied 8 days post-
immunisation in distant lymphoid organs. 3µg of CCL19 were injected in the same foot 6 h prior to 
sacrifice. a) Flow cytometry data, as to the % of lymphocytes, for MBCs in distLN. b) Flow 
cytometry data, as to the % of lymphocytes, for MBCs in blood. c) Flow cytometry data, as to the % 
of lymphocytes, for MBCs in the spleen. d) Flow cytometry data, as to the % of lymphocytes, for 





MBCs that have migrated to the subcapsular sinus. 1 independent experiment. Each pair of symbols 
represents one mouse. Horizontal line represents the median.  
Key: i.v: intravenously; s.c: subcutaneously; distLN: distant lymph node; MBC: memory B cell; PBS: 
phosphate buffer saline 
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4.3.1 Memory B cells appear in higher numbers in distant LNs of ACKR4
-/-
 mice 
The results presented in this chapter have shown that the distant LNs of ACKR4
-/-
 mice 
have an elevated number of MBCs. While not obvious at the earliest stages of MBC 
generation (5 days post-immunisation), the effect is clear from day 8 post-
immunisation. In order to track T-dependent MBC generation and migration, the Cγ1-
Cre mTmG mouse model was used where B cells that have interacted with T cells 
express membrane-tethered GFP (Casola, Cattoretti et al. 2006). These include GC B 
cells, GC-derived PCs and MBCs, and also some of the PCs and MBCs that have been 
generated via GC-independent extrafollicular pathway (Y. Zhang, unpublished). 
Elevated numbers of MBCs in the distLNs may be caused by several reasons. 
Alternatives are: (i) increased differentiation into MBCs in ACKR4
-/-
 mice leading to 
generally increased number of MBCs, (ii) increased exit from drLN leading to a larger 
number of circulating MBCs, (iii) increased entrance of recirculating MBCs into 
ACKR4
-/-
 distLNs leading to elevated MBC numbers in distLNs, and (iv) increased 
retention of MBCs in ACKR4
-/-
 distLN leading to higher frequencies of MBCs in 
ACKR4
-/-
 distLNs.  
Increased generation of MBCs in ACKR4
-/-
 mice can be excluded due to the fact that 
drLN of ACKR4
-/-
 mice have a similar number of MBCs to WT mice. An increase in 
exit from the drLN into the recirculating pool is compatible with the observation that in 
the drLN of ACKR4
-/-
 mice, MBCs appear in the SCS at a higher frequency than in WT 
mice.  Increased entrance into the distLN is also compatible with the data obtained in 
complete ACKR4
-/-
 mice. Increased retention in ACKR4
-/-
 distLN can be excluded 





4.3.2 The expression of ACKR4 in the environment retains memory B cells in drLN 
In order to determine if the increased appearance of MBCs in the distLNs of ACKR4
-/-
 
mice was caused by the expression of ACKR4 on the MBCs or on the environment, 
double transfers of NP-specific WT or ACKR4
-/-
 B cells into WT or ACKR4
-/-
 hosts 
were performed.  
Strikingly, MBC numbers were greatly reduced in the draining LN when the host was 
ACKR4
-/-
. In the blood of ACKR4
-/-
 hosts, MBC numbers were increased. Reduced 
numbers in the drLN and increased numbers of MBCs in the blood indicate that when 
ACKR4 is absent from the environment of antigen-specific B cells, MBCs are able to 
leave the drLN in higher number, leading to elevated number in blood and in distLNs.   












 have an intermediate mutation level (Zuccarino-Catania, Sadanand 
et al. 2014). Reduced numbers of CD80
+
 MBCs may indicate that ACKR4
-/-
 MBCs do 
not accumulate as many mutations as WT MBCs due to GC intrinsic effects, but this 
possibility needs to be investigated further. 
On the other hand, in distLN the differences in the number of MBCs were linked to 
ACKR4 expression on antigen specific B cells, and not on the environment. ACKR4
-/-
 
MBCs were present in the distLN in higher number than ACKR4
+/+
 MBCs, 
independently of the genotype of the host. The different ACKR4
-/-
 MBC subpopulations 
migrated in the same percentages to the distLN as the WT MBC subpopulations. 
However, the frequencies of the different MBC subpopulations in the distLN did not 
correlate to those observed in the drLN. The frequency of CD80
+
 MBCs was increased 
and the frequency of PDL2
+
 MBCs was decreased in the distLN compared to the drLN. 
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MBCs are better in seeding GCs (Zuccarino-Catania, Sadanand et al. 2014). This 
dichotomy may explain why in our model there were more PDL2
+
 MBCs and less 
CD80
+
 in the drLN than in the distLN, as CD80
+
 MBCs are more prone to differentiate 
into PCs, so they have to distribute all over the body to fight secondary infections, while 
the more prone to seed GCs would be mainly needed to reconstitute the MBC 
population. This dichotomy may also indicate that the different MBC subpopulations 
have different migratory properties. It has been shown that without re-exposure to 
antigen MBCs do not transform into other subsets (Tomayko, Steinel et al. 2010) so it is 
unlikely that in their migration towards distLN, MBCs shifted their CD80 and PDL2 
expression. CD73
+
 MBCs correspond to the more naïve-like MBCs as they have a low 
level of mutation and are usually not switched (Tomayko, Steinel et al. 2010). In our 
model, CD73
+
 MBCs appeared in distLN in the same frequencies as in the drLN.  
In tumours, ACKR4 expression has been described as a marker with negative 
correlation for metastasis. In a model of breast cancer, ACKR4 expression has been 
linked with reduced metastasis to lymph node and lack of expression correlates with 
lower survival rates. Moreover, ACKR4 sequestrates homeostatic chemokines 
inhibiting intra-tumour neovascularity (Feng, Ou et al. 2009) (Cheng and Hung 2009) 
(Chew, Tan et al. 2013). In colorectal cancer, ACKR4 expression by the tumour 
correlates with reduced metastases and increased patient survival (Zhu, Tang et al. 
2014). In addition, from an analysis of tissues from cervical squamous cell cancer a 
negative correlation between ACKR4 expression with metastases to lymph nodes was 
also observed, as to whether individually expressed or co-expressed with DARC, 
another atypical chemokine receptor (Hou, Liang et al. 2013). There are also 
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contradictory findings about the tumorigenicity of ACKR4-expressing tumours. In an in 
vitro model of mammary carcinoma overexpressing ACKR4 there was an increase in 
spontaneous metastases caused by an enhanced epithelial-mesenchymal transition due 
to their increased invasive and migrating abilities and lower adhesion to the matrix or to 
other tumour cells (Harata-Lee, Turvey et al. 2014). 
Similar to what has been described for the role of ACKR4 in metastasis, our results 
indicate a role for ACKR4 in the emigration of MBCs from their origin of 
differentiation, the drLN. When ACKR4 is absent in the host environment, there is 
more migration leading to more MBCs appearing in distLN, similar to the finding that 
the absence of ACKR4 expression in tumours leads to more metastases. The 
observation that there are more metastases in lymph nodes is also interesting, as MBCs 
according to the experiments described here migrate preferentially to distLN. ACKR4
-/-
 
MBCs are also more prone to enter distLN compared to WT MBCs. 
 
4.3.3 The CCL19/CCL21 gradient retains memory B cells in the follicle of the drLN 
Complete ACKR4 deficiency causes the disruption of CCL19/21 functional gradients, 
as ACKR4 expression in the SCS scavenges CCL19/21, which are produced in the T 
zone creating a gradient from the T zone to the SCS (Ulvmar, Werth et al. 2014). This 
disruption is able to influence DC migration on their entrance from the afferent 
lymphatics towards the T zone. The data presented here are consistent with a role for the 
gradient of CCL19/21 in LNs in the emigration of MBCs from the drLN. Absence of 
the CCL19/21 gradient between the SCS and the follicle in ACKR4
-/-
 mice may be 
affecting MBC positioning within the drLN and migration to the SCS, resulting in 
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increased appearance of MBCs in the SCS and in the blood of ACKR4
-/-
 mice and, 
therefore, increased appearance in distLN.  
Murine ACKR4 binds with high affinity to the homeostatic chemokines CCL19, CCL21 
and CCL25 (Townson and Nibbs 2002). CCL25 binds canonically to CCR9 (Zaballos, 
Gutierrez et al. 1999). As CCR9 is expressed at a low level in lymph nodes (Zaballos, 
Gutierrez et al. 1999) and is not expressed in B cells according to Immgen (Fig. 4.39), it 
was decided to focus on the behaviour of CCR7
-/-
 MBCs to see if CCR7 deficiency in 
antigen-specific B cells results in effects comparable to ACKR4-deficiency. As mice 
completely deficient for CCR7 present profound effects on lymphoid architecture, such 
as lack of defined lymph nodes and mixed white pulps (Forster, Schubel et al. 1999), it 
is impossible to use these CCR7- deficient mice as recipients. Experiments using 
adoptive transfers of NP-specific WT and CCR7
-/- 
B cells competing in WT hosts were 
performed. Eight days post-immunisation, there were fewer CCR7
-/-
 antigen-specific B 
cells in the drLNs, but these cells differentiated to effector cells to the same extent, 
indicating that CCR7-deficiency is unlikely to affect B cell differentiation post-
activation. Intriguingly, in distant lymphoid sites such as distLN, spleen and bone 
marrow, CCR7
-/-
 MBCs appeared in higher numbers than WT MBCs, even though in 
the drLN CCR7
-/-
 MBCs were less abundant. This indicates that CCR7
-/-
 MBCs escape 
from the drLN far better than WT MBCs. The effect is similar to the effect of ACKR4-
deficiency in the B cell environment. Non-responsiveness to CCL19/21 gradients 
(CCR7-deficient B cells) leads to similar results as absence of the gradient (ACKR4-
deficiency in the environment). As the effect of CCR7-deficiency on the emigration on 
MBCs from the drLN has similar effects as ACKR4-deficiency in the B cell 
environment, it is unlikely that the axis ACKR4/CCR9-CCL25 has a major effect on 
MBC emigration from drLNs. 
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This is the first time, to our knowledge, that CCR7 has been shown to be involved in 
cell exit from LNs. In the lung, egress of CD8
+
 T cells has been shown to occur in a 
CCR7-dependent manner. After antigen encounter in a model of influenza virus, CCR7 
is downregulated and CD8
+
 T cell egress is reduced (Jennrich, Lee et al. 2012). CCR7 
has also been linked to the exit of lymphocytes from peripheral tissues and its 
deficiency leads to accumulation of B and T cells in the peritoneal cavities (Hopken, 
Winter et al. 2010). CCR7 deficiency also causes an accumulation of T cells in the 
asthmatic lungs and impaired exit of cells towards the afferent lymphatics (Bromley, 
Thomas et al. 2005) and  a defect in CD4
+
 T cell emigration from the skin (Debes, 
Arnold et al. 2005). Our results agree to some extent with these, as CCR7-deficient 
MBCs accumulate in distant sites, although their egress from these locations has not 
been studied. Five weeks post-primary response CCR7
-/-
 MBCs and ACKR4
-/-
 MBCs 
are contained in the distLNs in the same frequencies than WT MBCs, indicating that 
either secondary lymphoid organs have a limited capacity to sustain MBC survival or 
CCR7
-/-
 MBCs and ACKR4
-/-
 MBCs have intrinsic defects for long-term survival. The 
secondary response of CCR7
-/-
 MBCs and ACKR4
-/-
 MBCs is comparable to WT 
MBCs.  
The results described here support the hypothesis of the existence of a MBC niche that 
is only able to maintain up to a certain number of MBCs. In a system where the total 
number of cells is limited, the ability of cells to survive will depend on their interactions 
with ligands and availability of other resources, which are limited (Agenes, Rosado et 
al. 2000). MBCs have been shown to reside long-term in the spleen as their frequency in 
humans is about 4 times higher than in peripheral blood several decades after 
vaccination (Mamani-Matsuda, Cosma et al. 2008). Some factors have been identified 
as essential for MBC long-term survival, such as Cadherin-17, an adhesion molecule 
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which is expressed in splenic BECs (blood endothelial cells) (Funakoshi, Shimizu et al. 
2015). MBCs express TACI but not BCMA or BAFF-R while their survival and 
function are independent from BAFF and APRIL (Benson, Dillon et al. 2008). On the 
other hand, long-lived PCs downregulate TACI and BR3 expression and upregulate 
BCMA (Goenka, Scholz et al. 2014), which supports the idea that the MBC pool, the 
long-lived PC pool and the naïve pool are maintained in independent niches, as BCMA 
uses APRIL as its primary ligand (Goenka, Scholz et al. 2014). Syk and, therefore, 
BCR, have also been shown to be required for MBC survival (Ackermann, Nys et al. 
2015). PLC-γ2 (phospholipase C γ2), another component of the BCR signalling, has 
also been reported to be essential for MBC generation and maintenance (Hikida, Casola 
et al. 2009). As antigen engagement to the BCR is not necessary for MBC survival 
(Maruyama, Lam et al. 2000), PLC-γ2 and Syk role should be activated through 
signalling to a different cytokine receptor that also signals through BCR-Syk survival 




 MBCs survive at least 5 
weeks post-immunisation, so signalling through the CCL19/21-CCR7 pathway does not 
seem essential for MBC survival. The chemokine receptor CXCR3 has been shown to 
be expressed differentially in IgG
+
 human MBCs, and this expression is maintained 
when these cells differentiate into PCs (Muehlinghaus, Cigliano et al. 2005), 
exemplifying the role of other chemokine receptors in the maintenance of 
immunological B cell memory. 
Mice were injected with CCL19 to test the hypothesis that the presence of the 
CCL19/21 gradient, which is generated by the expression of ACKR4 on the SCS, 
organises MBC emigration from the drLN. The injection of large amounts of chemokine 
in the feet s.c. will drain into the SCS of the pLN and, therefore, increase the chemokine 
concentration in the whole LN, destroying any gradient. CCL19 and CCL21 have 
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similar affinity to CCR7 and there are signalling redundancies when these chemokines 
bind to CCR7, but they can also drive some biased signalling (Hauser and Legler 2016). 
Both CCL19 and CCL21 are able to polarise the actomyosin cytoskeleton, therefore, 
causing cells to migrate along chemokine gradients (Hauser and Legler 2016). CCL19 
causes CCR7 phosphorylation and internalization, which will lead to receptor 
desensitization, while CCL21 does not (Forster, Davalos-Misslitz et al. 2008). CCL21 is 
immobilised to GAGs, via its C-terminus extension of 40 highly charged amino acids, 
induces integrin activation and cell adhesion (Hauser and Legler 2016). The main effect 
we were interested in is cellular migration; CCL19 because of its better solubility was 
chosen to disrupt gradients. 
The presence of large amounts of CCL19 given 8 days post-immunisation did not have 
a noticeable effect on the differentiated B cell populations (GC B cells, PCs, MBCs) 
from WT and CCR7
-/-
 NP-specific B cells in the drLN. Disruption of the gradient had a 
profound effect on the numbers of WT MBCs in the distLN and blood. WT MBCs 
appeared in higher numbers in the blood and in distLN, when the gradient was 
disrupted, while CCR7
-/-
 MBC migration was unaltered. However, no differences were 
observed in the spleen and in the bone marrow. These results correlated and confirmed 
the hypothesis that the gradient of CCL19/21 influences MBC migration towards the 
SCS of the drLN and, therefore, the appearance of MBCs in other lymphoid sites. 
Attempts to bypass the effect of the SCS gradient on the retention of MBCs in the 
drLNs by placing MBCs directly in the blood stream did not produce significant results. 
MBCs were sorted from drLN of WT mice transferred with WT and ACKR4
-/-
 NP-
specific B cells and injected i.v. into naïve WT recipients which were then immunised. 
However, 5 days post-immunisation, barely any transferred cell could be detected by 
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flow cytometry. There are several reasons for this outcome. It is possible that the 











MBCs) was not large enough to cause a strong secondary response. As to other 
examples of attempts to transfer MBCs, investigators have managed to transfer around 
10 times more MBCs per mouse than in our experiments (Zuccarino-Catania, Sadanand 
et al. 2014). It is also possible that the sorting process affected the MBCs negatively, 
making them unable to respond adequately to a secondary stimulus. In addition, it is 
possible that there may be insufficient T cell help for MBC re-stimulation. The 
recipients were not antigen-primed and, therefore, there may not have sufficient 
numbers of pre-stimulated memory T cells available, essential for the induction of a 
secondary response to a TD antigen (Kurosaki, Kometani et al. 2015). Finally, loss of 
the expression of fluorescent proteins is an unlikely explanation, as when MBCs were 
re-stimulated in the same hosts they still expressed comparable levels of fluorescent 
protein than naïve B cells. 
Future experiments should confirm MBC migration in vitro. The migration properties in 
vitro of WT and CCR7
-/-
 MBCs generated in vivo in WT hosts will be studied. Cell 
suspension from drLNs can be stained for GC and PC markers in order to negatively 
distinguish MBCs and their migration pattern is being compared in the presence and 
absence of CCL19 in the medium to further confirm the model for MBC emigration 
from the drLN. 
In summary, the experiments presented here have shown that MBC emigration from 
drLN is dependent on the ability to respond to CCL19/21 gradients. In standard 
conditions there is a CCL19/21 gradient from T zones to the SCS that is generated by 
ACKR4-expression in the SCS. This gradient retains MBCs closer to the GCs in the 
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 MBCs, are able to 
migrate to a higher extent to the SCS leading to higher number of MBCs at distant sites. 
When the CCL19/21 gradient is absent, either due to ACKR4-deficiency in the 
environment or due to artificial CCL19-injection, the anchor that was retaining MBCs is 
lost and MBCs migrate to the SCS in a higher frequency, independently of their 
genotype. 
It has also been demonstrated that the entrance of MBCs into distLN is also ACKR4-
dependent. In this situation ACKR4-deficiency in B cells correlates with a higher 
entrance into distLN, probably due to an increased adhesion to CCL21-expressing HEV 
(Carlsen, Haraldsen et al. 2005).  
CCR7-expression is essential for B and T lymphocyte entry into lymph nodes in 
homeostatic conditions (Okada, Ngo et al. 2002). Therefore, it is plausible that in order 
to leave drLNs as a MBC these cells need to loose responsiveness to CCR7-ligands. 
CCL21 has been shown to act as a homing chemokine for lymphocytes from tissues into 
draining lymphatics through its expression in lymphatic endothelium (Gunn, 
Tangemann et al. 1998). Moreover, cytokine-activated lymphatic endothelial cells 
(LECs) bind lymphocytes in vitro so they may be capable of influencing cell entry into 
the lymph (Young, Marston et al. 2000). Therefore, MBCs may be able to bind LECs on 
their way out of drLN, which is comparable to naïve lymphocytes binding LECs on 
their way in. Chemokinesis to certain locations in tissues is the result of a balance of 
attractive and retentive signals. The factors that attract MBCs to the SCS, counteracting 




Figure 4.39: CCR9 is not expressed in B cells. Ccr9 gene expression in the haematopoietic cells 
as revealed from the Immgen database. 
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Chapter 5. Conclusions 
Activated B cells migrate to the T zone – B follicle interphase, where they receive 
positive signals from antigen-specific CD4
+
 T cells (MacLennan, Toellner et al. 2003). 
These activated B cells will follow one of three pathways (Sagaert, Sprangers et al. 
2007). Some will join the extrafollicular plasma cell foci, which will secret non-mutated 
low-affinity antibody. Others will become GC-independent MBCs. Some activated B 
cells will re-enter the follicle to form germinal centres and undergo extensive 
proliferation. The GC is the hallmark of a TD response and is divided into two distinct 
zones: the light zone and the dark zone. In the LZ, Tfh-dependent selection occurs and 
in the DZ, GC B cells proliferate and diversify their Ig variable genes, through somatic 
hypermutation (MacLennan 1994) (Victora and Nussenzweig 2012). GC B cells 
recirculate between the DZ and LZ in a chemokine-dependent manner. GC B cells in 
the DZ express more CXCR4 while LZ GC B cells tend to express more CXCR5 
(Allen, Ansel et al. 2004). The responsiveness of GC B cells to chemokines and other 
factors needs to be tightly regulated in order to coordinate proliferation, selection and 
further differentiation into high-affinity plasma cells or memory B cells. The signals 
that regulate the differentiation of PCs and MBCs from GC B cells are far from being 
fully understood.  
The data presented here identify a role for the chemokines CCL19/CCL21 in the later 
stages of the GC response. Deficiency of the CCL19/CCL21-scavenging receptor 
ACKR4, which is specifically expressed on GC B cells, causes dysregulation in the 
LZ/DZ distribution, with smaller DZ and larger LZ areas. This dysregulation is caused 
by increased activation of the downstream signalling components of CCR7, as there is 
more ligand binding to this receptor when ACKR4 is absent (Fig. 5.1). Downstream 
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signalling components include p-Akt and c-Myc. The role of c-Myc in the GC has been 
controversial, as GCs express a low level of c-Myc in comparison to the surrounding 
tissues (Klein, Tu et al. 2003). However, c-Myc is essential for the formation and 
maintenance of GCs. GCs have a cyclic dependence on c-Myc for proliferation; LZ GC 
B cells transiently express c-Myc when they interact with T cells and this expression 
triggers proliferation and re-entry into the DZ (Calado, Sasaki et al. 2012) (Dominguez-
Sola, Victora et al. 2012). ACKR4-deficiency specifically in the GC B cells increases 
their expression of c-Myc and retains GC B cells in the LZ, preventing them from 
accessing the DZ. These data correlate with a low expression of ACKR4 in the c-Myc
+
 
GC B cells, while the c-Myc
-
 population expresses higher levels of ACKR4. 
Upregulation of ACKR4 expression after c-Myc trigger would facilitate c-Myc 
downregulation and therefore, re-entry into the DZ area (see Figure 5.1). 
On the other hand, ACKR4 is also expressed in a layer of stromal cells that surrounds 
the marginal zone in the spleen and in LECs that are present in the subcapsular sinus of 
the lymph node (Ulvmar, Werth et al. 2014). ACKR4 expression at this location creates 
a gradient of CCL19/21 from the T zone to the SCS and helps to maintain GC shape, as 
mice deficient for ACKR4 present GCs with fuzzy perimeters and infiltration of naïve B 
cells into the GC area. Uniform concentrations of CCL19/21 in the GC may attract 
naïve B cells into the GC area and therefore increase their infiltration (Fig. 5.1).  
The skewed LZ/DZ distribution, with enlarged LZ in ACKR4
-/-
 mice, appears to have 
consequences on the differentiation of GC B cells into MBCs as ACKR4-deficient 
antigen-specific B cells form reduced numbers of CD80
+
 MBCs within the drLN. CD80
 
is a marker for MBCs that have been longer in the GC and, therefore, accumulated more 
mutations (Zuccarino-Catania, Sadanand et al. 2014). Although overall MBC numbers 
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are not changed by ACKR4-deficiency, an inability of ACKR4-deficient GC B cells to 
cycle back into the DZ should prevent the accumulation of mutations and, therefore, the 
appearance of CD80
+
 MBCs.  
When GC B cells differentiate to MBCs and PCs, they need to change their 
responsiveness to chemokines in order to be able to leave the GC and home to their 
respective niches. While PC migration to the bone marrow is well-understood, MBC 
migration is less clear. MBCs have shown to appear in blood and remote LNs from one 
week post-immunisation (Blink, Light et al. 2005), although the route they follow 
within the LN and from the LN into the circulation is not clear.  Data first produced by 
Y. Zhang (Fig. 4.13) have led to the proposal that MBCs migrate to the SCS from where 
they are able to distribute through lymph and blood to other lymphoid organs. The 
results presented in this thesis show that this migration towards the SCS is dependent on 
the ability to overcome the attraction of CCL19/CCL21 generated in the centre of the 
LN and are consistent with a role for this gradient in the exit of MBCs from the drLN. 
CCL19/CCL21 are produced in the T zone and ACKR4 expression in the SCS causes a 
gradient of CCL19/CCL21 from the T zone to the SCS that can influence cell migration 
(Ulvmar, Werth et al. 2014). ACKR4-deficient mice have elevated numbers of MBCs in 
the distant LNs. This is due to two steps during the migration of MBCs: the exit of 
MBC from the drLN is governed by the expression of ACKR4 in the LECs of the SCS. 
ACKR4
-/-
 mice have less MBCs in the drLN and more in the blood, indicating that 
MBCs are able to escape the LN easier when ACKR4 is absent from the SCS. 
Accordingly, MBCs reach the SCS of reactive LN more easily. The second step is the 
entrance of MBCs into the distLN, which is governed by the expression of ACKR4 on 
the MBCs themselves. ACKR4
-/-
 MBCs enter into the distLN better than WT MBCs 
independent on the expression of ACKR4 in the LN environment. Further evidence for 
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 MBCs also appear in higher frequencies than WT MBCs in the 
distant lymphoid sites, including bone marrow and spleen. Artificial disruption of the 
CCL19/CCL21 by injection of an antagonistic amount of CCL19 in the drLN affects the 
migration of WT MBCs whilst migration of CCR7
-/-
 MBCs is unaffected. 
Chemokinesis in a specific direction is the response to a balance of signals coming from 
different directions. While it has been shown here that responsiveness to CCL19/CCL21 
retains MBCs closer to the GCs in the drLN, there must be other signals that actively 
attract migrating MBCs to the drLN periphery and the SCS. These chemotactic factors 
able to override the retention signals from CCL19/CCL21 gradients on MBCs are not 






Figure 5.1: Graphic representation for the effects of ACKR4 on the GC response. The left 
side of the figure shows a GC in a drLN of an immunised ACKR4
+/+
 mice. The right side shows 
an ACKR4
-/-
 GC. After Tfh selection, centrocytes upregulate c-Myc, which triggers 
proliferation and migration back to the DZ. In WT mice, ACKR4 is upregulated in centroblasts 
and facilitates c-Myc downregulation by reducing the signalling through CCR7-p-Akt-c-Myc 
signalling pathway. In ACKR4
-/-
 mice, the deficiency of ACKR4 prevents the downregulation 
of c-Myc and therefore, centrocyte recirculation into the DZ, leading to enlarged LZ areas and 
reduced DZ areas. ACKR4
-/-
 GCs show fuzzy perimeters due to infiltration of IgD
+
 B cells in to 
the GC area. This effect is dependent on the expression of ACKR4 by the GC environment. 





Figure 5.2: Graphic representation for the effects of ACKR4 on MBC migration. The main part 
of the figure (a) represents the drLN, the upper (b) part shows a distLN. a) The left side of the figure 
represents a drLN from an immunised ACKR4
+/+
 mice, the right side shows an ACKR4
-/-
 drLN. Blue 
arrows indicate that MBCs leave the GC from the LZ and migrate towards the SCS. ACKR4 
expression in the SCS creates a gradient of CCL19/21. In WT mice, MBCs are retained in the follicles 




 MBCs are not retained because CCR7 as well as 
ACKR4 facilitate chemoattraction by CCL19/21. Also in complete ACKR4
-/-
 mice, MBCs are not 
retained in follicles due to the absence of the CCL19/21 gradient letting MBCs reach the SCS more 





 MBCs appear in higher numbers than WT MBCs, and this is independent of ACKR4 
expression in the environment. MBCs distribute preferentially into the follicles and lymphatic vessels. 
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